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Articular cartilage which covers the surfaces of synovial joints is designed to 
allow smooth contact between long bones and to absorb shock induced during joint 
movement. Tissue engineering, a means of combining cells, biomaterials, bioreactors and 
bioactive agents to produce functional tissue replacements suitable for implantation, 
represents a potential long-term strategy for cartilage repair. The interplay between 
environmental factors, however, gives rise to complex culture conditions that influence 
the development of tissue-engineered constructs. A fibrous capsule that is composed of 
abundant type I collagen molecules and resembles fibrocartilage usually forms at the 
outer edge of neocartilage, yet the understanding of its modulation by environmental cues 
is still limited. Therefore, this dissertation was aimed to characterize the capsule 
formation, development and function through manipulation of biochemical parameters 
present in a hydrodynamic environment while a chemically reliable media preparation 
protocol for hydrodynamic cultivation of tissue-engineered cartilage was established. To 
this end, a novel wavy-wall bioreactor (WWB) that imparts turbulent flow-induced shear 
stress was employed as the model system and polyglycolic acid scaffolds seeded with 
bovine primary chondrocytes were cultivated under varied biochemical conditions.  
The results demonstrated that tissue morphology, biochemical composition and 
mechanical strength of hydrodynamically engineered cartilage were maintained as the 
serum content decreased by 80% (from 10% to 2%). Transient exposure of the low-serum 
constructs to exogenous insulin-like growth factor-1 (IGF-1) or transforming growth 
factor-β1 (TGF-β1) further accelerated their development in comparison with continuous 
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treatment with the same bioactive molecules. The process of the capsule formation was 
found to be activated and modulated by the concentration of serum which contains 
soluble factors that are able to induce fibrotic processes and the capsule development was 
further promoted by fluid shear stress. Moreover, the capsule formation in hydrodynamic 
cultures was identified as a potential biphasic process in response to concentrations of 
fibrosis-promoting molecules such as TGF-β. Comparison between the capsule-
containing and the capsule-free constructs, both of which had comparable tissue 
properties and were produced by utilizing the WWB system in combination with IGF-1 
and TGF-β1, respectively, showed that the presence of the fibrous capsule at the 
construct periphery effectively improved the ability of engineered cartilage to integrate 
with native cartilage tissues, but evidently compromised its tissue homogeneity. 
Characterization of the fibrous capsule and elucidation of the conditions under 
which it is formed provide important insights for the development of tissue engineering 
strategies to fabricate clinically relevant cartilage tissue replacements that possess 
optimized tissue homogeneity and properties while retaining a minimal capsule thickness 







 Articular cartilage is a white, flexible connective tissue that is found at the ends of 
bones in synovial joints. It contains sparse cells called articular chondrocytes and a well-
organized extracellular matrix (ECM) primarily composed of collagens (mainly type II 
collagen), proteoglycans and water which come together to form a smooth, resilient layer 
that protects the underlying subchondral bones from external loading. The ability of 
articular cartilage to resist tensile forces is attributed to the presence of collagen fibrils 
within the tissue, which construct a highly cross-linked solid framework. Proteoglycans 
that contain negatively charged glycosaminoglycan (GAG) branches are encapsulated in 
the established collagen network and interact with water molecules to provide the tissue 
with its compressive strength. The combination of both solid and fluid constituents 
allows articular cartilage to bear shearing loads.  
Several causes such as aging, disease, mechanical injury and immobilization can 
trigger cartilage degeneration leading to pain, stiffness and swelling of joints. The lack of 
blood vessels in articular cartilage, however, largely limits the tissue’s ability to repair 
itself. In addition, delay in diagnosis and treatment usually due to the aneural nature of 
cartilage may give rise to severe joint damage (Brown, Johnston et al. 2006). Depending 
on the severity of the defect, several therapeutic approaches aimed to repair or restore 
cartilage functions have been developed, such as microfracture, cell and tissue graft 
transplantation and total joint replacement (Brittberg, Lindahl et al. 1994; Hangody, Kish 
et al. 1998; Kish, Módis et al. 1999; Andres, Mears et al. 2001; Hangody, Feczkó et al. 
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2001; Sgaglione, Miniaci et al. 2002; Bos and Ellermann 2003; Hand, Lobo et al. 2003; 
Huntley, Bush et al. 2005; Jakobsen, Engebretsen et al. 2005; Saris, Vanlauwe et al. 2008; 
Ronn, Reischl et al. 2011). While there has been some success in short-term treatment of 
cartilage lesions, long-term cartilage restoration remains elusive (Nerem and Sambanis 
1995; Temenoff and Mikos 2000), suggesting that these methods are unable to replicate 
intact native cartilage.  
Tissue engineering techniques hold promise for development of functional tissue 
substitutes and thereby offer a potential long-term solution to cartilage degeneration. 
Typically, tissue-engineered constructs are assembled by encapsulating cells into 
biodegradable or biocompatible substrates and are grown ex vivo within a chemically and 
mechanically defined culture environment for a certain period of time. In order to 
fabricate tissue replacements suitable for implantation, engineered grafts must satisfy 
specific functional criteria related to their mechanical properties, biochemical 
composition, tissue ultrastructure, immunological compatibility and integration capability. 
Recent efforts to design and utilize novel biomaterials and bioreactor systems in 
combination with various cell sources and growth factors have made significant advances 
in cartilage tissue engineering (Temenoff and Mikos 2000; Darling and Athanasiou 2003; 
Chung and Burdick 2008; Nisbet, Forsythe et al. 2009; Mathieu and Loboa 2012), yet 
engineered constructs that resemble articular cartilage in all aspects have not been 
achieved. Thus, many challenges still need to be addressed. Examples include how to 
facilitate functional maturation of constructs by efficiently increasing synthetic activities 
of encapsulated cells and how to engineer constructs with ultrastructure, such as collagen 
organization and orientation, similar to that of native cartilage. It is also necessary to 
3 
 
broaden our limited understanding of the complex interplay between mechanical stimuli 
and bioactive molecules that are sensitive to such stimuli in neocartilage formation 
through the development of bioreactor systems that imparts different physical 
stimulations such as compressive (Steinmeyer and Knue 1997; Mauck, Soltz et al. 2000; 
Davisson, Kunig et al. 2002; Kisiday, Jin et al. 2004; Waldman, Spiteri et al. 2004) and 
shear (Jin, Emkey et al. 2003; Waldman, Spiteri et al. 2003) deformation, hydrostatic 
pressure (Hall, Horwitz et al. 1996; Smith, Rusk et al. 1996; Smith, Trindade et al. 2000; 
Elder and Athanasiou 2009) and hydrodynamic forces (Vunjak-Novakovic, Martin et al. 
1999; Martin, Obradovic et al. 2000; Pazzano, Mercier et al. 2000; Emin, Koç et al. 
2008). This knowledge will be beneficial in order to optimize the bioprocessing 
conditions for in-vitro cultivation of tissue-engineered constructs. 
 In natural and reparative healing processes, articular cartilage defects are usually 
reconstructed with fibrocartilage or scar tissues composed of a large content of type I 
collagen as opposed to type II found in normal cartilage (Shapiro, Koide et al. 1993; 
Andres, Mears et al. 2001; Knutsen, Engebretsen et al. 2004; Ronn, Reischl et al. 2011). 
Although the formation of fibrocartilage at the injury or integration site alleviates pain 
and swelling of joints, fibrocartilage is mechanically weaker than healthy articular 
cartilage (Knutsen, Engebretsen et al. 2004; Khan, Gilbert et al. 2008). Inhomogeneity of 
mechanical strength across the regenerated tissue can lead to at least three types of 
disruption within the tissue or at the integration site, i.e. opening, in-phase shear and out-
of-phase shear fracture (Ahsan and Sah 1999), and recurring tissue degeneration may 
occur (Shapiro, Koide et al. 1993; Khan, Gilbert et al. 2008). To overcome this hurdle, 
implanted grafts must have tissue morphology and functional properties comparable to 
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those of the surrounding host cartilage. Additionally, newly synthesized ECM at the 






Figure 1.1 Characterization of a fibrous capsule in tissue-engineered cartilage. (A) 
Immunohistochemical staining of type I collagen (dark). (B) Histological staining of 
GAG (red) and cytoplasm (green). The capsule contains an increased chondrocyte 
population and a decreased GAG content. Adapted and modified from (Kisiday, Kurz et 





 A unique structure which resembles the matrix composition of fibrocartilage is 
observed at the periphery of tissue-engineered cartilage (Vunjak-Novakovic, Freed et al. 
1996; Kisiday, Kurz et al. 2005; Bueno, Bilgen et al. 2008; Kelly, Fisher et al. 2008). 
This fibrous cell outgrowth also referred to as the capsule consists mainly of type I 
collagen and is characterized by increased cell density and decreased (virtually none) 
GAG deposition (Figure 1.1). It is believed that the formation of a fibrous capsule is 
attributed to the direct contact of chondrocytes with medium supplements, such as 
platelet-derived growth factor (PDGF) and transforming growth factor-β (TGF-β), which 
induce and promote fibrotic processes (Ignotz and Massagué 1986; Lohmann, Schwartz 
et al. 2000; Kelly, Fisher et al. 2008). Interestingly, a structurally well-organized capsule 
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is commonly present at the periphery of constructs cultivated under continuous fluid 
shear conditions (Tsao and Gonda 1999; Vunjak-Novakovic, Martin et al. 1999; Bueno, 
Bilgen et al. 2005; Bueno, Bilgen et al. 2008). Vunjak-Novakovic and coworkers 
suggested that when chondrocytes are directly exposed to fluid flow, they tend to deform 
into a flattened, elongated fibroblast-like shape and thereby synthesize a matrix with 
increased type I collagen, but decreased GAG contents, which promotes the formation of 
a solid fibrous capsule (Vunjak-Novakovic, Freed et al. 1996). Nevertheless, the factors 
that drive and/or modulate the capsule formation and the roles of the capsule in cartilage 
tissue development and integration have not been fully understood. 
 Taken together, the objective of this project was to evaluate the combined effects 
of fluid shear stress and soluble biochemical factors on the capsule formation while a 
chemically reliable low-serum medium supplemented with shear-sensitive growth factors 
was developed for hydrodynamic cultivation of tissue-engineered cartilage. A custom-
designed wavy-walled bioreactor (WWB) system (Chapter 2.3.2.5) was employed to 
provide a turbulent flow-induced shear environment for neocartilage development. 
Moreover, the influence of a fibrous capsule on tissue homogeneity of engineered 
cartilage and on construct integration with native cartilage tissues was also elucidated. 
Our central hypothesis was that tissue properties and morphology of engineered cartilage 
constructs can be modulated through manipulation of environmental factors, i.e. 
hydrodynamic forces and soluble biochemical cues in this dissertation work. The 




Specific Aim 1: Develop a low-serum culture medium for hydrodynamic cultivation 
of tissue-engineered cartilage 
Fetal bovine serum (FBS) provides a variety of nutrients that are essential for cell 
growth and has widely been utilized in cell and tissue culture. However, its varied 
composition composed of undefined constituents can significantly affect experimental 
results and the use of high serum contents may reduce the clinical relevance of the 
outcome. It has recently become a practice to replace FBS either partially or completely 
with serum substitutes such as Nutridoma (Glowacki, Yates et al. 2005) and insulin-
transferrin-selenium (ITS) (Kisiday, Jin et al. 2004; Bian, Lima et al. 2008; Kelly, Fisher 
et al. 2008; Gigout, Buschmann et al. 2009)  in order to establish a chemically reliable 
culture environment. Therefore, the objectives of this aim were to examine the feasibility 
of reduced FBS contents (0%, 0.2% and 2%, v/v) in combination with ITS (1%, v/v) to 
support the development of chondrocyte-seeded polyglycolic acid (PGA) scaffolds 
cultivated under static or hydrodynamic conditions and to investigate the synergistic roles 
of continuous fluid shear stress and serum in the capsule formation. The results were 
compared with the traditional high-serum (10% FBS, v/v) cultures. 
FBS contains growth factors that are sensitive to mechanical forces. For example, 
the signaling pathways of TGF-β (Ohno, Cooke et al. 1995; Sakai, Mohtai et al. 1998; 
Negishi, Lu et al. 2001; Malaviya and Nerem 2002), insulin-like growth factor-1 (IGF-1) 
(Jin, Emkey et al. 2003; Kapur, Mohan et al. 2005; Lau, Kapur et al. 2006) and bone 
morphogenetic protein (BMP) (Lau, Kapur et al. 2006) are known to be responsive to 
shear stress, suggesting that these bioactive agents may play a more critical role in 
hydrodynamic cultures than in static cultures and can interact synergistically with shear 
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forces to further accelerate functional maturation of engineered tissues. Thus, we 
hypothesized that a minimal content of shear-sensitive soluble molecules present in 
serum is required in cultures supplemented with ITS in order to produce 
hydrodynamically engineered constructs morphologically, compositionally and 
mechanically similar to the high-serum constructs. In addition, because FBS also contains 
fibrosis-promoting molecules such as TGF-β (O'connor-Mccourt and Wakefield 1987) 
and PDGF (Childs, Proper et al. 1982), we hypothesized that the thickness of a fibrous 
capsule at the construct periphery increases with increasing serum concentration used in 
culture. Chapter 3 describes the details of this study. 
 
Specific Aim 2: Determine the effects of transient exposure to exogenous IGF-1 and 
TGF-β1 on hydrodynamic cultivation of tissue-engineered cartilage 
Expression and production of shear-sensitive growth factors by cells increase 
when the cells are exposed to fluid shear stress (Ohno, Cooke et al. 1995; Sakai, Mohtai 
et al. 1998; Negishi, Lu et al. 2001; Lau, Kapur et al. 2006), which potentially provides 
an endogenous source to support neocartialge development. Therefore, the objective of 
this aim was to evaluate the effects of transient supplementation of exogenous growth 
factors on tissue properties and morphology of engineered cartilage cultivated under 
hydrodynamic stimuli. To this end, the low-serum culture medium developed in Specific 
Aim 1 was further supplemented with TGF-β1, a fibrosis-promoting factor, or IGF-1, a 
non-fibrosis-promoting factor, both of which have been extensively used in cartilage 
tissue engineering. For each growth factor, a minimal concentration was selected from 
their most commonly reported ranges of effective doses for neocartilage cultivation (IGF-
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1: 100-300 ng/mL; TGF-β1: 10-30 ng/mL (Blunk, Sieminski et al. 2002; Pei, Seidel et al. 
2002; Mauck, Nicoll et al. 2003)) and was applied either for the first two weeks of the 
culture (transient supplementation) or throughout the entire 4-week cultivation 
(continuous supplementation). The hypotheses were that (1) hydrodynamically 
engineered constructs continuously nourished with exogenous growth factors do not 
necessarily exhibit improved tissue properties over constructs transiently treated with the 
same bioactive molecules and (2) engineered constructs nourished with a fibrosis-
promoting molecule, i.e. TGF-β1 in this study, will form a thicker fibrous capsule 
compared with the untreated ones. The framework and the outcome of this study are 
detailed in Chapter 4. 
 
Specific Aim 3: Determine the role of the fibrous capsule in the development of 
tissue-engineered cartilage cultivated under hydrodynamic stimuli 
In Specific Aim 2, treatment with different exogenous growth factors yielded 
hydrodynamically engineered cartilage with divergent tissue morphologies. Specifically, 
constructs nourished with IGF-1 retained a solid fibrous capsule whereas exposure to 
TGF-β1 eliminated the capsule formation regardless of the duration of the 
supplementation. Based on the distinguishable tissue morphologies, we hypothesized that 
the capsule-containing (IGF-1) constructs exhibit compromised tissue homogeneity and 
have a less strong inner core compared with the capsule-free (TGF-β1) constructs. To test 
this hypothesis, a central core was punched out of each of the 4-week constructs and 
tissue homogeneity was determined by evaluating radial variations in tissue properties 
(inner core versus outer annulus). Furthermore, the ability of the intact hydrodynamic 
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neocartilage with or without a fibrous capsule to integrate with native cartilage tissues 
was also assessed using an in-vitro cartilage explant model. The detailed experimental 
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2.1 Articular Cartilage 
2.1.1 Composition and Mechanical Properties 
Articular cartilage is a lubricant substrate that serves as a cushion between the 
bones of diarthrodial joints. The main function of articular cartilage is to provide a 
smooth medium for force transfer between long bones; therefore, its tough, but resilient 
structure is designed to endure constant cyclic loading and to further protect the 
underlying bones. Structurally, articular cartilage has no nerves and blood vessels and 
consists of 65‒80 wt. % of water, 10‒20 wt. % of collagen fibrils and 5‒10 wt. % of 
proteoglycans (Kuettner 1992; Cohen, Foster et al. 1998). Very few cells, called articular 
chondrocytes, reside in the cartilage tissue and secrete a matrix primary of collagen and 
proteoglycan (Figure 2.1). Type II collagen, a triple helix made up of three identical 
polypeptide chains, contributes about 95% of the total collagen content within articular 
cartilage (Cole and Malek 2004). These collagen fibrils form a highly cross-linked 
network to establish a well-organized extracellular architecture and thereby grant 
cartilage tensile strength (20 MPa). Aggrecan containing branched negatively charged 
GAG molecules is the predominant proteoglycan in articular cartilage and is encapsulated 
in the collagen mesh. As a result, the trapped negatively charged components create a 
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repelling force and recruit massive water molecules, together which generate a high 
swelling pressure against external compressive loading (0.5‒1 MPa). The shear capability 
(10 MPa) of articular cartilage is attributed to a combination of both solid and fluid 
constituents. Taken together, the mechanical behavior of articular cartilage is modulated 
by three major factors: (1) elasticity of the solid matrix, (2) swelling property of the ionic 
elements and (3) solid-fluid interactions. 
 
2.1.2 Zonal Organization 
Articular cartilage is an anisotropic material made up of four distinct zones along 
the depth of the tissue. From the articular surface to the subchondral bone, these zones 
are the superficial (tangential) zone, the middle zone, the deep zone, and the calcified 
zone (Figure 2.1). The middle zone (40-60% of the cartilage thickness) is the thickest 
layer in articular cartilage, followed by the deep zone (30% of the cartilage thickness) 
and then the superficial zone (10-20% of the cartilage thickness). The calcified layer is 
extremely thin and lies between the deep zone and the subchondral bone to separate 
articular cartilage from bone, and only very few and small chondrocytes reside in this 
area. Matrix compositions and organizations are quite different in each zone (Jeffery, 
Blunn et al. 1991; Hwang, Li et al. 1992; Cohen, Foster et al. 1998; Temenoff and Mikos 
2000). Specifically, the superficial zone contains the lowest content of proteoglycans and 
the highest amount of water while thin collagen fibrils are aligned in the same direction 
as the articular surface. Abundant flattened chondrocytes are found in this region with 
their long axes parallel to the joint surface. More rounded chondrocytes occupy the 
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middle zone composed of more proteoglycans, less water and fewer, but thicker collagen 
fibrils  
 
Figure 2.1 Ultrastructure (A) and microstructure (B) of articular cartilage. 





whose orientation is nearly random. The deep zone is comprised of the highest content of 
proteoglycans, the least water and the largest collagen fibrils that are vertically arranged. 
Within the deep zone, chondrocytes are rounded and stacked along the thickness of the 
tissue. Amongst all the layers, chondrocytes within the middle and the deep zones 
possess higher ECM synthetic activities than those in the superficial zone (Hidaka, Cheng 
et al. 2006) while the deep zone exhibits the strongest mechanical strength (Klein, 
Chaudhry et al. 2007). 
 
2.1.3 Cartilage Mechanics 
At rest, the synovial fluid transmits hydrostatic pressure to the interstitial water 
within the cartilage matrix. During normal ambulation, articular cartilage undergoes 
direct compression thousands of times each day without causing damage. Under a 
loading period, deformation of cartilage results in changes in environmental conditions 
experienced by chondrocytes, such as matrix organization, tissue permeability and water 
content within the tissue (Grodzinsky, Levenston et al. 2000). When cartilage is 
compressed, water molecules tend to escape from the tissue, yet they cannot instantly 
leave the tissue due to the reduced permeability such that the interstitial fluid absorbs the 
majority of mechanical energy and becomes pressurized. As the fluid eventually exits the 
matrix into the synovial cavity, the gaps in the collagen network shrink and GAG 
molecules are thereby in closer proximity, producing stronger resistance against 
compression. The movement of the interstitial fluid precipitates several events. For 
instance, transient fluid flow generates shear stress that not only directly acts on cells but 
activates some latent bioactive agents such as transforming growth factor-β (TGF-β) 
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(Ahamed, Burg et al. 2008). The release of the fluid also enhances the efficiency of the 
removal of waste produced by chondrocytes and fresh nutrients can be brought back to 
the tissue as cartilage is relaxed. As a result, this complex mechanism supports the 
development of articular cartilage and maintains its functionality. Conversely, 
immobilization of diarthrodial joints can accelerate the deterioration of articular cartilage 
(Jurvelin, Kiviranta et al. 1986). 
 
2.2 Cartilage Degeneration and Repair 
2.2.1 Arthritis, Rheumatoid Arthritis, Osteoarthritis and Post-Traumatic Osteoarthritis 
 Degeneration of articular cartilage can be induced under several various 
conditions such as aging, disease and sports or mechanical injury, which leads to pain, 
stiffness and swelling of joints. Arthritis, a form of musculoskeletal disorders which 
involves joint inflammation and cartilage breakdown, is the most frequent cause of 
disability in the United States. It affects 50 million Americans including not only middle-
aged and older people but also children, resulting in costs of $128 billion annually 
(Cheng, Hootman et al. 2010). Rheumatoid arthritis (RA) and osteoarthritis (OA) are the 
most common forms of arthritis. RA is a systemic autoimmune disease that occurs mostly 
in women and is generally characterized by the inflammation of the membrane lining the 
joint. Although RA is primarily diagnosed in synovial joints, it can also induce 
inflammation throughout the body and affect many other tissues and organs such as heart 
(Persson 2012). OA is a chronic degenerative disease where the cartilaginous layers 
covering the ends of the bones gradually wear away, which increases the friction 
coefficient of the articular surface and yields the exposure of the subchondral bone.  
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Moreover, in the event that an injury compromises the articular surface, a 
degenerative condition coined post-traumatic osteoarthritis (PTOA) may soon follow, 
which if allowed to progress persistently could lead to chronic, debilitating pain and 
swelling. PTOA results in an estimated cost of $13.5 billion per year in work loss and 
direct medical costs in the United States alone (Brown, Johnston et al. 2006). Because 
self-repair of articular cartilage is limited and the damaged tissue is usually reconstructed 
with fibrocartilage which exhibits weaker mechanical strength than articular cartilage 
(Knutsen, Engebretsen et al. 2004; Khan, Gilbert et al. 2008), the injury site becomes a 
nucleating center for the progressive degeneration of the articular surface by altering the 
native loading state of the joint. The subsequent abnormal wear on the articular surface as 
a result of this altered loading state, becomes accelerated and ultimately leads to end-
stage OA. PTOA can occur as soon as three months after a severe injury and despite 
advances in surgical treatment and rehabilitation of injured joints, the risk of PTOA has 
not decreased in the last 50 years (Brown, Johnston et al. 2006). Thus, new therapeutic 
approaches aimed to regenerate or repair articular cartilage with respect to biological and 
mechanical functions are sought, which may prevent the onset of PTOA and mitigate 
future physical and medical costs associated with end-stage OA. 
  
2.2.2 Surgical Therapies 
Current strategies for cartilage repair and restoration include abrasion arthroplasty, 
subchondral drilling, microfracture, cell and tissue graft transplantation and total joint 
replacement. For large defects, total joint replacement surgeries are required to replace 
the joint with metal or polymeric materials, yet a revision may need to be performed due 
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to infection, instability or malpositioning of the implanted joint and worn-out implants 
(Andres, Mears et al. 2001; Sgaglione, Miniaci et al. 2002; Jakobsen, Engebretsen et al. 
2005; Ronn, Reischl et al. 2011). For relatively small lesions, abrasion arthroplasty, 
subchondral drilling and microfracture are marrow-stimulation methods which promote 
migration of chondrocyte progenitor cells or mesenchymal stem cells (MSCs) and 
delivery of growth factors to the defect by creating the access to the subchondral bone 
(Andres, Mears et al. 2001; Sgaglione, Miniaci et al. 2002; Jakobsen, Engebretsen et al. 
2005; Ronn, Reischl et al. 2011). In these approaches, the defect is generally filled with 
fibrocartilage which relieves pain, but is mechanically compromised. Another option is 
transplantation of chondrocytes (Brittberg, Lindahl et al. 1994; Saris, Vanlauwe et al. 
2008) or cartilage grafts (Hangody, Feczkó et al. 2001; Bos and Ellermann 2003; Hand, 
Lobo et al. 2003; Huntley, Bush et al. 2005) harvested from non-load bearing regions to 
the injury site. However, several disadvantages associated with this method have been 
reported, such as donor site morbidity, limited access to patients’ healthy autologous 
chondrocytes and possible rejection responses to the allogeneic implants. To overcome 
these obstacles and provide alternative therapeutic strategies, tissue engineering has 
emerged as a promising approach. 
 
2.2.3 Cartilage Tissue Engineering 
The production of tissue-engineered cartilage typically involves cultivation of 
primary chondrocytes on three-dimensional biodegradable polymer scaffolds or naturally 
derived hydrogels within controlled environments of bioreactor culture systems (Darling 
and Athanasiou 2003; Bilodeau and Mantovani 2006) (Figure. 2.2). In order to be 
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clinically relevant, cartilage substitutes must meet specific functional criteria related to 
their mechanical properties, biochemical composition, tissue ultrastructure, 
immunological compatibility and integration capability. However, all of these properties 
of engineered cartilage are still inferior to those of native tissues. One of the explanations 
for this gap is that cultured chondrocytes undergo a process of rapid in-vitro hypertrophic 
maturation such that tissue development is impeded (Böhme, Winterhalter et al. 1995). In 
vitro, harvested chondrocytes may only have a limited lifespan and potential to develop 
Figure 2.2 Main elements in cartilage tissue engineering: cell sources, 




into mature articular cartilage tissues when they are exposed to culture conditions. 
Researchers seek to develop novel biomaterials and bioreactor systems in order to 
improve current tissue engineering strategies that can maximize the efficacy of 
chondrocytes within their restricted lifetime. 
 
2.3 Environmental Stimuli 
Microenvironments define the immediate surroundings of a cell, which 
encompass essential elements that mediate cellular activities and further tissue formation. 
These elements include, but are not limited to, soluble molecules, ECM components 
bound to the cell and adjacent cells. Therefore, the development of functional tissue 
replacements requires a thorough understanding of the roles environmental factors play in 
natural and culture environments. Among these factors, biochemical agents are thought to 
be involved in cell-to-cell communication and signaling, in which extracellular 
biomolecules, such as growth factors, cytokines and chemokines, transmit chemical 
signals directly to individual cells and activate a series of chain reactions inside the cells 
that give rise to particular transcription factors in response to external stimulation and 
changes in environmental conditions. It is also believed that mechanical stimuli present in 
the physiological or culture environments can significantly influence cell shape, 
orientation, apoptosis, gene expression, secretion of signaling molecules as well as 
synthesis and degradation of ECM components by cells though the mechanisms that 
transduce mechanical cues into chemical signals that trigger cellular responses are still 
not fully understood (Grodzinsky, Levenston et al. 2000). It has been reported that there 
may be several regulatory pathways by which cells can respond to mechanical forces, 
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including crosstalk between chemo- and mechano-sensitive signaling mediators (Davies 
1995; Das, Schurman et al. 1997) and possible mechanisms that alter cellular activities in 
transcription (Holmvall, Camper et al. 1995; Valhmu, Stazzone et al. 1998; Smith, 
Trindade et al. 2000), translation and post-translational modifications (Kim, Grodzinsky 
et al. 1996; Smith, Rusk et al. 1996). The role of biophysical, biochemical and 




2.3.1.1 Biophysical Signals 
 Biomaterials provide a powerful tool to deliver biophysical signals to cultured 
cells through manipulation of material properties of synthesized substrates, such as 
elasticity and stiffness, which emulate physiological conditions. For instance, a study 
reported by McBeath et al. demonstrated that MSC differentiation could be predicted by 
control of cell shape using a micropatterning technique (Mcbeath, Pirone et al. 2004). 
Specifically, when human MSCs were cultivated on the surfaces of polydimethylsiloxane 
substrates coated with large areas of fibronectin that enhanced cell spreading, they 
experienced strong cytoskeletal tension and tended to differentiate into osteoblasts. 
Conversely, adipogenic commitment occurred when cells were on small islands of 
fibronectin and remained round. In addition, Engler and coworkers cultured human 
MSCs on the surfaces of collagen-modified polyacrylamide hydrogels with the tissue-
level elasticity ranged from 0.1 to 40 kPa (Engler, Sen et al. 2006). Cells exhibited the 
neurogenic, myogenic and osteogenic potential when grown on the soft, intermediate, and 
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stiff substrates, respectively, in the absence of exogenous inductive molecules. 
Committed cells could be reprogramed by the addition of soluble inducers during the first 
week of the cultivation whereas phenotype commitment was irreversible in longer 
cultures. When nonmuscle myosin II was inhibited, MSCs lost the ability to respond 
matrix stiffness and were not able to differentiate. These studies substantiate that MSCs 
can secrete various soluble molecules in response to the microenvironment that alters 







Figure 2.3 Morphology of articular chondrocytes grown on a plastic surface. (A) 
Primary chondrocytes possess the typical cobblestone shape. (B) Passaged chondrocytes 





2.3.1.2 Hydrogels and Synthetic Meshes 
Articular chondrocytes are a rounded, three-dimensional cell type. When 
expanded in monolayer, they tend to undergo rapid dedifferentiation and can experience 
phenotypic changes as early as the first passage (Darling and Athanasiou 2005). The 
dedifferentiated chondrocytes demonstrate a fibroblast-like phenotype and morphology 
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(Figure 2.3). Therefore, the best approach to culture chondrocytes is to grow them in a 
three-dimensional environment. Biodegradable and biocompatible materials have been 
incorporated into tissue engineering strategies to provide three-dimensional substrates 
and appropriate microenvironments for cell growth and tissue development. These 
substrates need to mimic the natural environment of cells and are fabricated to meet the 
requirements for cell survival, matrix biosynthesis, mechanical integrity and integration 
capacity with host tissues. Among these smart biomaterials are hydrogels and synthetic 
meshes. Hydrogels are formed by gelation of polymers dissolved in a liquid medium, 
usually water. Depending on the mechanism of crosslinking, the network structure of 
hydrogels can be physically or chemically bonded. Hydrogels that are utilized in cartilage 
repair are commonly composed of agarose (Mauck, Soltz et al. 2000; Hunter and 
Levenston 2004; Mauck, Yuan et al. 2006; Byers, Mauck et al. 2008; Erickson, Huang et 
al. 2009; Sheehy, Buckley et al. 2011), alginate (Perka, Schultz et al. 2000; Caterson, 
Nesti et al. 2001; Kavalkovich, Boynton et al. 2002; Mo, Guo et al. 2009), fibrin (Nixon, 
Fortier et al. 1999; Perka, Schultz et al. 2000; Hunter and Levenston 2004; Pelaez, 
Charles Huang et al. 2008), collagen (Yokoyama, Sekiya et al. 2005; Hannouche, Terai et 
al. 2007; Koga, Muneta et al. 2008; Roy, Boskey et al. 2008), hyaluronic acid 
(Kavalkovich, Boynton et al. 2002; Liu, Shu et al. 2006; Chung and Burdick 2008; 
Erickson, Huang et al. 2009) or self-assembling peptides such as KLD-12 (Kisiday, Jin et 
al. 2002; Kisiday, Kopesky et al. 2008) and Puramatrix (Erickson, Huang et al. 2009). 
Although hydrogels yield more homogeneous distribution of encapsulated cells and have 
high flexibility in size and shape, they are usually less porous and exhibit inferior 
mechanical properties in comparison with meshed scaffolds (Chung and Burdick 2008).  
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Meshed synthetic scaffolds such as PGA (Freed, Marquis et al. 1993; Obradovic, 
Martin et al. 2001), poly-L-lactic acid (PLA) (Lohmann, Schwartz et al. 2000; Moyer, 
Wang et al. 2010) and polycaprolactone (PCL) (Li, Danielson et al. 2003; Shao, Goh et al. 
2006) may be preferred in the fabrication of tissue replacements because of their tunable 
biomechanical properties that can be modified using techniques like soft lithography 
(Vozzi, Flaim et al. 2003), UV polymerization (Fischer, Dickhut et al. 2010) and 
electrospinning (Chiu, Luu et al. 2005; Liang, Hsiao et al. 2007). A meshed poly(ethylene 
oxide) terephthalate/poly(butylene) terephthalate scaffold has been recently fabricated to 
possess mechanical strength comparable to the level of native cartilage (Moroni, De Wijn 
et al. 2006). Electrospinning is a novel approach to the manufacture of nanofibrous 
scaffolds. This type of scaffold provides three-dimensional architecture that mimics the 
network of fibrillar ECM components in nanoscale and has high porosities and surface-
area-to-volume ratios that are suitable for cell adhesion and proliferation (Chiu, Luu et al. 
2005; Liang, Hsiao et al. 2007). More importantly, electrospun scaffolds can be 
engineered to consist of highly aligned nanofibers that will be useful for regeneration of 
specific tissue types such as tendon and the superficial and the deep zones of articular 
cartilage (Li, Danielson et al. 2003; Janjanin, Li et al. 2008). 
 
2.3.1.3 Drug/Molecule Delivery Vehicles 
 Delivery of soluble factors such as growth factors, cytokines and small molecules 
to cultured cells is mostly through the direct addition of bulk molecules to culture media 
(Sah, Trippel et al. 1996; Yaeger, Masi et al. 1997; Martin, Vunjak-Novakovic et al. 1999; 
Blunk, Sieminski et al. 2002; Pei, Seidel et al. 2002; Jin, Emkey et al. 2003; Mauck, 
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Nicoll et al. 2003; Davies, Blain et al. 2008; Emin, Koç et al. 2008; Duraine, Neu et al. 
2009). This method requires excess additives to increase the probability of cells capturing 
these molecules and continuous supplementation is usually applied, which makes this 
strategy less economic. Alternatively, growth factors can be embedded in microparticles 
or scaffolding materials such as hydrogels for local distribution (Holland, Tabata et al. 
2005; Park, Temenoff et al. 2005; Defail, Chu et al. 2006; Holland, Bodde et al. 2007; 
Park, Temenoff et al. 2007; Bouffi, Thomas et al. 2010; Lim, Oh et al. 2010; Spiller, Liu 
et al. 2012). When loaded microparticles are further encapsulated into scaffolds, it largely 
reduces the burst release of incorporated molecules (Defail, Chu et al. 2006; Chung and 
Burdick 2008). In this fashion, the release of growth factors is based on loading density, 
diffusivity and properties of biomaterials, such as the size of microparticles and 
degradation rate of hydrogels (Chung and Burdick 2008). Several studies have 
demonstrated that constructs loaded with TGF-β and/or IGF-1 microcarriers exhibit a 
higher level of chondrogenesis than the non-loaded ones (Park, Temenoff et al. 2005; 
Holland, Bodde et al. 2007; Park, Temenoff et al. 2007; Bouffi, Thomas et al. 2010; 
Spiller, Liu et al. 2012). A novel approach utilizing layer-by-layer (LbL) polyelectrolyte 
techniques to incorporate proteins into meshed biodegradable scaffolds has been 
developed. In this system, single or multiple growth factors are coated onto the surfaces 
of scaffolds based on electrostatic properties of biomolecules in a water-based, room 
temperature environment (Wood, Chuang et al. 2006; Macdonald, Rodriguez et al. 2008; 
Macdonald, Rodriguez et al. 2010; Shukla, Fleming et al. 2010; Macdonald, Samuel et al. 
2011; Shah, Macdonald et al. 2011) to avoid the use of solvents, heat or other severe 
conditions that are necessary in the traditional polymer encapsulation process and may 
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denature the encapsulated proteins (Fu, Pack et al. 2000). The controlled release of 
growth factors from LbL vehicles can be modulated by simply adjusting the architecture 
of the nanolayered film and the number of incorporated growth factor layers (Wood, 
Chuang et al. 2006; Macdonald, Rodriguez et al. 2008; Macdonald, Rodriguez et al. 
2010). BMP-2/vascular endothelial growth factor (VEGF)-loaded LbL PCL scaffolds 
have been shown to successfully recruit host progenitor cells at the implant site to foster 
in-situ development of regenerating bone (Macdonald, Samuel et al. 2011; Shah, 
Macdonald et al. 2011). To our best knowledge, however, this technique has not been 
extensively utilized in cartilage repair. 
 
2.3.2 Bioreactor Systems 
 In order to compensate for low quality of tissue-engineered constructs derived 
from static cultures, bioreactor systems have been designed to impart mechanical loading 
to facilitate the development of different types of tissues, such as cardiovascular and 
musculoskeletal tissues (Darling and Athanasiou 2003; Bilodeau and Mantovani 2006). 
Bioreactors do their part by providing a well-defined culture environment to control 
biochemical and mechanical parameters. This section will discuss the common bioreactor 
systems that have been utilized in cartilage tissue engineering applications. 
 
2.3.2.1 Deformational Loading 
 Ex-vivo compression, in both confined and unconfined fashions (Figure 2.4A), at 
certain amplitudes and frequencies has been considered to be capable of replicating joint 
activities and thereby stimulating chondrocyte and cartilage growth (Gray, Pizzanelli et al. 
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1989; Sah, Kim et al. 1989; Sah, Doong et al. 1991; Kim, Grodzinsky et al. 1996; 
Steinmeyer and Knue 1997). However, such loading has been shown to possibly reduce 
the efficiency at which the synthesized ECM components are encapsulated in the tissue 
network as a result of frequent flow movement that increases the release of those 
molecules into the surroundings (Gray, Pizzanelli et al. 1989; Sah, Doong et al. 1991). 
Given that stimulatory effects of compressive loading on protein synthesis can last for 
hours (Gray, Pizzanelli et al. 1989; Sah, Kim et al. 1989), tissue constructs are usually 
exposed to intermittent compression in long-term experiments in order to maximize the 
retention of ECM components within engineered tissues (Mauck, Soltz et al. 2000; 
Davisson, Kunig et al. 2002; Kisiday, Jin et al. 2004; Waldman, Spiteri et al. 2004). 
Studies have demonstrated that dynamic compression can enhance gene expression of 
aggrecan by cultured chondrocytes (Valhmu, Stazzone et al. 1998) and influence 
chondrocyte-specific biosynthetic pathways (Kim, Grodzinsky et al. 1996), resulting in 
improved biochemical and mechanical properties of cell-laden agarose (Mauck, Soltz et 
al. 2000) and self-assembling peptide (Kisiday, Jin et al. 2004) hydrogels. These 
dynamically loaded samples can achieve at least 20 to 50% greater ECM deposition and 
mechanical strength than static tissue constructs (Mauck, Soltz et al. 2000; Kisiday, Jin et 
al. 2004; Waldman, Spiteri et al. 2004). 
 Dynamic compression yields a culture condition as complex as the natural 
environment within the synovial capsule. Under dynamic compressive loading, cells or 
tissues experience not only volumetric deformation, but also gradients in osmotic stress, 
hydrostatic pressure, hydrodynamic forces, electric field stimulation and more 
(Grodzinsky, Levenston et al. 2000). This complexity increases the difficulty in isolating 
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the effects of a single environmental factor on the development of tissue-engineered 
cartilage. Therefore, the design of bioreactors has shifted to systems that only emulate 
one of many conditions that take place in the knee or other joints. For example, using 
parallel impermeable platens (Figure 2.4B), sinusoidal shear deformation has been 
successfully applied to cartilage explants in a range of 0.5‒6% strain amplitude at 0.1 Hz 
without introducing significant interstitial fluid flow (Jin, Emkey et al. 2003). The shear-
loaded cartilage tissues exhibited 35% and 25% greater protein and proteoglycan 
synthesis, respectively, than the non-loaded tissues in a 24-hour loading period. This 
enhancement of tissue properties, however, was independent of amplitude and frequency 
Figure 2.4 Bioreactor systems in cartilage tissue engineering. (A) Confined and 
unconfined compressive loading. (B) Shear deformation. (C) Hydrostatic pressure. (D) 
Direct perfusion. (E) Rotating vessel. (F) Spinner flask. 
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of applied shear deformation. Similar shear instruments have also been utilized in the 
long-term cultivation of chondrocyte-seeded substrates. The intermittent dynamic shear 
deformation resulted in engineered cartilage with a 6-fold higher stiffness than the static 
controls (Waldman, Spiteri et al. 2003). 
 
2.3.2.2 Hydrostatic Pressure 
 Bioreactor systems that reproduce physiological levels of hydrostatic pressure in 
diarthrodial  joints have been fabricated in the laboratory by compressing a gas or liquid 
phase that transmits load through culture media to cells (Figure 2.4C) (Elder and 
Athanasiou 2009). Hydrostatic pressure in the physiological range of 7 to 10 MPa is 
preferred in this type of application because loading at such levels stimulates tissue 
constructs without causing evident deformation of samples and thus maintains the 
integrity of matrix architecture (Hall, Horwitz et al. 1996; Darling and Athanasiou 2003). 
A study in which the effects of the loading profile of hydrostatic pressure at 10 MPa on 
articular chondrocytes was evaluated in a 4-hour loading period demonstrated that, 
relative to the non-loaded cells, intermittent pressure applied at 1 Hz was found to 
increase aggrecan and type II collagen mRNA signals by 31% and 36%, respectively, 
whereas constant pressure did not influence mRNA expression (Smith, Rusk et al. 1996). 
A follow-up experiment was conducted to investigate the time-dependent effects of 
intermittent hydrostatic pressure loaded at 10 MPa and 1 Hz for up to 24 hours. A 
biphasic behavior was detected in mRNA expression of type II collagen by loaded 
chondrocytes with a peak value at the 4-hour period while aggrecan signals continuously  
increased with the loading period (Smith, Trindade et al. 2000). Intermittent hydrostatic 
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pressure was also applied to grow tissue-engineered cartilage and was shown to 
positively regulate functional maturation of neocartilage (Elder and Athanasiou 2009). 
 
2.3.2.3 Laminar Flow 
 In addition to direct deformation and hydrostatic pressure, fluid flow also plays a 
key role in the development of both native and engineered cartilage. In vivo, joint 
movement during normal walking or exercise not only alters pericellular concentrations 
of cytokines, growth factors, enzymes and more other molecules, driving protein or ion 
flux in and out of the cartilage tissue, but also forces the exchange of substances between 
the interstitial fluid within cartilage and the surrounding synovial fluid. Because of the 
avascular nature of articular cartilage, nutrient delivery to and waste removal from 
chondrocytes largely rely on this flow-enabled exchange. The individual contributions of 
diffusion and convection to the transport of neutral and charged proteins within articular 
cartilage have been examined (Garcia, Frank et al. 1996; Garcia, Lark et al. 1998). These 
studies suggest that when cartilage is stimulated by fluid flowing at a velocity of 1 µm/s 
(flow velocity within articular cartilage at normal walking frequencies (Hou, Mow et al. 
1992)), the efficiency of mass transfer of solutes is tremendously enhanced. Fluid flow 
bioreactor systems can be divided into two major categories based on flow profile, i.e. 
laminar or turbulent flow (Dunkelman, Zimber et al. 1995; Vunjak-Novakovic, 
Obradovic et al. 1998; Vunjak-Novakovic, Martin et al. 1999; Martin, Obradovic et al. 
2000; Pazzano, Mercier et al. 2000; Emin, Koç et al. 2008). 
 Among the systems that generate laminar flow, direct perfusion systems (Figure 
2.4D) push culture media through cell-seeded scaffolds such that cells within constructs 
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can directly sense hydrodynamic shear stress as fluid flows through the pores. In order to 
achieve uniform medium flow, constructs have to tightly fit in the perfusion chamber and 
no gaps between samples and the chamber wall are allowed. Cells under perfusion 
stimulation become aligned in the direction of the flow, which makes it possible to 
engineer a tissue with specific cell orientations (Dunkelman, Zimber et al. 1995; Pazzano, 
Mercier et al. 2000). Although it has been demonstrated that the perfusion flows at both 
low (1 µm/s) (Pazzano, Mercier et al. 2000) and high (11 µm/s) (Dunkelman, Zimber et 
al. 1995) velocities significantly increase ECM contents of tissue-engineered cartilage, 
denser matrix deposition tends to occur near the surface facing the oncoming flow. As a 
result, the nonhomogeneous matrix distribution along the thickness of the construct 
affects overall mechanical properties of engineered cartilage. This “one-side effect”, 
however, can be overcome by reversing medium flow periodically during the cultivation 
(Darling and Athanasiou 2003). 
 Another representative system that employs laminar flow is the rotating vessel 
bioreactor (Figure 2.4E) which utilizes fluid flow and gravity to apply a relatively low 
level of shear stress to cells or tissue constructs suspended in culture media (Vunjak-
Novakovic, Martin et al. 1999; Martin, Obradovic et al. 2000; Emin, Koç et al. 2008). 
Remarkably, a research group has shown that chondrocyte-seeded PGA scaffolds 
cultivated within a rotating vessel bioreactor were able to develop into robust tissues with 
equilibrium moduli and GAG contents similar to or better than native cartilage after 
seven months in culture (Martin, Obradovic et al. 2000). Nevertheless, a major concern 
with this type of bioreactor is that the path of the suspended constructs within flow is 
unpredictable such that it is difficult to build a simulation model to optimize the 
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bioprocessing conditions (Darling and Athanasiou 2003). A hybrid bioreactor combining 
perfusion and rotating vessel systems was designed, in which cartilage constructs are 
mounted in the perfusion chamber while the outer wall of the reactor simultaneously 
spins during the cultivation (Farooque 2008). A computational fluid dynamics (CFD) 
model was established to define this unique hydrodynamic environment. Experimentally, 
the hybrid bioreactor system further improved chondrocyte doubling rate and collagen 
accumulation within engineered tissues in comparison with the system without the 
perfusion flow. This evidence suggests that development of tissue-engineered cartilage 
can potentially benefit from enhanced hydrodynamic forces such as those introduced by 
turbulent flow. 
 
2.3.2.4 Turbulent Flow 
 Turbulent flow-induced shear environments can be established within a simple 
mechanically stirred bioreactor system equipped with an impeller or stir bar and referred 
to as a spinner flask (Figure 2.4F). Under mixing, oxygen and nutrients can be efficiently 
delivered to cells seeded within and/or on the scaffolds. It has been suggested by Vunjak-
Novakovic et al. that mechanically stirred bioreactors can yield the best cell attachment 
efficiency to meshed synthetic scaffolds during the cell seeding process (Vunjak-
Novakovic, Obradovic et al. 1998). The induced hydrodynamic shear stress possesses the 
ability to organize matrix architecture. Figure 2.5 demonstrates that the orientation of 
newly synthesized collagen fibrils is in the same direction as fluid flow at the periphery 
of engineered tissues which is in direct contact with the flow, but is disorderly in the 
interiors of the constructs. On the other hand, cultured cells can also be damaged when 
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exposed to extremely high agitation rates (150-300 rpm) (Papoutsakis 1991). Therefore, 






Figure 2.5 Orientation of collagen fibrils in tissue-engineered cartilage cultivated 
under turbulent flow. Collagen fibrils at the construct periphery are aligned in the same 
direction whereas those close to the center of the construct are less organized. Scanning 





2.3.2.5 Wavy-Walled Bioreactor (WWB) 
 A novel WWB system (Figure 2.6A) designed in our laboratory is an alternative 
version of the conventional spinner flask (Figure 2.6B) whose circular glass wall is 
modified into a sinusoidal curve. The internal radius (r) of the WWB is a function of the 
radial angle (θ) and can be expressed in the form of Equation 2.1. 
 
                       Equation 2.1 
   where r and θ: cylindrical coordinates 
    Ravg: average internal radius 
    A: peak amplitude 








Figure 2.6 Configuration of the wavy-walled bioreactor (A) and the spinner flask (B), 







Mass transport within the WWB is achieved through mixing of culture media. 
The wavy shape of the WWB was designed to mimic baffles that increase hydrodynamic 
instabilities and thereby enhance the efficiency of fluid mixing. The initial intent of the 
WWB design was to cultivate suspended mammalian cells and it has previously been 
demonstrated by Barabino and coworkers that increased CHO cell proliferation in 
microcarriers can be accomplished in the WWB when compared with the traditional 
spinner flask (Barabino, Metghalchi et al. 1993). This WWB prototype had a capacity of 
250 mL, an average radius of 3.50 cm, a peak amplitude of 0.65 cm and a total number of 
6 lobes. The WWB then underwent several modifications to meet the requirements for 
cartilage tissue engineering. For example, the peak amplitude was changed from the 
initial measure, 0.65 cm, to the current version, 0.45cm, in order to avoid the 
accumulation of cultured chondrocytes at the lobes. The present WWB has a capacity of 
120 mL, an average radius of 3.35 cm, a peak amplitude of 0.45 cm and a total number of 
6 lobes (Bueno, Bilgen et al. 2004; Bueno, Bilgen et al. 2005). In a scaffold-free, cell 
aggregation study, the WWB was able to yield the formation of chondrocyte aggregates 
45% faster than the spinner flask when both types of the bioreactors were agitated at the 
same rate (Bueno, Bilgen et al. 2004).  
In the cultivation of chondrocyte-seeded scaffolds, the WWB is equipped with 
four 6-in long, 21 gauge stainless steel needles that are fixed onto a rubber stopper at the 
equidistant positions (r = 1.6 cm) (Figure 2.6C). Two scaffolds are then threaded onto 
each of the needles and are separated by a silicon spacer with a diameter of 3 mm, 
provided a total of eight constructs per bioreactor. The unique hydrodynamic culture 
environment within the WWB has previously been characterized using computational 
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fluid dynamics (CFD) simulation which was further validated by particle image 
velocimetry (PIV) methods (Bilgen, Sucosky et al. 2006; Bilgen and Barabino 2007). 
This characterization suggests that three hydrodynamic parameters (1) the average shear 
stress, (2) axial and (3) tangential fluid velocities on the control volume surface that is 
created around tissue constructs explain more than 99.9% of the variability of the 
hydrodynamic environment. In comparison with the spinner flask, the WWB yields a 
43% higher axial velocity, but 50% lower shear stress applied to the construct surfaces 
(Bilgen and Barabino 2007). These conditions lead to increased chondrocyte seeding 
efficiency (Bueno, Laevsky et al. 2007) and improved cell proliferation and ECM 
deposition within engineered cartilage (Bueno, Bilgen et al. 2005; Bueno, Bilgen et al. 
2008). A mathematical model composed of four elements, (1) a CFD model, (2) a kinetic 
growth model, (3) an artificial neural network that empirically correlates hydrodynamic 
parameters with kinetic constants and (4) a second artificial neural network that correlates 
biochemical compositions of constructs with their material properties, was developed to 
predict the dynamics of tissue growth with respect to their compositional and mechanical 
properties (Bilgen, Uygun et al. 2009). The model also suggested an optimal agitation 
rate of 50 rpm for neocartilage cultivation. 
 
2.3.3 Bioactive Molecules 
Extracellular biochemical signals are required to both initiate a series of 
biological reactions associated with specific cellular activities in response to external 
stimulations and provide essential elements for regulation of cell growth and tissue 
development. In vitro, nutrients assimilated by cells mainly originate from the 
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constituents present in culture media. These bioactive molecules are transported between 
culture media and cells and as such are important mediators in the soluble local 
environment of developing tissues. 
 
2.3.3.1 Fetal Bovine Serum (FBS) 
 FBS is a typical medium supplement in the cultivation of mammalian cells 
because it contains rich proteins such as growth factors and cytokines. Although culture 
media supplemented with high serum contents (10-20%, v/v) have been extensively 
utilized to grow different types of cells and tissues, contradictory reports on the effects of 
serum have been documented. These variations may result from highly undefined serum 
composition and varied concentrations of its constituents when extracted from different 
individuals, thereby introducing unpredictable experimental outcomes. For instance, 
while high serum contents have been shown to increase cell doubling rate (Glowacki, 
Yates et al. 2005) and to effectively support in-vitro development of engineered tissues 
(Freed, Marquis et al. 1993; Mauck, Soltz et al. 2000), serum has also been shown to 
interfere with particular cellular activities and the function of exogenous growth factors. 
Specifically, chondrocyte proliferation (Mandl, Van Der Veen et al. 2002) and cartilage 
matrix production (Glowacki, Yates et al. 2005) in serum-containing cultures were 
compromised in comparison with serum-starved cultures supplemented with basic 
fibroblast growth factor (FGF-2) and TGF-β, respectively. It has also been demonstrated 
that embryonic bodies in culture with FBS had less capability to differentiate into 
functional neuronal cells (Zhang, Li et al. 2005) whereas serum-free media were shown 
to induce massive neural differentiation of embryonic carcinoma cells (Pacherník, Bryja 
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et al. 2005). Furthermore, serum-containing cultures failed to support the differentiation 
of porcine stromal vascular cells into adipocytes as indicated by reduced glycerol-3-
phosphate dehydrogenase activities while the addition of insulin and hydrocortisone to 
serum-free media facilitated adipose differentiation (Suryawan and Hu 1993). Recent 
studies also indicated that the presence of serum components led to chondrocyte 
dedifferentiation (Lin, Willers et al. 2006) and decreased the activity of TGF-β1 in 
chondrogenesis of synoviocyte pellet cultures (Bilgen, Orsini et al. 2007). Thus, there is a 
need to reduce the dependency on serum while retaining its beneficial effects in the 
preparation of chemically defined culture media for cell and tissue engineering. 
 
2.3.3.2 Insulin-Like Growth Factor-1 (IGF-1) and Transforming Growth Factor-β (TGF- 
β): Shear-Sensitive Growth Factors 
 Incorporation of soluble factors into tissue engineering strategies as medium 
supplements is a vital step in the development of engineered cartilage constructs. These 
molecules include, but are not limited to, growth factors such as IGF-1 (Sah, Trippel et al. 
1996; Yaeger, Masi et al. 1997; Jin, Emkey et al. 2003; Mauck, Nicoll et al. 2003; Davies, 
Blain et al. 2008), TGF-β (Yaeger, Masi et al. 1997; Blunk, Sieminski et al. 2002; 
Malaviya and Nerem 2002; Pei, Seidel et al. 2002; Mauck, Nicoll et al. 2003; Glowacki, 
Yates et al. 2005; Davies, Blain et al. 2008; Emin, Koç et al. 2008; Duraine, Neu et al. 
2009), FGF-2 (Sah, Trippel et al. 1996; Martin, Vunjak-Novakovic et al. 1999), and 
BMPs (Khalafi, Schmid et al. 2007; Kim and Im 2008; Shen, Wei et al. 2008; An, Cheng 
et al. 2010), and other stimulating agents like chondroitin sulfate (Basalo, Chahine et al. 
2007; Bian, Kaplun et al. 2009), Genipin (Lima, Tan et al. 2009) and trimethylamine N-
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oxide (O'connell, Fong et al. 2012). Among exogenous growth factors, IGF-1 and TGF-β 
are two of the most common stimulating biomolecules in cartilage biology (Chung and 
Burdick 2008). In articular cartilage, IGF-1 is one of the main molecules responsible for 
cartilage homeostasis and balancing matrix synthesis and degradation by chondrocytes. 
IGF-1 has the potential to maintain the viability of native cartilage (Sah, Trippel et al. 
1996), to stimulate gene expression of both aggrecan and type II collagen by 
chondrocytes (Yaeger, Masi et al. 1997; Davies, Blain et al. 2008) and subsequent 
biosynthesis of associated protein molecules (Jin, Emkey et al. 2003), and to enhance 
stiffness of engineered cartilage (Mauck, Nicoll et al. 2003). 
 The TGF-β family is a more complex group that consists of at least three isoforms, 
TGF-β1, -β2 and -β3, which are associated with chondrocyte activities. The major 
functions of TGF-β molecules are to induce ECM deposition and inhibit protease 
production by cells. Although these isoforms have a high degree of similarity (65-80%) 
in their structure (Derynck, Lindquist et al. 1988) and most studies have reported an 
overall stimulatory effect of TGF-β on chondrocyte proliferation and cartilage maturation 
(Yaeger, Masi et al. 1997; Blunk, Sieminski et al. 2002; Malaviya and Nerem 2002; Pei, 
Seidel et al. 2002; Mauck, Nicoll et al. 2003; Glowacki, Yates et al. 2005; Davies, Blain 
et al. 2008; Emin, Koç et al. 2008; Duraine, Neu et al. 2009), they may still serve 
different biological roles. For instance, it has been found that the distribution of these 
three isoforms in the pathological joint is quite discrete. Specifically, abundant TGF-β1 
molecules were localized in the superficial chondrocytes of osteophyte cartilage (Uchino, 
Izumi et al. 2000) while TGF-β2 was present within lining layer and pannus over the 
joint surface and TGF-β3 was only observed in the sparse cells within the deeper layers 
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of the synovia in an arthritic mouse model (Mu¨Ssener, Litton et al. 1997). Moreover, in 
fracture healing, TGF-β1 was expressed in early callus and the expression further 
increased during chondrogenesis and endochondral ossification whereas no stable trend 
was detected in both TGF-β2 and -β3 expression throughout the healing process (Rosier, 
O'keefe et al. 1998). Nevertheless, the total expression of TGF-β isoforms in mRNA level 
was found to increase in the early phase of osteoarthritic cartilage (Van Der Kraan, 
Glansbeek et al. 1997). This evidence substantiates their functional roles in cartilage 
regeneration mechanisms. 
IGF-1 (Blunk, Sieminski et al. 2002; Pei, Seidel et al. 2002; Jin, Emkey et al. 
2003; Mauck, Nicoll et al. 2003) and TGF-β (Blunk, Sieminski et al. 2002; Pei, Seidel et 
al. 2002; Mauck, Nicoll et al. 2003; Emin, Koç et al. 2008) are two of the bioactive 
molecules that are sensitive to mechanical stimuli such as shear stress, meaning that they 
are capable of interacting synergistically with mechanical forces to further accelerate 
functional maturation of engineered tissues. Differential responses to varied levels of 
shear or other mechanical loads have been observed. For example, Gooch and coworkers 
showed that engineered cartilage stimulated by exogenous IGF-1 exhibited increased 
ECM deposition when they were cultivated under laminar flow induced within a rotating 
vessel bioreactor, but not in a spinner flask that imparts turbulent flow (Gooch, Blunk et 
al. 2001). Several groups have also reported that IGF-1 and/or TGF-β in combination 
with shear stress resulted in accelerated cell proliferation, enhanced ECM synthesis and 
better tissue development (Ohno, Cooke et al. 1995; Malaviya and Nerem 2002; Jin, 
Emkey et al. 2003). Furthermore, the production of these shear-sensitive molecules by 
cells can be promoted when the cells are cultivated under fluid shear conditions (Ohno, 
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Cooke et al. 1995; Sakai, Mohtai et al. 1998; Negishi, Lu et al. 2001; Kapur, Mohan et al. 
2005). In addition, TGF-β in particular is synthesized in a latent form by cells, which can 
be activated when exposed to shear conditions, and the activation largely depends on the 
magnitude of applied shear stress (Ahamed, Burg et al. 2008). These findings speak to 
the complexity of fluid shear stress in the modulation of not only tissue morphology and 
properties but also synthesis, activation and function of the shear-sensitive growth factors.  
 
2.4 Summary 
 The limited self-repair ability of injured or diseased articular cartilage persists as a 
challenge for orthopedic medicine. Tissue engineering approaches combining cells, 
bioactive molecules and biocompatible/biodegradable scaffolds in scalable bioreactor 
systems for fabrication of functional tissue replacements hold promise. The ultimate and 
clinical goals of cartilage tissue engineering are to replace damaged cartilage with tissue-
engineered constructs that are mechanically strong and functionally reliable and are able 
to integrate with the host tissues to support the integrity of the entire regenerating tissue.  
Successful creation of functional tissue substitutes suitable for implantation 
requires a thorough understanding of environmental factors that control and regulate 
cellular behavior and tissue formation. Recent efforts to develop engineering tools such 
as novel biomaterials and bioreactor systems have made remarkable progress in cartilage 
tissue engineering by improving the quality of engineered constructs. Yet, the knowledge 
of the formation and the role of a type I collagen-based fibrous capsule, a unique 
structure only present at the periphery of tissue-engineered cartilage, is still limited. In 
this dissertation, we employed a simple tool, the WWB system, to investigate the 
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modulation of the capsule formation by the interplay between fluid shear stress and 
biochemical factors through the systematic development of a chemically reliable culture 
environment that is favorable for hydrodynamic cultivation of tissue-engineered cartilage. 
IGF-1 and TGF-β1 were chosen to be incorporated into the system because of their shear-
sensitive nature. We further aimed to answer the question of whether or not the presence 
of the fibrous capsule at the construct periphery would hinder neocartilage development. 
Exploiting the synergy between mechanical and biochemical stimuli is an important step 
toward the optimization of bioprocessing conditions for the achievement of clinically 




















Adapted and modified from Yang, Y.-H. and Barabino, G.A. (2011) Requirement for Serum in 
Medium Supplemented with Insulin-Transferrin-Selenium for Hydrodynamic Cultivation of Engineered 
Cartilage. Tissue Engineering Part A. 17(15-16): 2025-2035. 
CHAPTER 3 
REQUIREMENT FOR SERUM IN MEDIUM SUPPLEMENTED WITH 
INSULIN-TRANSFERRIN-SELENIUM FOR HYDRODYNAMIC 






Achievement of viable engineered tissues through in vitro cultivation in 
bioreactor systems requires a thorough understanding of the complex interplay between 
mechanical forces and soluble biochemical cues. Bioreactors that impart various 
mechanical stimuli have been utilized to support the development of different tissue types 
such as cardiovascular tissues (Barron, Lyons et al. 2003; Hahn, Mchale et al. 2007), 
tendon (Angelidis, Thorfinn et al. 2009), bone (Cartmell, Porter et al. 2003; Yu, 
Botchwey et al. 2004; Duty, Oest et al. 2007), and cartilage (Vunjak-Novakovic, Martin 
et al. 1999; Mauck, Soltz et al. 2000; Darling and Athanasiou 2003; Gemmiti and 
Guldberg 2006; Elder and Athanasiou 2009). In cartilage tissue engineering, bioreactor 
systems have been designed to provide deformational loading, hydrostatic pressure and 
hydrodynamic forces. The use of dynamic compressive loading to apply physiological 
levels of strain has been shown to improve mechanical and biochemical properties of 
chondrocyte-laden agarose (Mauck, Soltz et al. 2000) and self-assembling peptide 
(Kisiday, Jin et al. 2004) hydrogels. In these studies, the compressively loaded samples 
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exhibited an at least 20% increase in GAG accumulation inside the construct, which led 
to equilibrium compressive moduli improved by about 40-50% in comparison with the 
non-loaded ones. It has also been demonstrated that temporal hydrostatic pressure applied 
at a magnitude in the range of 1 to 10 MPa with a frequency between 0.1 and 1 Hz can 
enhance the deposition of ECM components and the stiffness of engineered cartilage 
(Elder and Athanasiou 2009). The application of continuous fluid flow-induced shear 
stress is aimed to improve mass transport mechanisms through fluid mixing and 
simultaneously provide physical stimuli across or through the cell-seeded construct. Thus 
far, improved tissue quality has been reported when engineered cartilage constructs are 
cultivated under fluid shear conditions (Vunjak-Novakovic, Martin et al. 1999; Cartmell, 
Porter et al. 2003; Bueno, Bilgen et al. 2004; Yu, Botchwey et al. 2004; Bueno, Bilgen et 
al. 2005; Gemmiti and Guldberg 2006; Bueno, Laevsky et al. 2007; Bueno, Bilgen et al. 
2008). Continuous fluid shear bioreactors include customized perfusion systems 
(Cartmell, Porter et al. 2003; Gemmiti and Guldberg 2006), rotating wall vessels 
(Vunjak-Novakovic, Martin et al. 1999; Yu, Botchwey et al. 2004), spinner flasks 
(Vunjak-Novakovic, Martin et al. 1999) and WWBs (Bueno, Bilgen et al. 2004; Bueno, 
Bilgen et al. 2005; Bueno, Laevsky et al. 2007; Bueno, Bilgen et al. 2008). 
Extracellular soluble molecules are an important regulator in both natural and 
experimental tissue growth environments. In vitro, nutrients are delivered to cultured 
cells mainly through culture media supplemented with a variety of constituents. FBS 
contains abundant growth factors and cytokines and is traditionally used as a medium 
supplement in the cultivation of mammalian cells. Although culture media supplemented 
with high serum contents (10-20%, v/v) have been shown to support the development of 
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good quality tissue substitutes (Freed, Marquis et al. 1993; Mauck, Soltz et al. 2000), 
FBS elicits many issues. For instance, FBS composition is highly undefined and the 
concentration of its constituents may vary when extracted from different donors, thereby 
introducing unpredictable effects on cultured cells and tissues. The evidence includes its 
interference with the differentiation of pluripotent and multipotent cells (Suryawan and 
Hu 1993; Zhang, Li et al. 2005; Bilgen, Orsini et al. 2007). In addition, FBS also contains 
antibodies and binding proteins that may neutralize exogenous growth factors added to 
the system (Friedrich, Haring et al. 2009). As a result, it is necessary to minimize the 
serum concentration while retaining its beneficial effects in the formulation of chemically 
reliable culture media for cell and tissue engineering. 
ITS is a commercially available medium supplement and each of its components, 
i.e. insulin, transferrin and selenium, is associated with essential cellular activities 
(Mcquillan, C J Handley et al. 1986; Shapiro and Wagner 1988; Shapiro and Wagner 
1989; Venkateswaran, Klotz et al. 2002). Specifically, insulin is a peptide hormone that 
facilitates cellular uptake of glucose and amino acids from blood. Transferrin, an iron 
transport protein, is responsible for detoxification of culture media from oxygen radicals 
and peroxides while selenium forms the active center of the enzymes that reduce oxygen 
radicals. In cartilage tissue engineering, the standard concentration of ITS (1%, v/v, [10 
μg/mL insulin, 5.5 μg/mL transferrin, and 5 μg/mL selenium]) added to culture media is 
based on the concentration of insulin previously found to stimulate proteoglycan 
synthesis in cultured cartilage explants (Mcquillan, C J Handley et al. 1986; Kisiday, 
Kurz et al. 2005). Low-serum or serum-free media supplemented with ITS have been 
used in the in-vitro cultivation of chondrocytes (Mandl, Van Der Veen et al. 2002; Chua, 
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Aminuddin et al. 2005; Gigout, Buschmann et al. 2009) and engineered cartilage 
(Fitzsimmons, Sanyal et al. 2004; Kisiday, Jin et al. 2004; Chua, Aminuddin et al. 2005; 
Kisiday, Kurz et al. 2005; Bian, Lima et al. 2008; Kelly, Fisher et al. 2008). In these 
studies, ITS has been shown to be suitable as a partial (Kisiday, Jin et al. 2002; 
Fitzsimmons, Sanyal et al. 2004; Kisiday, Kurz et al. 2005; Kelly, Fisher et al. 2008) or 
full (Kisiday, Kurz et al. 2005; Bian, Lima et al. 2008) substitute for FBS. For instance, 
Kelly and coworkers demonstrated that the supplementation of ITS could reduce the FBS 
content from 20% to 2% while stiffness and biochemical compositions of engineered 
constructs were either maintained or enhanced (Kelly, Fisher et al. 2008). Moreover, 
Kisiday et al. revealed that the replacement of FBS with ITS may largely depend on the 
substrate material since agarose-based cartilage constructs could be grown in a serum-
free ITS-supplemented culture medium whereas ITS media alone did not support the 
development of chondrocyte-laden self-assembling peptide gels (Kisiday, Kurz et al. 
2005). Most of these studies, however, were evaluated under loading-free culture 
conditions or, in a few cases, under conditions of dynamic compressive loading (Kisiday, 
Jin et al. 2004; Kisiday, Kurz et al. 2005; Kelly, Fisher et al. 2008), none of these studies 
employed or investigated the role of hydrodynamic forces. 
Mechanical and biochemical stimuli can act synergistically to regulate cellular 
activities, tissue morphology and tissue properties. In vitro, improved cell function and 
tissue formation have been achieved through the combined application of mechanical 
loading and exogenous growth factors (Ohno, Cooke et al. 1995; Malaviya and Nerem 
2002; Jin, Emkey et al. 2003; Lau, Kapur et al. 2006). Some growth factors, like TGF-β, 
IGF-1 and BMPs, are known to be shear-sensitive, suggesting that their synthesis is 
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promoted in shear-stimulated cells and further that the up-regulation of their signaling 
pathways contributes to differential anabolic activities of cells in response to fluid shear 
stress (Ohno, Cooke et al. 1995; Sakai, Mohtai et al. 1998; Negishi, Lu et al. 2001; Lau, 
Kapur et al. 2006). This evidence substantiates the potential involvement of these soluble 
molecules in mechanotransduction mechanisms.  
A type I collagen-based fibrous capsule (Chapter 1) that is a unique feature of 
tissue-engineered cartilage may be one of the representative examples attributed to the 
combined effects of hydrodynamic forces and soluble biochemical factors. In the present 
study, by employing the WWB system (Chapter 2.3.2.5), we examined the feasibility of 
reduced FBS contents (0%, 0.2% and 2%, v/v) in combination with ITS (1%, v/v) to 
support the development of chondrocyte-seeded PGA scaffolds cultivated under static or 
hydrodynamic conditions and also focused on the synergistic roles of continuous fluid 
shear stress and serum in the capsule formation, given that serum contains both shear-
sensitive and fibrosis-promoting soluble molecules. The results were compared with the 
traditional high-serum (10% FBS, v/v) cultures. We hypothesized that (1) a minimal 
content of shear-sensitive molecules present in serum is required in cultures 
supplemented with ITS in order to produce hydrodynamically engineered constructs 
morphologically, compositionally and mechanically similar to the high-serum constructs 
and (2) the thickness of a fibrous capsule at the construct periphery increases with 






3.2 Materials and Methods 
3.2.1 Materials 
 High glucose Dulbecco’s modified eagle medium (hgDMEM), N-(2-
hydroxyethyl)piperazine N’-2-ethanesulfonic acid (HEPES), L-ascorbic acid, Dulbecco’s 
phosphate-buffered saline (PBS), ethylenediaminetetraacetic acid (EDTA), cysteine, 
Sigmacote®, 1-9-dimethylmethylene blue (DMMB), chondroitin sulfate, chloramines-T 
hydrate, p-dimethylaminobenzaldehyde (pDAB), and hydroxyproline were from Sigma 
(St. Louis, MO). Sodium bicarbonate, L-proline, FBS, penicillin-streptomycin, non-
essential amino acid (NEAA), ITS, 0.4% trypan blue solution, 10% formalin, 6-in. long, 
21 gauge stainless steel needles, magnetic stir bars, silicone tubing, and robber stoppers 
were purchased from VWR International (West Chester, PA). Fungizone, collagenase 
type II, and PicoGreen quantification kit were from Gibco (Carlsbad, CA). Papain 
enzyme was from Worthington (Lakewood, NJ). PGA biofelt (2 mm thick x 85 mg/mL 
bulk density, 97% void volume) was from Concordia Medical (Warwick, RI). Knee joints 
of 1- to 2-week-old bovine calves were obtained from Research 87 (Marlborough, MA). 
 
3.2.2 Bioreactor and Scaffold Preparation 
 Conventional spinner flasks were purchased from Bellco Glass, Inc. (Vineland, 
NJ) and sent to G. Finkenbeiner, Inc. (Waltham, MA) for WWB fabrication based on the 
configuration described in Chapter 2.3.2.5. Briefly, a WWB was assembled by fitting 
them with two Teflon side-arm caps, a magnetic stir bar (0.8 cm diameter x 4 cm long), 
and a rubber stopper. Four 6-in. long, 21 gauge needles were inserted through the stopper 
at equidistant positions. The interiors of bioreactors, needles, and stir bars were then 
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treated with Sigmacote® to form a thin silicone film that prevents cell adherence. After 
evaporation of Sigmacote®, the assembled bioreactors were washed gently, air-dried and 
steam-sterilized. 
 10-mm diameter PGA discs were sterilized by three successive 15-min 
submersions in sterile 70% ethanol and three subsequent 15-min rinses with sterile 
deionized water followed by a 30-min exposure to ultraviolet light. Two sterilized PGA 
discs were threaded onto each of the 21 gauge needles and separated by a 3-mm diameter 
silicone spacer, resulting in a total of eight PGA scaffolds per bioreactor. The WWBs 
were then filled with 120-mL hgDMEM supplemented with 10% FBS, 100 U/mL 
penicillin, 100 U/mL streptomycin, 10 mM HEPES, 0.4 mM L-proline, 0.1 mM NEAA, 
3.6 mg/mL sodium bicarbonate, 2.5 µg/mL fungizone and 50 µg/mL ascorbic acid, and 
were allowed to stabilize overnight with a stir bar spinning at 50 rpm inside a humidified, 
37°C, 5% CO2 incubator. The two side-arm caps were loosened for gas exchange. 
 
3.2.3 Cell Isolation, Cell Seeding and Tissue Culture 
 Isolation of primary chondrocytes was based on the work done by Freed et al 
(Freed, Marquis et al. 1993). Briefly, articular cartilage sections were harvested 
aseptically from the femoropatellar groove of freshly slaughtered 1- to 2-week-old calves. 
Tissue explants were then minced into 1-2 mm
3
 cubes, followed by digestion with type II 
collagenase in hgDMEM at a concentration of 1.5 mg/mL for 17 hours. The supernatant 
of the digested tissues was collected and centrifuged at 1000 rpm for 12 min to obtain 
chondrocyte pellets. Pellets were washed three times with 0.02% EDTA in PBS and 
chondrocytes were then resuspended in the medium specified above. Cell number and 
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viability were determined using a trypan blue exclusion assay. The average cell viability 
remained greater than 90%. A small aliquot of chondrocytes in suspension was then 
added to each of the sterilized bioreactors at a density of five million live cells per 
scaffold. Cell seeding was allowed to proceed for 3-4 days until 95% of the chondrocytes 
achieved attachment.  
At the end of the seeding period, media were completely removed from the 
bioreactors and replaced with fresh hgDMEM supplemented with four different 
combinations of FBS and ITS: (A) 0% FBS + 1% ITS, (B) 0.2% FBS + 1% ITS, (C) 2% 
FBS + 1% ITS and (D) 10% FBS. This point was considered as day zero. Cell-seeded 
PGA scaffolds were then cultured in the WWB agitated by a stir bar at 50 rpm inside an 
incubator for 28 days, and culture media were renewed every 3 days thereafter. 
Constructs were aseptically removed from the bioreactors at specific time points for 
evaluation. A static control experiment without fluid agitation was carried out under the 
same culture conditions as the hydrodynamic study. Figure 3.1 shows a schematic 
overview of the experimental design. 
 
3.2.4 Biomechanics 
 Equilibrium compressive moduli of constructs were determined using an 
unconfined compression test. During examination, a preload of 0.01 N was applied to 
samples until equilibrium was achieved. A stress relaxation test was carried out at strains 
of 5, 10, 15, 20 and 25%, after which samples were allowed to equilibrate. Equilibrium 
moduli were obtained from the slope of the plot of equilibrium force normalized to the 








Figure 3.1 Schematic overview of the experimental design. Dynamic cell seeding 
process was performed in the WWB for 3-4 days and the culture medium was 
supplemented with 10% FBS. Cell-seeded constructs were then cultivated with (A) 1% 
ITS, (B) 0.2% FBS + 1% ITS, (C) 2% FBS + 1% ITS, or (D) 10% FBS in the WWB for 
an additional 28 days in the presence (hydrodynamic groups) or absence (static groups) 






 Prior to biochemical analyses, engineered tissues were weighed (wet weight), 
frozen, lyophilized using a speed vacuum for 24 hours, weighed (dry weight), and 
digested with papain enzyme in a PBS/EDTA/cysteine solution for 17 hours at 60°C. 
DNA was quantified using a PicoGreen dsDNA kit employing a fluorescence 
spectrometer and the number of chondrocytes per construct was calculated by assuming 
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7.7 pg of DNA per chondrocyte (Kim, Sah et al. 1988). Sulfated GAG contents retained 
inside the construct were assessed spectrophotometrically at 525 nm using a DMMB dye-
binding assay (Farndale, Buttle et al. 1986). Chondroitin sulfate was used to create a 
standard curve and a ratio of chondroitin sulfate to GAG of 1 was assumed. Total 
collagen contents were determined using an orthohydroxyproline colorimetric assay, 
assuming a 1:10 orthohydroxyproline-to-collagen concentration ratio (Woessner 1961). 
The concentration of hydroxyproline was measured spectrophotometrically at 550 nm 
after acid hydrolysis and reaction with chloramine-T and pDAB. GAG and total collagen 
contents are presented in values normalized to the wet weight of constructs. 
 
3.2.6 Histology 
 In preparation for histology, constructs were fixed in 10% formalin, embedded in 
paraffin (Histocentre 2, Shandon), and sectioned in 5-7-μm thick slices (Isomet 1000 
Precision Saw, Buehler). The slices were fixed on glass slides and then stained with 
hematoxylin and eosin for cells, safranin-O and fast green for GAG, and Masson’s 
trichrome for collagen. Color images were captured using a standard light microscope 
(Nikon E600, Japan). 
 
3.2.7 Measurement of Capsule Thickness 
 Safranin-O and fast green images captured at 10X magnification were collected 
for image analysis to quantify the thickness of a fibrous capsule. The images were 
converted to grayscale using the RGB split function in ImageJ software (NIH), followed 
by background subtraction and threshold selection. Irrelevant artifacts were then removed 
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and the processed images were sent to NIS-Elements AR 3.0 software (Nikon) for image 
analysis (0.49 µm / pixel). The average thickness of a capsule was calculated by 
normalizing the area of the capsule to its length averaged from the two long sides. 
 
3.2.8 Statistical Analyses 
The hydrodynamic study was repeated three times using the same batch of 
primary chondrocytes collected from three calves, while cells employed in the duplicate 
static experiments were mixed from three other donors. In each set of experiments, two 
(hydrodynamic) or three (static) constructs were harvested from each group at each time 
point for analysis of macroscopic, mechanical and biochemical properties or for 
histological evaluation. Samples collected from identical experiments were assessed 
together (n = 6) and biochemical assays were performed in duplicate. Twenty histological 
images per group, which were randomly selected from the slides that represented the six 
28-day construct blocks, were used for image analysis of capsule thickness (n = 20). 
Statistical data are presented as means ± one standard deviation and statistical analyses 
were performed by Student’s t-test (two-tailed) for comparison between two groups or by 
one-way or two-way analysis of variance (ANOVA) in conjunction with the Bonferroni 
post test for multiple comparisons. Statistical significance was achieved when p-values 












3.3.1 Static Controls 
 To substantiate the importance of shear-sensitive soluble factors in hydrodynamic 
cultivation of tissue-engineered cartilage, a static control study preceded the 
hydrodynamic experiments. Briefly, at the end of the cultivation, similar biochemical 
compositions were observed in the serum-free, low-serum, and high-serum groups 
(Figure 3.2). The average values were 8.58 ± 1.52 million cells per construct, 0.69 ± 
0.13% of wet weight in collagen content and 1.16 ± 0.18% of wet weight in GAG content, 
respectively. The histological specimens (Figure 3.3) revealed that a fibrous capsule 
which is characterized by increased cell density and decreased GAG accumulation was 
only observed at the outer edge of the 2% FBS + ITS and the 10% FBS constructs. These 
thin capsules were about 12.73 μm and 20.79 μm thick in the 2% FBS + ITS and the 10% 






Figure 3.2 Cell number (A), total collagen content (B) and GAG content (C) of 28-
day constructs cultivated with different media in the absence of hydrodynamic stimuli. 
Reduced serum (0-2%) media supplemented with 1% ITS were able to maintain the 
levels of construct properties achieved in the high-serum (10%) group. No statistical 




Table 3.1 Capsule Thickness of 28-Day Static Constructs 
Culture 
Condition 




ND ND 12.73 ± 4.44 20.79 ± 3.10
† 
†







Figure 3.3 Light microscopy images of 28-day static constructs stained with safranin-
O and fast green. GAG, nuclei and cytoplasm are stained red, black and green, 
respectively. The tubular structures represent remaining PGA fibers. The static cultures 
yielded low ECM deposition and an imperceptible fibrous capsule was only observed in 




3.3.2 Hydrodynamic Constructs 
3.3.2.1 Macroscopic Properties 
 The wet weight (Figure 3.4A) of constructs remained similar across the 
experimental groups in the first two weeks of the cultivation whereas the serum-free 
group had at least a 50% reduction in the average wet weight compared with the serum-
containing groups at day 28 (*p < 0.05). In addition, the wet weights of the 0.2% FBS + 
ITS and the 2% FBS + ITS constructs at day 28 were significantly higher than those of 
the same groups at day 3 (^p < 0.05) and day 14 (
#
p < 0.05).  
The dry weight values (Figure 3.4B) of the serum-free constructs at days 14 and 
28 were significantly lower than those of the serum-containing groups at the same time 
points (*p < 0.05) and reached its maximum value at day 3 (
&
p < 0.05). At day 14, the 
dry weights of the 2% FBS + ITS and the 10% FBS constructs decreased about 25% 
when compared with the corresponding 3-day values (
$
p < 0.05). At day 28, the 2% FBS 
+ ITS group was the only experimental group which showed significantly greater dry 
weight than that measured at day 14 (
#
p < 0.05). 
At day 14, the water content (Figure 3.4C) of the serum-free group was higher 
than those of the 2% FBS + ITS and the 10% FBS groups (*p < 0.05). Overall, the water 
contents of all the constructs, except for the serum-free samples, increased over time, and 
significantly greater contents were measured at day 28 when compared with those 








Figure 3.4 Wet weight (A), dry weight (B) and water content (C) of chondrocyte-
seeded constructs cultivated with different media in the presence of hydrodynamic 
stimuli over a 4-week period. *indicates significant difference between the groups; ^and 
#
 
indicate significant increase compared with the 3-day and the 14-day values, respectively, 
within the group; 
$
indicates significant decrease versus the 3-day values within the group; 
&
indicates significant increase compared with both the 14-day and the 28-day values 
within the group; 
@
indicates significant decrease versus both the 14-day and the 28-day 







Figure 3.5 Cell number of chondrocyte-seeded constructs cultivated with different 
media in the presence of hydrodynamic stimuli over a 4-week period. At the end of the 
cultivation, the 2% FBS + ITS and the 10% FBS cultures yielded higher cell proliferation 
than the other two groups. *indicates significant difference between the groups; 
#
indicates 
significantly higher values in comparison with the 14-day values within the group; 
@
indicates significant decrease versus both the 14-day and the 28-day values within the 





3.3.2.2 Cell Proliferation 
 Three days after the initiation of the culture, the cell number per construct (Figure 
3.5) was close to the cell seeding density (five million cells / scaffold) in all the groups 
and the values were 1- to 3.5-fold lower than those achieved at days 14 and 28 (
@
p < 
0.05). At day 14, increased chondrocyte proliferation was detected when the FBS 
concentration was at least 2%. Specifically, both the 2% FBS + ITS (10.00 ± 1.58 million 
cells per construct) and the 10% FBS (11.29 ± 1.52 million cells per construct) values 
were significantly greater than the serum-free value (8.19 ± 0.90 million cells per 
construct) while the average cell number of the 10% FBS constructs was also higher than 
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that of the 0.2% FBS + ITS constructs (8.67 ± 1.03 million cells per construct) (*p < 
0.05). At day 28, constructs in the 2% FBS + ITS (20.56 ± 0.62 million cells per 
construct) and the 10% FBS (20.00 ± 1.90 million cells per construct) groups had 
undergone about two cell population doublings. Conversely, the 0.2% FBS + ITS 
constructs (16.75 ± 2.01 million cells per construct) exhibited less than two population 
doublings while the average cell number in the serum-free group (8.37 ± 2.21 million 
cells per construct) remained unchanged after two weeks in culture. 
 
3.3.2.3 Total Collagen Content 
 At day 3, no significant differences in collagen production (Figure 3.6) were 
observed across the groups, and the values were about 2- to 10-fold lower than those at 
days 14 and 28 (
@
p < 0.05). At day 14, the collagen contents of the 2% FBS + ITS (1.63 
± 0.24% of wet weight) and the 10% FBS (1.65 ± 0.22% of wet weight) constructs were 
significantly higher than those of the 0.2% FBS + ITS (1.33 ± 0.10% of wet weight) and 
the serum-free (1.20 ± 0.10% of wet weight) constructs (*p < 0.05). When compared 
with the corresponding 14-day values, the collagen contents at day 28 increased at least 
38% in the serum-containing groups (
#
p < 0.05) while a 46% reduction was detected in 
the serum-free constructs (
$
p < 0.05). At day 28, similar collagen contents were 
determined in the 2% FBS + ITS (2.46 ± 0.08% of wet weight) and the 10% FBS (2.30 ± 
0.08% of wet weight) groups, both of which were significantly higher than the 0.2% FBS 
+ ITS (1.82 ± 0.13% of wet weight) and the serum-free (0.64 ± 0.06% of wet weight) 
values (*p < 0.05). Overall, the collagen deposition in the serum-free, the 0.2% FBS + 
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ITS and the 2% FBS + ITS constructs reached about 28%, 79% and 106% of the high-






Figure 3.6 Total collagen content of chondrocyte-seeded constructs cultivated with 
different media in the presence of hydrodynamic stimuli over a 4-week period. At the end 
of the cultivation, the serum-free constructs had a compromised total collagen content 
while the 0.2% FBS + ITS and the 2% FBS + ITS values were close to about 79% and 





 indicate significantly higher and lower values, respectively, in comparison 
with the 14-day values within the group; 
@
indicates significant decrease versus both the 





3.3.2.4 GAG Content 
 Similar to total collagen content, GAG accumulation (Figure 3.7) was comparable 
across all the experimental groups at day 3, with values reaching approximately 0.40 ± 
0.10% of wet weight. These values were 2.5- to 6-fold lower than those measured at days 
14 and 28 (
@
p < 0.05). No differences in the GAG content were observed among the 
groups at day 14, where the values fell in the range of 1.42 ± 0.39% of wet weight. 
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Differences emerged at day 28, however, as the GAG contents of the 2% FBS + ITS 
(2.85 ± 0.14% of wet weight) and the 10% FBS (2.99 ± 0.23% of wet weight) groups 
were both significantly higher than those of the serum-free (1.39 ± 0.20% of wet weight) 
and the 0.2% FBS + ITS (2.32 ± 0.16% of wet weight) groups (*p < 0.05). In comparison 
with the corresponding 14-day values, the serum-containing constructs increased GAG 
contents by at least 75% at day 28 (
#
p < 0.05) while the values held steady for the serum-
free group at both time points. Overall, the GAG deposition in the serum-free, the 0.2% 
FBS + ITS and the 2% FBS + ITS constructs reached about 47%, 78% and 95% of the 






Figure 3.7 GAG content of chondrocyte-seeded constructs cultivated with different 
media in the presence of hydrodynamic stimuli over a 4-week period. At the end of the 
cultivation, the serum-free, the 0.2% FBS + ITS and the 2% FBS + ITS constructs 
exhibited 47%, 78% and 95% of the GAG content achieved by the high-serum constructs, 
respectively. *indicates significant difference between the groups; 
#
indicates significantly 
higher values in comparison with the 14-day values within the group; 
@
indicates 
significant decrease versus both the 14-day and the 28-day values within the group; p < 






 Figure 3.8 includes the histological results of 3-day and 28-day hydrodynamic 
constructs. No differences were observed in histology of any 3-day constructs. 
Qualitatively, most chondrocytes initially attached to the outer regions of the PGA 
scaffolds and fewer cells populated the interiors of the constructs. In addition, abundant 
large PGA fibers were present in constructs at this early time point.  
At day 28, the serum-containing samples were more intensely stained for cells 
and ECM components in comparison with the serum-free group. Since polymer scaffolds 
degraded over time, fewer and thinner PGA fibers were observed in the 28-day 
histological specimens. This degradation, however, was not spatially uniform because 
polymer fibers were rare at the construct periphery, but were common towards the center 
of the construct. Interestingly, a fibrous capsule at the periphery of 28-day constructs was 
not observed when the FBS concentration was equal to or less than 0.2%, whereas the 2% 
FBS + ITS and the 10% FBS constructs had a solid fibrous capsule with an average 
thickness of 74.54 μm and 80.84 μm, respectively (Table 3.2). 
 
3.3.2.6 Equilibrium Modulus 
 At the end of the 4-week cultivation, the serum-free constructs (4.94 ± 1.30 kPa) 
were mechanically compromised in comparison with the constructs nourished with FBS 
(^p < 0.05). The 2% FBS + ITS (40.43 ± 7.04 kPa) and the 10% FBS (45.43 ± 5.43 kPa) 
groups demonstrated a comparable level of equilibrium moduli while both the constructs 










Figure 3.8 Light microscopy images of 3-day (1
st





hydrodynamic constructs taken at 10X magnification. Hematoxylin and eosin staining 
(left column): cell nuclei are blue-purple; Masson’s trichrome staining (middle column): 
collagen fibrils are blue and nuclei are black; safranin-O and fast green staining (right 
column): GAG, nuclei and cytoplasm are stained pink/red, black and green, respectively. 
The tubular structures are remaining PGA fibers. More intense ECM staining was 
achieved in the serum-containing groups. A solid fibrous capsule was only observed at 


















4.94 ± 1.30^ 19.74 ± 7.09
 
40.43 ± 7.04* 45.43 ± 5.43*
 
 Capsule thickness: †statistical significance versus the 2% FBS + ITS group; p < 0.01; 
n = 20. ND: non-detectable. 
 Equilibrium modulus: ^significant decrease versus the other groups; *significance 






Our long-term objective is to acquire a broader understanding of the complex 
interplay between fluid shear stress and soluble biochemical factors in neocartilage 
development and capsule formation. To this end, we first focused on the serum effects in 
the present study. Chondrocyte-seeded PGA scaffolds were cultivated with media 
supplemented with various low-serum contents (0%, 0.2% or 2% FBS) plus 1% ITS or 
with typical high-serum concentration (10% FBS) in the presence or absence of turbulent 
flow-induced shear forces generated within the WWB system that provides a defined 
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hydrodynamic environment (Bilgen, Chang-Mateu et al. 2005; Bilgen, Sucosky et al. 
2006; Bilgen and Barabino 2007). In agreement with the previous reports (Fitzsimmons, 
Sanyal et al. 2004; Kisiday, Jin et al. 2004; Chua, Aminuddin et al. 2005; Kisiday, Kurz 
et al. 2005; Bian, Lima et al. 2008; Kelly, Fisher et al. 2008), our data reveal that 
constructs stimulated by ITS-supplemented serum-free or low-serum culture media 
possessed biochemical properties exactly like those of the high-serum constructs in a 4-
week static cultivation process (Figure 3.2). This evidence suggests that ITS is a potential 
substitute for FBS in the static chondrocyte/PGA culture system and that serum is not a 
requirement. In general, the properties of static constructs paled in comparison with those 
of hydrodynamic constructs. 
In contrast to static cultivation, we found that ITS alone was not sufficient for 
hydrodynamic development of neocartilage (Figures 3.5, 3.6 and 3.7). Our observation 
that hydrodynamic constructs cultured with ITS-supplemented low-serum media had 
similar biochemical properties to the high-serum constructs implies that some critical 
constituents in serum are sensitive to fluid shear stress and thus promote shear-stimuli-
induced cell proliferation and ECM production. Our results also suggest that the presence 
of these shear-sensitive components is required to support hydrodynamic cultivation of 
tissue-engineered cartilage. Shear-sensitive soluble molecules associated with 
chondrocyte activities include TGF-β (Ohno, Cooke et al. 1995; Negishi, Lu et al. 2001; 
Malaviya and Nerem 2002), IGF-I (Jin, Emkey et al. 2003), IL-6 (Mohtai, Gupta et al. 
1996) and matrix metalloproteinase (MMPs) (Yokota, Goldring et al. 2003).  
When stimulated by fluid shear stress, the 2% FBS + ITS constructs exhibited 
biochemical (Figures 3.5, 3.6 and 3.7) and mechanical (Table 3.2) properties comparable 
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to those of the high-serum engineered tissues. This is in agreement with a previous study 
carried out by Kelly et al., where dynamic compressive loading was applied to 
chondrocyte-laden agarose gels grown under low-serum conditions (Kelly, Fisher et al. 
2008). Both studies suggest that, under mechanical loading, the biochemical stimuli in 
the 2% FBS + ITS group are not compromised relative to the high-serum condition. 
Similarly, the 0.2% FBS + ITS hydrodynamic constructs demonstrated total collagen 
(Figure 3.6) and GAG (Figure 3.7) contents that were close to 79% and 78% of the 
corresponding high-serum levels. From the standpoint of eliminating or minimizing the 
deleterious effects introduced by serum on in-vitro generation of tissue substitutes, the 
0.2% FBS + ITS formula would yield a more reliable culture environment than the 2% 
FBS + ITS combination. Yet, the 2% FBS + ITS culture medium may be preferred due to 
the significantly superior mechanical strength (Table 3.2) of the construct grown under 
this specific condition. To further elucidate the requirement for ITS in the low-serum 
hydrodynamic cultivation of tissue-engineered cartilage, a follow-up experiment was 
conducted, in which chondrocyte-seeded scaffolds were cultivated with 1% ITS, 2% FBS 
or 2% FBS + ITS. The results (Figure 3.9) indicate that the properties of hydrodynamic 
constructs decreased when ITS was removed from culture media, suggesting that ITS is 
an essential supplement in the 2% FBS + ITS recipe in order to support WWB cultivation 
of neocartilage. In addition, the evidence that a fibrous capsule remained in the 2% FBS 
constructs (Figure 3.10) suggests that FBS rather than ITS plays a more predominant role 






Figure 3.9 Biochemical and mechanical properties of 28-day hydrodynamic 
constructs cultivated with 1% ITS, 2% FBS or 2% FBS + 1% ITS. *indicates significant 








Figure 3.10 Safranin-O and fast green staining of 28-day hydrodynamic constructs 




Our data also reveal that, at days 3 and 14, the wet weight of hydrodynamic 
constructs remained similar in serum-free, low-serum and high-serum groups whereas the 
dry weight of the serum-free constructs decreased drastically when compared with the 
serum-containing groups (Figure 3.4). This reduction in dry weight was likely due to the 
rapid degradation of and/or shear-induced damage to PGA scaffolds since the total dry 
weight of a construct is the sum of cell, ECM and PGA contents and similar biochemical 
compositions were detected in all the groups at day 3 and in the serum-free and the 0.2% 
FBS + ITS constructs at day 14. We recognize that this PGA degradation may be mainly 
attributed to hydrolysis (Agrawal, Athanasiou et al. 1997) instead of other variables such 
as material porosity and permeability, temperature and loading (Agrawal, Mckinney et al. 
2000) because a significant increase in the water content of the serum-free constructs was 
determined in the first two weeks of the cultivation, which possibly accelerated PGA 
degradation. However, it is difficult to validate this degradation process using the WWB 
since a scaffold is anchored in the bioreactor by a stainless steel needle and a 3-mm 
silicone spacer. As polymers degrade with time, the scaffold becomes fragile and can 
easily separate from the needle. It is also noteworthy that both wet and dry weights of the 
serum-free constructs were significantly lower than those of the serum-containing groups 
at the end of the cultivation, which may result from the combined effects of early and 
rapid PGA degradation, poor cell proliferation and insufficient ECM deposition. 
In both static (Figure 3.3) and hydrodynamic (Figure 3.8) studies, a fibrous 
capsule was not induced when engineered tissues were cultured with the FBS 
concentration equal to or less than 0.2%. This outcome agrees with other reports in the 
literature, in which different chondrocyte/hydrogel systems were tested (Kisiday, Jin et al. 
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2002; Kisiday, Kurz et al. 2005; Kelly, Fisher et al. 2008), and suggests that the 
formation of a fibrous cell outgrowth can be reduced by decreasing the serum content in 
culture. A basic mechanism that accounts for the capsule formation is the direct contact 
of chondrocytes at the construct periphery with sufficient amounts of certain serum 
constituents that induce and facilitate fibrosis, such as TGF-β and PDGF (Ignotz and 
Massagué 1986; Lohmann, Schwartz et al. 2000; Kelly, Fisher et al. 2008). As a result, 
the drastic reduction in capsule formation/thickness when the FBS concentration 
decreased from 2% to 0.2% or lower suggests that concentrations of these fibrosis-
promoting molecules did not reach the level required for induction of a capsule.  
A fibrous capsule is more significant in hydrodynamic constructs than in those 
cultivated under loading-free or dynamic compressive loading conditions (Vunjak-
Novakovic, Martin et al. 1999; Kelly, Fisher et al. 2008). As indicated in Chapter 1, this 
observation can result from the direct exposure of articular chondrocytes to continuous 
fluid flow, which own a flattened, elongated cell shape and thereby demonstrate a 
fibroblast-like phenotype (Vunjak-Novakovic, Freed et al. 1996). Another possible 
explanation is that some of the fibrosis-promoting soluble factors are also sensitive to 
fluid shear stress, such as TGF-β (Ignotz and Massagué 1986; Malaviya and Nerem 2002), 
and thus further facilitate the capsule formation in hydrodynamic cultivation of tissue-
engineered cartilage. Additional studies on identification of such molecules and on how 
these factors modulate capsule formation and development are necessary. Taken together, 
our results suggest that the serum content can function as a switch to initiate the process 
of the formation of a fibrous capsule while hydrodynamic forces promote its development. 
Furthermore, although it has been suggested that the removal of this type I collagen-
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based fibrous capsule may be preferred in order to eliminate the interference induced in 
biochemical assays due to a nonchondrocytic phenotype (Kisiday, Kurz et al. 2005), a 
similar fibrous layer was observed in both in-vivo (Fujisato, Sajiki et al. 1996) and in-
vitro (Vinardell, Thorpe et al. 2009) cartilage repair models. This evidence implies that 
the fibrous capsule may enhance the integration of native and engineered cartilage tissues. 
Successful tissue engineering strategies must produce tissue replacements that 
meet the requirements for clinical implantation with respect to their biological, 
mechanical and functional compatibilities with host native tissues. Engineered constructs 
derived from static cultures only exhibit limited potential to satisfy such criteria due to 
the compromised mechanical and biochemical properties, which makes them unsuitable 
tissue substitutes (Bilodeau and Mantovani 2006). The application of turbulent flow-
induced hydrodynamic forces that is aimed to improve mass transport mechanisms of 
nutrients and waste and simultaneously to deliver mechanical stimuli provides an 
alternative approach to the cultivation of three-dimensional cell-biomaterial complexes 
(Freed and Vunjak-Novakovic 1995; Vunjak-Novakovic, Martin et al. 1999; Bilgen, 
Chang-Mateu et al. 2005). However, hurdles attributed to culture media containing high 
concentrations of unreliable serum constituents remain unsolved in hydrodynamic 
cultivation of tissue-engineered cartilage. In addition, the combined effects of serum and 
continuous fluid shear stress on the formation of a fibrous capsule that is commonly 
present in hydrodynamically engineered cartialge have not been thoroughly addressed. 
Therefore, in the current study, we replaced FBS partially or completely with ITS to 
investigate the serum effects on neocartilage development and capsule formation in the 
presence or absence of fluid shear stress induced within the WWB.  
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One of our major findings indicates that, other than insulin, transferrin, and 
selenium, a minimal content of serum is required to support hydrodynamic cultivation of 
neocartilage in order to produce engineered constructs morphologically, compositionally 
and mechanically comparable to the traditional high-serum constructs. The neocartilage 
development supported by the low-serum culture medium may result from the presence 
of shear-sensitive soluble molecules in serum whose expression is up-regulated by fluid 
shear stress and in turn enhances cellular functions and tissue growth. Conversely, under 
the serum-free condition, the removal of these shear-sensitive cues from the culture 
system leads to inferior development of hydrodynamic cartilage constructs. This evidence 
implies that cultured constructs may not benefit from continuous fluid shear stress in the 
absence of shear-sensitive soluble molecules and thereby improved tissue quality cannot 
be achieved. It has been suggested by Malaviya et al. that such regulatory mechanism is 
not solely mediated by a single factor, but by the synergy between all the shear-sensitive 
cues (Malaviya and Nerem 2002). Furthermore, our results also demonstrate that the 
formation of a solid fibrous capsule requires not only sufficient fibrosis-promoting 
soluble molecules but also hydrodynamic forces. Specifically, the process of the capsule 
formation can be activated by certain soluble factors present in the culture environment 
and further promoted by fluid shear stress. Additional studies are necessary to determine 
the soluble biomolecules that are sensitive to fluid shear stress and are involved in the 
fibrosis of neocartilage and to understand how they modulate tissue properties and 
morphology of engineered constructs. In conclusion, this chapter substantiates the 
importance of shear-sensitive signals derived from serum constituents in hydrodynamic 
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cultivation of tissue-engineered cartilage and identifies potential mechanisms that 



























Adapted and modified from Yang, Y.-H. and Barabino, G.A. (in press) Differential Morphology and 
Homogeneity of Tissue-Engineered Cartilage in Hydrodynamic Cultivation with Transient Exposure to 
Insulin-Like Growth Factor-1 and Transforming Growth Factor-β1. Tissue Engineering Part A. 
CHAPTER 4 
IMPROVED BIOCHEMICAL AND MECHANICAL PROPERTIES AND 
DIFFERENTIAL TISSUE MORPHOLOGY OF ENGINEERED CARTILAGE IN 
HYDRODYNAMIC CULTIVATION WITH TRANSIENT EXPOSURE TO 







Arthritis, a form of musculoskeletal disorders which involves joint inflammation 
and cartilage breakdown, affects 50 million Americans, resulting in costs of $128 billion 
annually (Cheng, Hootman et al. 2010). Articular cartilage is a lubricant substrate that 
serves as a cushion between the bones of diarthrodial joints, but only has a limited ability 
for self-healing due to its avascular nature. Tissue engineering is a promising technique 
for restoration of small cartilage defects, which typically involves cultivation of 
chondrocytes or mesenchymal progenitor cells on three-dimensional biodegradable 
scaffolds or hydrogels within bioreactor systems that provide chemically and 
mechanically controllable environmental conditions (Darling and Athanasiou 2003). In 
order to be clinically relevant, tissue-engineered cartilage must meet specific functional 
criteria related to their mechanical properties, biochemical composition, tissue 
ultrastructure, immunological compatibility and integration capability. However, all of 
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these properties of engineered cartilage constructs are still inferior to those of native 
tissues. 
 In-vivo development of avascular cartilage tissues largely relies on the movement 
of the interstitial fluid which is created by joint deformation during walking or exercise. 
This fluid movement generates protein or ion flux in and out of cartilage and thus 
initiates the exchange of trophic and waste substances between the tissue and the 
surrounding synovial fluid. Garcia et al. demonstrated that mass transfer of proteins and 
enzymes such as MMP-1 within articular cartilage could be improved by convection 
when the interstitial fluid flowed at a velocity of 1 µm/s that usually occurs at normal 
walking frequencies (Garcia, Frank et al. 1996; Garcia, Lark et al. 1998). Ex vivo, tissue 
engineering strategies have utilized agitation of medium fluid to enhance the efficiency of 
nutrient delivery to and waste removal from cultured cells. Specifically, laminar flow can 
be generated by perfusion systems (Dunkelman, Zimber et al. 1995; Pazzano, Mercier et 
al. 2000) and rotating vessel reactors (Vunjak-Novakovic, Martin et al. 1999; Martin, 
Obradovic et al. 2000; Emin, Koç et al. 2008) while turbulent flow agitation can be 
established within mechanically stirred bioreactors such as the spinner flask (Vunjak-
Novakovic, Freed et al. 1996; Vunjak-Novakovic, Obradovic et al. 1998; Gooch, Blunk 
et al. 2001) and the WWB (Bueno, Bilgen et al. 2004; Bueno, Laevsky et al. 2007; Bueno, 
Bilgen et al. 2008). 
Growth factors and cytokines are required to support cell growth and tissue 
development in both natural and culture environments. However, Gooch and coworkers 
found that treatment with exogenous IGF-1, a shear-sensitive factor (Jin, Emkey et al. 
2003; Lau, Kapur et al. 2006), could improve tissue properties of chondrocyte-seeded 
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PGA scaffolds when they were cultivated within a rotating vessel bioreactor, but not in 
the spinner flask (Gooch, Blunk et al. 2001). The exact mechanisms that contribute to this 
finding are still unclear, yet it may be attributed to the complex interplay between shear-
sensitive soluble molecules and shear-related parameters such as flow profile and 
magnitude of shear stress. Other possibilities including scaffold properties, such as 
porosity, and cell seeding density also need to be considered. Moreover, Gooch’s 
experiments employed a high-serum (10%) content which contains endogenous growth 
factors, antibodies and binding proteins that may interfere with the function of exogenous 
growth factors added to the culture systems (Friedrich, Haring et al. 2009). When these 
biochemical components are exposed to a hydrodynamic environment like that in the 
Gooch study, it may result in an even more complicated situation. To address this issue, 
we recently developed a low-serum (2%) ITS-supplemented culture medium for the 
WWB cultivation of tissue-engineered cartilage and found that the cultivated neocartilage 
constructs were morphologically, compositionally and mechanically similar to the 
traditional high-serum constructs (Chapter 3). 
 Transient supplementation of exogenous growth factors has recently been utilized 
to facilitate chondrogenesis of chondrocyte- (Lima, Bian et al. 2007; Byers, Mauck et al. 
2008) or MSC-laden (Huang, Stein et al. 2009; Kim, Erickson et al. 2012) hydrogels 
under loading-free or dynamically compressive conditions. In these studies, cell-
encapsulated agarose or hyaluronic acid gels transiently exposed to TGF-β3 demonstrated 
increased cartilage tissue properties relative to those continuously nourished with TGF-β3. 
As Byers et al. suggested, it may be that cultured cells require substantial time of 
approximately 2 weeks to adapt themselves to signaling cascades resulting from growth 
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factor removal from the surroundings before exhibiting stronger potential for ECM 
synthesis (Byers, Mauck et al. 2008). Yet, this beneficial effect has not been validated in 
hydrodynamic cultivation of engineered cartilage constructs. To extend our knowledge, 
the objective of the present study was to evaluate the feasibility of transient exposure of 
tissue-engineered cartilage to growth factors under continuous fluid shear stress induced 
within the WWB. Our central hypothesis was that hydrodynamic constructs continuously 
nourished with exogenous growth factors do not necessarily exhibit improved tissue 
properties over constructs transiently treated with the same bioactive molecules. We 
chose IGF-1 and TGF-β1, two of the key stimulating agents in cartilage development, as 
our model molecules. For each molecule, a minimal concentration was selected from 
their most commonly reported ranges of effective doses for neocartilage cultivation (IGF-
1: 100-300 ng/mL; TGF-β1: 10-30 ng/mL (Blunk, Sieminski et al. 2002; Pei, Seidel et al. 
2002; Mauck, Nicoll et al. 2003)). By quantifying the amount of growth factors 
remaining in waste culture media and the level of expression of the corresponding surface 
receptors by cultured cells, we explored a possible mechanism that accounts for the 
“transient” phenomenon. Between the two exogenous growth factors employed in the 
current study, TGF-β1 is a fibrosis-promoting factor (Ignotz and Massagué 1986; Kelly, 
Fisher et al. 2008; Dobaczewski, Bujak et al. 2010; Meng, Huang et al. 2010; Fragiadaki, 
Ikeda et al. 2011) whereas IGF-1 has not been found to necessarily participate in fibrotic 
processes. We further hypothesized that engineered constructs nourished with exogenous 





4.2 Materials and Methods 
4.2.1 Materials 
Unless specified otherwise, reagents were purchased from VWR (West Chester, 
PA), Sigma (St. Louis, MO), Thermo Fisher Scientific (Waltham, MA) or Life 
Technologies (Grand Island, NY). 
 
4.2.2 Bioreactor and Scaffold Preparation 
 Conventional spinner flasks were purchased from Bellco Glass, Inc. (Vineland, 
NJ) and sent to G. Finkenbeiner, Inc. (Waltham, MA) for WWB fabrication based on the 
configuration described in Chapter 2.3.2.5. Prior to each experiment, the interiors of 
bioreactors, needles, and stir bars were treated with Sigmacote® to prevent cell 
adherence. After evaporation of Sigmacote®, the assembled bioreactors were washed 
gently, air-dried and steam-sterilized. 
PGA discs (Biomedical Structures, Warwick, RI) (Ø10 mm x 2 mm thick, 85 
mg/mL bulk density, 97% void volume) were sterilized by a series of rinses in sterile 
70% ethanol and deionized water, followed by a 30-minute exposure to ultraviolet light. 
Two of the sterilized PGA discs were threaded onto each of the 21 gauge needles and 
separated by a silicone spacer, resulting in totally eight scaffolds per bioreactor. The 
WWBs were then filled with 120-mL hgDMEM and allowed to stabilize overnight with a 






4.2.3 Cell Isolation, Cell Seeding and Tissue Culture 
 Articular chondrocytes were isolated from femoropatellar grooves of freshly 
slaughtered 2-week-old calves (Research 87, Marlborough, MA) by digestion with type II 
collagenase as previously described (Freed, Marquis et al. 1993). Prior to each 
experiment, primary chondrocytes harvested from three donors were pooled together. 
Cell number and viability (> 85%) were determined using a trypan blue exclusion assay. 
A small aliquot of cells in suspension was added to each of the sterilized WWBs at a 
density of 5 million live cells per scaffold. The cell seeding process was carried out in the 
basal medium (BM) and allowed to proceed for 4 days under fluid agitation (50 rpm) 
until 95% of the cells achieved attachment (Figure 4.1). The BM was defined as the low-
serum ITS-supplemented (2% FBS + ITS) culture medium developed in Chapter 3 and 
was composed of hgDMEM, 2% FBS, 1% ITS, 100 U/mL penicillin/streptomycin, 10 
mM HEPES, 0.4 mM L-proline, 0.1 mM NEAA, 3.6 mg/mL sodium bicarbonate, 2.5 
µg/mL fungizone and 50 µg/mL ascorbic acid.  
 At the end of the seeding process, media were completely replaced with fresh BM. 
This point was considered as day zero. Chondrocyte/PGA complexes were then cultured 
in the WWBs agitated at 50 rpm for 28 days and media were completely renewed every 3 
days thereafter. In the groups nourished with exogenous growth factors, 100 ng/mL IGF-
1 or 10 ng/mL TGF-β1 (recombinant human proteins, R&D Systems, Minneapolis, MN) 
was added to fresh BM during medium exchanges either for the first 15 days of the 
culture (transient) or throughout the entire 4-week cultivation (continuous). Bioreactors 
were collected at designated time points (Figure 4.1) and engineered tissues were 
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harvested for evaluation. For the Smad study, constructs were also cultivated in the 






Figure 4.1 Schematic overview of the experimental design. The 4-day cell seeding 
process was carried out in the basal medium (BM). Chondrocyte-seeded constructs were 
nourished with IGF-1 or TGF-β1 and cultivated in the WWBs for 4 weeks. For 
transiently treated constructs, growth factor supplementation was discontinued at day 15 
and culture media were switched to the BM for the rest of the cultivation. Bioreactors 






 Equilibrium compressive moduli of constructs were determined using an 
unconfined compression test. During examination, a preload of 0.01 N was applied to 
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samples until equilibrium was achieved. A stress relaxation test was carried out at strains 
of 5, 10, 15, 20 and 25%, after which samples were allowed to equilibrate. Equilibrium 
moduli were obtained from the slope of the plot of equilibrium force normalized to the 
cross-sectional area of the construct versus the strains. 
 
4.2.5 Biochemistry 
 Prior to the biochemical assays, constructs were weighed (wet weight), frozen, 
lyophilized and then digested with papain enzyme. DNA weights were quantified using a 
PicoGreen dsDNA kit and the manufacturer’s instructions were followed. Cell numbers 
were calculated by assuming 7.7 pg of DNA per chondrocyte (Kim, Sah et al. 1988). 
Sulfated GAG contents were assessed using a DMMB dye-binding assay (Farndale, 
Buttle et al. 1986). Chondroitin sulfate was used to create a standard curve and a 
chondroitin sulfate-to-GAG ratio of 1 was assumed. Total collagen amounts were 
determined using an orthohydroxyproline colorimetric assay, assuming a 1:10 
orthohydroxyproline-to-collagen ratio (Woessner 1961). GAG and total collagen contents 
are presented in values normalized to the wet weight of constructs. 
 
4.2.6 Enzyme-Linked Immunosorbent Assay (ELISA) 
 Concentrations of IGF-1 and active TGF-β1 in waste media and levels of IGF-1 
receptor (IGF-1R) and TGF-β receptor type II (TGF-βRII) in engineered tissues were 
quantified using DuoSet Enzyme-Linked Immunosorbent Assay Developmental kits 
(R&D Systems) and the manufacturer’s instructions were followed. For detection of IGF-
1R and TGF-βRII, one half of each of harvested constructs was lysed and homogenized 
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in 1% Triton X-100 lysis buffer plus protease inhibitor cocktails, followed by a 15-
minute centrifugation at 10,000 × g at 4˚C. The supernatant was collected for ELISA and 
IGF-1R and TGF-βRII contents were estimated with recombinant human proteins, given 
the 97% and 91% similarity of amino acid sequence for IGF-1R and TGF-βRII, 
respectively. The other half was assessed to obtain the DNA amount. Data are presented 
in values normalized to the corresponding DNA weight. 
 
4.2.7 Western Blot 
 Proteins were isolated as described in the previous section on ELISA and total 
protein concentration was determined using a BCA Protein Assay kit. Equal amounts of 
proteins were electrophoresed on 10% polyacrylamide gels (Bio-Rad, Hercules, CA) and 
transferred to nitrocellulose membranes. The membranes were then incubated with 
blocking buffer for 1 hour and purified rabbit antibodies against phospho-Smad2 
(pSmad2), phospho-Smad3 (pSmad3) or Smad7 (1:1000) overnight. After several washes, 
the membranes were treated with IRDye 800CW secondary antibodies (1:5000, Li-Cor, 
Lincoln, NE) for 1 hour. Images were visualized using an infrared scanner (Odyssey, Li-
Cor). 
 
4.2.8 Histology and Immunohistochemistry 
 Constructs were fixed, embedded in paraffin and sectioned in 5-μm thick slices. 
The slices were deparaffinized and stained for GAG and collagen using safranin-O/fast 
green and Masson’s trichrome methods, respectively. 
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IGF-1R and TGF-βRII molecules were stained immunohistochemically. Briefly, 
deparaffinized sections were incubated with citrate buffer heated to 99°C for 25 minutes 
to retrieve antigens, followed by a 20-minute cooling at room temperature. The samples 
were then incubated with 0.3% hydrogen peroxide for 30 minutes, blocking buffer for 20 
minutes, and primary rabbit anti-bovine antibodies (1:1500, Abcam, Cambridge, MA) 
overnight. Finally, the sections were treated with biotinylated secondary antibodies 
(1:200, Vector Labs, Burlingame, CA) for 30 minutes and streptavidin-conjugated 
horseradish-peroxidase complex (Vector Labs) for another 30 minutes, followed by the 
incubation with diaminobenzidine chromogen reagent until optimal staining was 
developed. Samples incubated with normal rabbit serum substituted for primary 
antibodies were used as negative controls and no non-specific staining was observed. 
Color images were captured under a light microscope (Nikon Eclipse Ti, Japan). 
 
4.2.9 Measurement of Capsule Thickness 
For image analysis, twenty safranin-O and fast green histological images captured 
at 10X magnification were collected from each group (six constructs) in order to quantify 
the thickness of a fibrous capsule. The images were converted to grayscale using the 
RGB split function in ImageJ software (NIH), followed by background subtraction and 
threshold selection. Irrelevant artifacts were then removed and the processed images were 
sent to NIS-Elements AR 3.0 software (Nikon) for image analysis (0.49 µm / pixel). The 
average thickness of a capsule was calculated by normalizing the area of the capsule to its 




4.2.10 Statistical Analyses 
 Statistical data were obtained from experiments repeated three times with two to 
three replicates per group per time point per experiment and are presented as means ± one 
standard deviation. Statistical analyses were performed by one-way or two-way ANOVA 
in conjunction with the Bonferroni post test for multiple comparisons with significance at 
a p value of less than 0.05. 
 
4.3 Results 
4.3.1 Tissue Properties and Morphology 
 When stimulated by IGF-1 (Figure 4.2) or TGF-β1 (Figure 4.3), 14-day constructs 
exhibited increased cell proliferation, GAG and collagen deposition and mechanical 
strength in comparison with the untreated ones (*p < 0.05). Specifically, relative to the 
control group, the properties of the engineered tissues treated with either growth factor 
were improved by at least 29% in cell number, 47% in GAG content, 24% in collagen 
content and 34% in equilibrium modulus. 
At day 28, although treatment with exogenous growth factors did not necessarily 
result in a higher cell content, the nourished groups yielded engineered tissues 
biochemically and mechanically stronger than those in the control group while transient 
exposure to growth factors further enhanced construct properties in both the IGF-1 
(Figure 4.2) and the TGF-β1 (Figure 4.3) cases (*p < 0.05). Specifically, the transient 
IGF-1 constructs had predominant collagen (3.66 ± 0.20% of wet weigh vs. 2.52 ± 0.19% 
[control] and 2.80 ± 0.18% [continuous]) and GAG (4.21 ± 0.11% of wet weight vs. 2.43 
± 0.25% [control] and 2.83 ± 0.21% [continuous]) accumulation and equilibrium moduli 
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(87.82 ± 8.48 kPa vs. 39.43 ± 7.63 kPa [control] and 52.73 ± 3.36 kPa [continuous]). 
Similar trends were recognized in the TGF-β1 experiments in which the highest 
biochemical contents (4.30 ± 0.13% of wet weight in collagen and 3.67 ± 0.15% of wet 
weight in GAG) and mechanical stiffness (136.43 ± 29.99 kPa) were detected in the 
transient group though GAG contents of the transient and the continuous TGF-β1 
constructs were not statistically different. However, the difference in tissue quality 




Figure 4.2 Cell number, total collagen content, GAG content and equilibrium 
compressive modulus of hydrodynamic constructs in the IGF-1 study. ^represents 
significant difference from the corresponding 14-day value; *indicates statistical 












 At the end of the cultivation, a fibrous capsule which is usually characterized by 
increased cell density and decreased (virtually none) GAG deposition and consists mainly 
of type I collagen (Vunjak-Novakovic, Freed et al. 1996; Kisiday, Kurz et al. 2005; 
Bueno, Bilgen et al. 2008; Kelly, Fisher et al. 2008) was observed at the periphery of 
both the control and the IGF-1 constructs (Figure 4.4), and a similar thickness of the 
capsule was measured in these groups (Table 4.1). Conversely, exposure to TGF-β1 




Figure 4.3 Cell number, total collagen content, GAG content and equilibrium 
compressive modulus of hydrodynamic constructs in the TGF-β1 study. ^represents 
significant difference from the corresponding 14-day value; *indicates statistical 


























Figure 4.4 Histological images of 28-day hydrodynamic constructs taken at 10X 
magnification. Left column: collagen is stained blue. Right column: GAG and cytoplasm 
are stained red and green, respectively. Arrows indicate the structure of the fibrous 
capsule which only appeared at the periphery of the control and the IGF-1 hydrodynamic 
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4.3.2 IGF-1 and TGF-β1 in Waste Culture Media 
 IGF-1 or active TGF-β1 levels in waste media were quantified every 3 days to 
obtain the uptake/release curves of each molecule. The IGF-1 concentration (Figure 4.5A, 
left) in the continuous IGF-1 group rose over time and reached a steady-state level after 
21 days in culture, whereas the TGF-β1 level (Figure 4.5B, left) in the continuous TGF-
β1 group gradually decreased in the first two weeks of the cultivation then began to rise 
at day 18 and continuously increased thereafter. At day 27, the IGF-1 and TGF-β1 
concentrations detected in the corresponding continuous groups were 120.68 ± 2.00 
ng/mL and 14.90 ± 0.65 ng/mL, respectively. Conversely, the growth factor levels in both 
the transient groups remained relatively low and constant after two weeks in culture (
&
p < 
0.05). The final IGF-1 and TGF-β1 concentrations measured in the corresponding 
transient groups at day 27 were 3.57 ± 3.49 ng/mL and 2.74 ± 1.93 ng/mL, respectively. 
The control group showed extremely low concentrations of IGF-1 (Figure 4.5A, right) 
and TGF-β1 (Figure 4.5B, right) which were only detectable toward the end of the 4-
week cultivation (at day 27, the IGF-1 and TGF-β1 concentrations were 0.17 ± 0.08 






Figure 4.5 Quantification of IGF-1 (A) and TGF-β1 (B) in waste culture media in the 
IGF-1 and the TGF-β1 experiments, respectively. Dashed lines represent the 
concentrations of exogenous growth factors initially added to fresh media during medium 
exchanges in the continuous groups. 
&
indicates significant difference relative to the 





4.3.3 IGF-1R and TGF-βRII 
Quantification of IGF-1R (Figure 4.6A) and TGF-βRII (Figure 4.6B) in the 
respective experiments indicated that, at day 14, chondrocytes nourished with either 
growth factor expressed more receptors than the untreated ones (*p < 0.05). Figure 4.6A 
reveals that reduced IGF-1R expression was determined at day 28 in both the transient 
(442.86 ± 45.59 pg/µg DNA) and the continuous (300.50 ± 50.08 pg/µg DNA) IGF-1 
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groups compared with the corresponding 14-day value (608.51 ± 30.58 pg/µg DNA) (^p 
< 0.05). At the end of the cultivation, the IGF-1R level in the transient IGF-1 group was 
found significantly higher than that in the continuous IGF-1 group while both values 
were compromised relative to the control group (526.08 ± 19.65 pg/µg DNA) (*p < 0.05). 
Immunohistochemistry (Figure 4.7A) confirmed that the untreated (control) samples 
contained the most intense IGF-1R staining at day 28. 
Figure 4.6B demonstrates that chondrocytes transiently exposed to exogenous 
TGF-β1 expressed TGF-βRII at a level of 135.10 ± 21.61 pg/µg DNA at day 28, which 
remained similar to the corresponding 14-day value (129.14 ± 9.65 pg/µg DNA), but was 
significantly higher than the other groups at the same time point (*p < 0.05). 
Qualitatively, the control specimens (Figure 4.7B) were intensely stained for TGF-βRII 
 
 
Figure 4.6 Quantitative evaluation of IGF-1 receptor (IGF-1R) (A) and TGF-β 
receptor type II (TGF-βRII) (B) in the IGF-1 and the TGF-β1 experiments, 
respectively. IGF-1R and TGF-βRII contents were quantified and estimated with the 
corresponding recombinant human proteins. ^represents significant difference from 
the corresponding 14-day value; *indicates statistical significance between the groups; 

























in the region close to the edge of engineered tissues whereas both the transient and the 
continuous TGF-β1 specimens showed weak TGF-βRII signals at the construct periphery, 






Figure 4.7 Qualitative evaluation of IGF-1 receptor (IGF-1R) (A) and TGF-β 
receptor type II (TGF-βRII) (B) in the IGF-1 and the TGF-β1 experiments, respectively. 
IGF-1R and TGF-βRII are stained brown in the corresponding 28-day hydrodynamic 
constructs. Images were taken under the same optical conditions for each molecule. Scale 






Figure 4.8 Western blot of phospho-Smad2 (pSmad2), phospho-Smad3 (pSmad3), 
Smad7 and GAPDH. Chondrocyte-seeded constructs were cultivated with (+) or without 
(-) TGF-β1 in the presence (dynamic) or absence (static) of fluid shear stress induced 






 Regulation of major intracellular mediators in the TGF-β signaling pathway by 
TGF-β1 and fluid shear stress was evaluated. In this study, constructs were cultivated 
with or without TGF-β1 in the presence or absence of hydrodynamic forces. Western blot 
results (Figure 4.8) revealed that, without TGF-β1, more Smad2 and Smad3 were 
phosphorylated under hydrodynamic stimuli at days 14 and 28. In both static and 
dynamic groups, TGF-β1-nourished samples demonstrated more intense pSmad2 than the 
untreated ones at the same time points. However, relative to the untreated groups, 
supplementation with exogenous TGF-β1 increased pSmad3 signals under static 
conditions, but decreased its intensity in the presence of fluid shear stress at both time 
points. At day 28, the dynamic group with shortened TGF-β1 nourishment (+/T) did not 
surrender pSmad2 and pSmad3 in comparison with that under continuous TGF-β1 
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stimulation (+/C). Smad7 was only determined in the dynamic groups. Specifically, 
stronger Smad7 signals were detected in the TGF-β1-treated group at day 14 whereas 
similar intensity was observed among the groups at day 28. 
 
4.4 Discussion 
 In this chapter, chondrocyte-seeded PGA scaffolds were cultured transiently or 
continuously with IGF-1 or TGF-β1 in the WWBs for 4 weeks. Our results reveal that 
IGF-1 and TGF-β1 effectively promoted the early development of neocartilage, 
suggesting that early growth factor supply is required to enhance cell signaling and 
communication. Yet, engineered tissues did not largely benefit from continuous growth 
factor stimulation over time, especially in IGF-1 cultures (Figure 4.2). This observation 
implies that the prolonged exposure to IGF-1 may constrain the development of 
hydrodynamic constructs. Conversely, discontinuation of growth factors at day 15 
eventually led to constructs with better biochemical and mechanical properties (Figure 
4.2 and Figure 4.3). Our findings suggest that economical tissue engineering approaches 
can be developed to produce robust neocartilage through the combination of 
hydrodynamic bioreactor systems and transient supplementation of exogenous growth 
factors. 
A similar beneficial effect on chondrocyte growth has previously been 
documented (Lima, Bian et al. 2007; Byers, Mauck et al. 2008). In contrast to the present 
work demonstrating this “transient” effect under continuous fluid agitation, however, the 
study reported by Lima and coworkers indicated that the advantage of TGF-β3 removal 
vanished in neocartilage cultivation with continuous deformational loading (Lima, Bian 
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et al. 2007). It was speculated that the application of dynamic compressive forces could 
retain 2-to-3-fold greater concentrations of growth factors inside an engineered construct 
than free swelling conditions (Mauck, Hung et al. 2003) such that the localized growth 
factors reached the level where cellular catabolic activities were elicited (Lima, Bian et al. 
2007). Such detrimental results were eliminated by delayed compressive stimuli applied 
after the termination of the TGF-β3 supply, suggesting that preconditioning of 
chondrocytes with growth factors can facilitate construct development during subsequent 
exposure to deformational loading (Lima, Bian et al. 2007). Although the contexts of 
culture systems, for example, type of growth factor, scaffolding material and loading 
condition and profile are quite different in Lima’s and our studies, making direct 
comparisons challenging, all of these findings indicate the complexity involved in 
mechanotransductive signaling that cells may elicit in response to various external 
mechanical stimuli and the corresponding loading protocols. 
We further explored the kinetics of growth factor uptake/release by stimulated 
cells in relation to the duration of exposure to IGF-1 or TGF-β1. Diverse time-dependent 
trends were identified in the IGF-1 (Figure 4.5A, left) and the TGF-β1 (Figure 4.5B, left) 
cultures, indicating that the need for each growth factor in articular chondrocytes is 
governed by differential mechanisms. The final growth factor concentrations in waste 
culture media measured in all of the groups were higher than those added to fresh media, 
suggesting that chondrocytes possess the ability to secrete endogenous IGF-1 (Schlechter, 
Russell et al. 1986; Clemmons, Busby et al. 2002) and TGF-β (Villiger and Lotz 1992; 
Cheung, Lee et al. 2001) for self-supplementation such that their desire for exogenous 
growth factors gradually decreases. It has also been demonstrated that both IGF-1 and 
92 
 
TGF-β are shear-responsive molecules, meaning their expression and synthesis can be 
promoted by fluid shear stress (Negishi, Lu et al. 2001; Lau, Kapur et al. 2006). This 
evidence may account for the elevated concentrations of IGF-1 and TGF-β1 detected in 
culture media and implies the unnecessity of the continuous addition of these two growth 
factors to hydrodynamic culture systems. 
 The modulation of growth factor secretion into the surroundings by 
supplementation protocols also altered the expression of the associated surface receptors, 
i.e. IGF-1R and TGF-βRII.  The IGF-1R levels in both the transient and the continuous 
IGF-1 samples decreased over time (Figure 4.6A) while a similar decline in TGF-βRII 
was noticed in the continuous TGF-β1 group (Figure 4.6B). It is believed that overdoses 
of growth factors can suppress the expression of their own receptors (Krupp and Lane 
1981; Gebken, Feydt et al. 1999) possibly through enhanced receptor degradation 
(Kosmakos and Roth 1980). Future inquiries into changes in receptor numbers due to 
their interactions with other environmental factors such as ECM components (Takeuchi, 
Nakayama et al. 1996) are necessary. Besides, the inclusion of ITS as part of medium 
supplements, which contains 10 μg/mL insulin, may also contribute to the IGF-1 
accumulation in culture media (Figure 4.5A) and the IGF-1R down-regulation in cells 
(Figure 4.6A) determined in the current study. Rationally, insulin and IGF-1 are highly 
similar in molecular structure, both of which are capable of cross-reacting with insulin 
receptor and IGF-1R (Schumacher, Mosthaf et al. 1991; Dupont, Khan et al. 2001). 
Although each receptor attracts its own ligand with a 100-to-1000-fold higher affinity 
than that to the other heterologous molecules (Dupont, Khan et al. 2001), it is possible 
that insulin present in the BM interfered with the binding between IGF-1 and IGF-1R 
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such that the disturbed expression of both molecules was observed. The dose of ITS (1%) 
employed here has been shown to be essential to support the WWB cultivation of tissue-
engineered cartilage in the presence of a minimal content of serum (Chapter 3). Taken 
together, one of the contributing mechanisms to the suppressed influence of continuous 
exposure to IGF-1 or TGF-β1 on construct development may be attributed to the 
accumulation of exogenous and endogenous growth factors in the culture environments 
which elicits a negative feedback response that inhibits cellular expression of specific 
surface receptors and probably accelerates subsequent catabolic activities (Morales and 
Roberts 1988; Lima, Bian et al. 2007). On the contrary, transient exposure to IGF-1 or 
TGF-β1 is likely to maintain chondrocyte homeostasis and thus promotes their anabolic 
functions under hydrodynamic stimuli. 
 The formation of a fibrous capsule at the construct periphery is believed to result 
from the direct contact of chondrocytes with medium supplements that induce fibrotic 
processes (Ignotz and Massagué 1986; Lohmann, Schwartz et al. 2000; Kelly, Fisher et al. 
2008), and is further promoted as rounded articular chondrocytes deform into a flattened, 
elongated fibroblast-like shape under fluid agitation (Vunjak-Novakovic, Freed et al. 
1996) and thus produce more type I collagen, but less GAG (Guh, Yang et al. 1996; 
Darling and Athanasiou 2005). We also reported that sufficient fibrosis-promoting 
soluble factors are necessary to initiate the process of the capsule formation even in 
hydrodynamic cultivation (Chapter 3). Although one of the two hypotheses of the present 
study was that engineered tissues treated with TGF-β1, a molecule capable of facilitating 
fibrosis of different tissues and organs (Ignotz and Massagué 1986; Dobaczewski, Bujak 
et al. 2010; Meng, Huang et al. 2010; Fragiadaki, Ikeda et al. 2011), will form a thicker 
94 
 
fibrous capsule in comparison with the untreated ones, we found that it was valid only 
when constructs were exposed to static conditions (data included in the next paragraph). 
Conversely, a capsule was eliminated from hydrodynamic neocartilage transiently or 
continuously nourished with exogenous TGF-β1 (Figure 4.4). One possible explanation is 
that elongated cells at the periphery of the TGF-β1 constructs expressed a minimal level 
of TGF-βRII (Figure 4.7B),  the molecule which is associated with the initial binding of 
TGF-β and triggers subsequent intracellular reactions (Gebken, Feydt et al. 1999), so they 
were blocked from receiving TGF-β1 signals and thus acted like normal chondrocytes. In 
addition, discontinuation of TGF-β1 supplementation at day 15 did not rescue the fibrous 
capsule in hydrodynamic constructs, indicating that this fibrotic process is mostly 
governed and influenced by environmental factors present in early neocartilage 
development. In combination with the findings reported in Chapter 3, we suggest a 
biphasic dose-dependent effect of TGF-β on the capsule formation in hydrodynamic 
cultivation of tissue-engineered cartilage. Given that the concentration of TGF-β in FBS 
is approximately 16 ng/mL after being activated (Danielpour, Kim et al. 1989; 
Danielpour 1993), a fibrous capsule can be eliminated from hydrodynamic cartilage 
constructs when they are cultured with a TGF-β level lower than 0.032 ng/mL (i.e. 0.2% 
FBS) or higher than 10.32 ng/mL (2% FBS + 10 ng/mL TGF-β1). Supportively, a recent 
study revealed that high doses of TGF-β (10 ng/mL) could suppress type I collagen 
synthesis by fibroblasts via up-regulation of CUX1, a transcription factor (Fragiadaki, 
Ikeda et al. 2011). Regulation of chondrocyte-related fibrosis by TGF-β at the 
transcriptional level requires further investigations. It is also noteworthy that 
chondrocytes in the TGF-β1 constructs did not accumulate at the outer edges of the 
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constructs, where a fibrous capsule usually occurs. It has been demonstrated in several 
cell types including mast cells, fibroblasts and lymphocytes that cell aggregation can 
cause fibrosis of various tissues and organs such as bone marrow (Chiu, Nanaji et al. 
2009), lung (Katzenstein 1985; Bantsimba-Malanda, Marchal-Sommé et al. 2010) and 
liver (Carthew, Edwards et al. 1991). Therefore, it is possible that a lower degree of 






Table 4.2 Biochemical Properties and Capsule Thickness of 28-Day Static and 
Hydrodynamic Constructs 

































































 Total collagen and GAG contents: ^significant decrease versus the corresponding 
dynamic group; *significant increase versus the control group under the same 
loading conditions; 
#
significant difference from the transient group under the same 
loading conditions; p < 0.05; n = 4 (static) or 7 (dynamic). WW: wet weight. 
 Capsule thickness: ^significance versus the static control group (p < 0.05); 
†
significance versus the static control group (p < 0.001); *significance versus the 
















We further investigated regulation of predominant cytoplasmic mediators in TGF-
β signaling by TGF-β1 and/or fluid shear stress and attempted to connect their expression 
to neocartilage development and capsule formation. Amongst these biomolecules, both 
Smad2 and Smad3 are receptor-regulated proteins while Smad7 is an inhibitory factor 
(Derynck and Zhang 2003; Shi and Massagué 2003). We found that TGF-β1 or fluid 
shear stress alone increased the phosphorylation of both Smad2 and Smad3 (Figure 4.8), 
leading to enhanced cartilage growth and capsule formation (Table 4.2 and Figure 4.9). 






Figure 4.9 Staining of GAG and type I collagen in 28-day constructs cultured 




 rows: GAG and cytoplasm are stained 
pink/red and green, respectively. 3
rd
 row: type I collagen is stained brown. Images 










amplified pSmad2 signals, but lowered pSmad3 intensity, yielding improved cartilage 
quality, but reduced capsule structure. Evaluation of Smad7 (Figure 4.8) indicated that 
the reduction in pSmad3 was likely due to the direct action of Smad7 on Smad3 signaling 
in the early dynamic cultivation, but might be managed by other mechanisms in the later 
stage. Previously, Brown and coworkers identified the diverse roles Smad2 and Smad3 
play in epithelial cells and fibroblasts (Brown, Pietenpol et al. 2007). We herein suggest 
that Smad2 and Smad3 primarily dominate chondrocyte- and fibroblast-specific 
phenotypes, respectively, in articular chondrocytes and both the pathways are potently 
promoted by TGF-β or fluid shear stress.  However, TGF-β reversely regulates Smad2 
and Smad3 signaling pathways in the presence of hydrodynamic stimuli partially through 
Smad7. Table 4.3 summarizes fluid shear stress/TGF-β-regulated Smad expression in 




Table 4.3 Summary of Potential Smad Regulation on Chondrocyte Activities in 









Cell/Tissue Responses  
(versus Control) 
Static 
TGF-β1 or  
Fluid shear stress 
pSmad2 ↑ 
pSmad3 ↑ 
Cartilage matrix ↑ 





Cartilage matrix ↑ 
Capsule formation ↓ 
*Smad7 inhibits phosphorylation of Smad3 in the early development of tissue-engineered 








 This chapter demonstrates a cost-efficient tissue engineering strategy for cartilage 
repair by combining transient exposure to exogenous growth factors with a 
hydrodynamic culture system. With this system, we identified a potential mechanism 
related to homeostasis between growth factor secretion and receptor expression to explain 
increased ECM production by chondrocytes cultured under transient stimulation of 
exogenous IGF-1 or TGF-β1. A biphasic response to concentrations of fibrosis-
promoting soluble molecules such as TGF-β was also recognized in the process of the 
capsule formation during the development of hydrodynamically engineered cartilage. 
Finally, we gained a preliminary understanding of chondrogenesis and fibrosis of 
chondrocytes governed by Smad2 and Smad3, respectively. Since the current study is 
limited to a single drug dose and one fluid agitation rate, future investigations are 
required to determine how varied combinations of growth factor concentration and shear 
stress magnitude impact the “transient” phenomenon, capsule formation and Smad 
expression. The strategy reported here holds promise for tissue engineering applications 
that utilize allogeneic chondrocytes harvested from healthy young donors. These juvenile 
cells may be preferred because they are thought to possess a stronger ability to regenerate 
cartilage tissues (Tran-Khanh, Hoemann et al. 2005) and can be isolated without causing 
further damage to patients. Collectively, our findings provide valuable insights for 
establishment of a better growth factor supplementation protocol, capsule formation and 
Smad regulation on chondrocyte activities, all of which can effectively contribute to the 








Adapted and modified from Yang, Y.-H. and Barabino, G.A. (in press) Differential Morphology and 
Homogeneity of Tissue-Engineered Cartilage in Hydrodynamic Cultivation with Transient Exposure to 
Insulin-Like Growth Factor-1 and Transforming Growth Factor-β1. Tissue Engineering Part A. 
CHAPTER 5 
DIVERSE EFFECTS OF A FIBROUS CAPSULE ON TISSUE HOMOGENEITY 







Articular cartilage which covers the surfaces of synovial joints is designed to 
allow smooth contact between long bones and to absorb shock induced during joint 
movement. The load-bearing function of articular cartilage is built upon a combination of 
its unique ECM components and properties which are both inhomogeneous and 
anisotropic. Aging, disease or abnormal loading (overloaded or immobilized) conditions 
applied to diarthrodial joints may cause degeneration of articular cartilage. To date, only 
a few therapeutic strategies aimed to restore the function of damaged cartilage tissues 
exist. Among the common surgical treatments for cartilage defects are abrasion 
arthroplasty, subchondral drilling, microfracture, transplantation of autografts or 
allografts and total joint replacement (Brittberg, Lindahl et al. 1994; Andres, Mears et al. 
2001; Hangody, Feczkó et al. 2001; Sgaglione, Miniaci et al. 2002; Bos and Ellermann 
2003; Hand, Lobo et al. 2003; Huntley, Bush et al. 2005; Jakobsen, Engebretsen et al. 
2005; Saris, Vanlauwe et al. 2008; Ronn, Reischl et al. 2011). Yet, formation of 
fibrocartilage or scar tissues at the defect site, which usually accompanies natural and 
100 
 
reparative cartilage healing processes, persists as a major issue in cartilage regeneration 
(Shapiro, Koide et al. 1993; Andres, Mears et al. 2001; Knutsen, Engebretsen et al. 2004; 
Ronn, Reischl et al. 2011). Although these fibrous tissues comfort patients by alleviating 
pain, they are composed of abundant type I collagen fibrils and therefore are 
biochemically and mechanically compromised relative to healthy articular cartilage 
(Knutsen, Engebretsen et al. 2004). Evidently, inhomogeneous mechanical properties 
owned by the regenerated cartilage tissue may elicit severe disruption within the tissue 
(Ahsan and Sah 1999) and lead to recurrence of tissue degeneration (Shapiro, Koide et al. 
1993; Khan, Gilbert et al. 2008). Tissue engineering as a means of producing high quality 
tissue substitutes by combining appropriate cell sources, materials, engineering tools and 
stimulating agents holds considerable promise for diminishing variations in functional 
properties between the implant and the surrounding host tissues. Nevertheless, tissue 
heterogeneity may also arise within each engineered construct (Kelly, Ng et al. 2006; 
Kelly, Ng et al. 2009; Sheehy, Buckley et al. 2011) and thus needs to be reviewed prior to 
implantation. 
A successful tissue-engineered construct also needs to integrate strongly and 
stably with native tissues to maintain the integrity of the regenerated tissue since poor 
integration can cause an altered property of the implant and ultimately its degradation 
(Khan, Gilbert et al. 2008). The quality of tissue integration depends on a variety of 
factors such as the developmental stage of the implant (Obradovic, Martin et al. 2001; 
Dimicco, Waters et al. 2002), architecture and composition of the implant and the 
adjacent tissues (Tognana, Chen et al. 2005), and choices of scaffolding materials 
(Hunter and Levenston 2004) and cell sources (Vinardell, Thorpe et al. 2009) for tissue-
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engineered constructs. Although many have demonstrated that a structure similar to 
fibrocartilage usually forms at the implant-cartilage interfaces (Shapiro, Koide et al. 1993; 
Fujisato, Sajiki et al. 1996; Khan, Gilbert et al. 2008; Vinardell, Thorpe et al. 2009), 
several approaches have been developed to improve integrative repair of articular 
cartilage. For instance, pre-incubation of the implant with Z-VAD-FMK or Necrostatin-1 
which inhibits cell apoptosis and necrosis, respectively, at the wound edge was found to 
strengthen its ability to integrate with native cartilage (Khan, Gilbert et al. 2008; Gilbert, 
Singhrao et al. 2009). A study reported by Djouad et al. further revealed that the blockage 
of extracellular regulated kinase (ERK) signaling pathways by an inhibitor, U0126, 
prevented the production of proteinases induced by pro-inflammatory cytokines such as 
interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) and thus doubled the 
adhesive stress at the integration site (Djouad, Rackwitz et al. 2009). Obradovic and 
coworkers showed that treatment of host cartilage with trypsin promoted its fusion with 
immature (5-day) engineered tissues, but had no apparent effects on the integration with 
mature (5-week) constructs or with intact cartilage explants (Obradovic, Martin et al. 
2001). In addition, cartilage tissue integration can also be improved by the use of 
biological glues like tissue transglutaminase (Jürgensen, Aeschlimann et al. 1997) and 
fibrin-based gels (Silverman, Bonasser et al. 2000; Peretti, Zaporojan et al. 2003; Peretti, 
Campo-Ruiz et al. 2006). A fibrin glue gel (made up of fibrinogen and thrombin) seeded 
with chondrocytes was utilized to join two separate pieces of cartilage to yield a thick 
tissue complex (~ 4 mm) (Silverman, Bonasser et al. 2000) and the sandwiched construct 
grew more homogeneously when the incorporated cartilage slices were decellularized 
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(Peretti, Campo-Ruiz et al. 2006). This evidence substantiates that the extent of tissue 
integration is greatly influenced by both extrinsic and intrinsic elements. 
A fibrous capsule represents a unique characteristic of tissue-engineered cartilage 
and is usually found at the outer edge of neocartilage (Vunjak-Novakovic, Freed et al. 
1996; Kisiday, Kurz et al. 2005; Bueno, Bilgen et al. 2008; Kelly, Fisher et al. 2008). The 
capsule consists of rich type I collagen and sparse GAG molecules and thereby resembles 
fibrocartilage (Guh, Yang et al. 1996; Darling and Athanasiou 2005). The formation of a 
fibrous capsule is modulated by the complex interactions of environmental factors 
present in culture, such as medium supplements and mechanical stimuli. We have 
demonstrated that the initiation of the capsule formation relies on the concentration of 
serum (Chapter 3). Specifically, when engineered cartilage is nourished with media 
containing a minimal FBS content of 2%, one can expect a fibrous capsule at the end of a 
4-week cultivation, whose thickness is at least 12 μm in static cultures or 74 μm in 
hydrodynamic cultures. As described in the previous chapters, engineered constructs 
exposed to turbulent flow-induced shear conditions display a solid capsule potentially 
due to the deformation of articular chondrocytes at the construct periphery, which leads 
to a phenotypic change of the cells from the chondrocytic nature to the fibroblastic nature 
(Vunjak-Novakovic, Freed et al. 1996). It has been suggested that it may be necessary to 
remove the capsule and only retain the central portion of tissue-engineered cartilage for 
further biochemical evaluations (Kisiday, Kurz et al. 2005) or implantation procedures 
(Moyer, Wang et al. 2010) in order to minimize the nonchondrocytic phenotype of the 
product. However, the mechanical integrity of the construct may be sacrificed due to the 
ECM damage created around and/or at the cut surface of the construct during capsule 
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removal. Besides, the role of the fibrous capsule in cartilage tissue integration remains 
unclear. 
Collectively, the present study was aimed to investigate how the presence of the 
fibrous capsule affects the homogeneity of tissue-engineered cartilage and alters the 
construct capability to integrate with native cartilage. We have previously utilized the 
WWB system in combination with exogenous growth factors, IGF-1 and TGF-β1, to 
produce two types of hydrodynamically engineered constructs, both of which exhibit 
comparable biochemical and mechanical properties, but different tissue morphologies 
(Chapter 4). Specifically, the properties of the IGF-1 and the TGF-β1 hydrodynamic 
constructs (transiently treated) are 4.21 ± 0.11% and 3.67 ± 0.15% of wet weight in GAG 
content, 3.66 ± 0.20% and 4.30 ± 0.13% of wet weight in total collagen content, and 
87.82 ± 8.48 kPa and 136.43 ± 29.99 kPa in equilibrium modulus, respectively. 
Morphologically, engineered tissues nourished with IGF-1 have a solid capsule with an 
average thickness of about 80 μm whereas treatment with TGF-β1 yields constructs 
without a capsule. This allows us to test the hypothesis that the capsule-containing (CC) 
(IGF-1) constructs will demonstrate compromised tissue homogeneity and have a less 
strong inner core compared with the capsule-free (CF) (TGF-β1) constructs. Moreover, 
the ability of the intact hydrodynamic neocartilage with or without a fibrous capsule to 
integrate with native cartilage tissues was assessed using an established in-vitro cartilage 
explant model (Obradovic, Martin et al. 2001; Dimicco, Waters et al. 2002; Hunter and 
Levenston 2004; Djouad, Rackwitz et al. 2009; Gilbert, Singhrao et al. 2009; Vinardell, 




5.2 Materials and Methods 
5.2.1 Materials 
Unless specified otherwise, reagents were purchased from VWR (West Chester, 
PA), Sigma (St. Louis, MO), Thermo Fisher Scientific (Waltham, MA) or Life 
Technologies (Grand Island, NY). 
 
5.2.2 Bioreactor and Scaffold Preparation 
 Conventional spinner flasks were purchased from Bellco Glass, Inc. (Vineland, 
NJ) and sent to G. Finkenbeiner, Inc. (Waltham, MA) for WWB fabrication based on the 
configuration described in Chapter 2.3.2.5. Prior to each experiment, the interiors of 
bioreactors, needles, and stir bars were treated with Sigmacote® to prevent cell 
adherence. After evaporation of Sigmacote®, the assembled bioreactors were washed 
gently, air-dried and steam-sterilized. 
10-mm (for the tissue homogeneity experiments) or 5-mm (for the tissue 
integration experiments) PGA discs (Biomedical Structures, Warwick, RI) (2 mm thick, 
85 mg/mL bulk density, 97% void volume) were sterilized by a series of rinses in sterile 
70% ethanol and deionized water, followed by a 30-minute exposure to ultraviolet light. 
Two of the sterilized PGA discs were threaded onto each of the 21 gauge needles and 
separated by a silicone spacer, resulting in totally eight scaffolds per bioreactor. The 
WWBs were then filled with 120-mL hgDMEM and allowed to stabilize overnight with a 





5.2.3 Cell Isolation, Cell Seeding and WWB Cultivation 
 Articular chondrocytes were isolated from femoropatellar grooves of freshly 
slaughtered 2-week-old calves (Research 87, Marlborough, MA) by digestion with type II 
collagenase as previously described (Freed, Marquis et al. 1993). Cell number and 
viability (> 85%) were determined using a trypan blue exclusion assay. A small aliquot of 
cells in suspension was added to each of the sterilized WWBs at a density of 5 million 
live cells per scaffold. Cell seeding was carried out in the BM (hgDMEM, 2% FBS, 1% 
ITS, 100 U/mL penicillin/streptomycin, 10 mM HEPES, 0.4 mM L-proline, 0.1 mM 
NEAA, 3.6 mg/mL sodium bicarbonate, 2.5 µg/mL fungizone and 50 µg/mL ascorbic 
acid) and allowed to proceed for 4 days under fluid agitation (50 rpm) until 95% of the 
cells achieved attachment.  
 Following the cell seeding process, chondrocyte-seeded PGA scaffolds were 
cultivated in the WWBs agitated at 50 rpm for an additional 28 days and were nourished 
with either 100 ng/mL IGF-1 or 10 ng/mL TGF-β1 (R&D Systems, Minneapolis, MN) 
for the first 15 days of the culture. Herein, we only employed constructs transiently 
exposed to exogenous growth factors since these engineered tissues were previously 
demonstrated to exhibit better biochemical and mechanical properties than those 
continuously treated with the same molecules (Chapter 4). Culture media were 
completely renewed every 3 days and the growth factors were added to fresh BM during 
medium exchanges. Tissue-engineered constructs were harvested at the end of the 





5.2.4 Experimental Design 
5.2.4.1 Tissue Homogeneity 
 A 5-mm central core was punched out of each of the 28-day hydrodynamic 
constructs (Ø10~11 mm) and variations in tissue properties between the inner core and 
the outer annulus (radial variations) were quantified to determine the homogeneity of 
tissue-engineered cartilage (Figure 5.1A).  
 
5.4.2.2 Tissue Integration 
 The ability of the 28-day hydrodynamic constructs (Ø~5 mm x ~2.5 mm thick) to 
integrate with native cartilage was evaluated using a cartilage explant model (Figure 
5.1B). Briefly, native cartilage explants were harvested from bovine donors and shaped 
into discs (Ø10 mm × 3 mm thick) by aseptically removing both superficial and deep 
zone cartilage tissues. A 5-mm central core was then punched out of each of the discs to 
yield a cartilage plug (Ø5 mm) and a cartilage outer ring (inner and outer diameters were 
5 mm and 10 mm, respectively). The thickness of the cartilage plugs was then reduced to 
2.5 mm. A disc/ring hybrid tissue composite was formed by randomly incorporating each 
of the three types of grafts, i.e. native cartilage plug, CF construct and CC construct, into 
one of the created cartilage rings by press-fit. The assembled hybrid composites were 
cultivated with a serum-free ITS-supplemented medium (hgDMEM, 1% ITS, 100 U/mL 
penicillin/streptomycin, 10 mM HEPES, 0.4 mM L-proline, 0.1 mM NEAA, 3.6 mg/mL 
sodium bicarbonate, 2.5 µg/mL fungizone and 50 µg/mL ascorbic acid) for 4 weeks 
under static conditions and were maintained in transwells (top and bottom compartments 







Figure 5.1 Schematic overview of the tissue homogeneity (A) and the tissue 
integration (B) studies. (A) Tissue homogeneity of 28-day hydrodynamic constructs was 
determined by evaluating radial variations in tissue properties (inner core versus outer 
annulus). (B) A disc/ring hybrid composite was formed by incorporating each graft into a 
created native cartilage ring by press-fit and was cultured in a transwell for 4 weeks 







 Equilibrium compressive moduli of engineered tissues were determined using an 
unconfined compression test. During examination, a preload of 0.01 N was applied to 
samples until equilibrium was achieved. A stress relaxation test was carried out at strains 
of 5, 10, 15, 20 and 25%, after which samples were allowed to equilibrate. Equilibrium 
moduli were obtained from the slope of the plot of equilibrium force normalized to the 
cross-sectional area of the construct versus the strains. 
 Adhesive strength is defined as the stress that fractures a hybrid composite at the 
integration site during a push-through test (Figure 5.2A). Briefly, the inner disc of a 
composite was gradually pushed out by a 4-mm plunger at a rate of 10 µm/s while the 
composite was placed on a custom-designed rigid annular ring with a 6-mm center hole. 
The force at ultimate failure (Figure 5.2B) was normalized to the lateral area of the inner 






Figure 5.2 Push-out test (A) and a representative force vs. time curve during a push-
out test (B). Adhesive strength of a hybrid composite at the integration site was 







 Prior to the biochemical assays, constructs were weighed (wet weight), frozen, 
lyophilized and then digested with papain enzyme. DNA weights were quantified using a 
PicoGreen dsDNA kit and the manufacturer’s instructions were followed. Sulfated GAG 
contents were assessed using a DMMB dye-binding assay (Farndale, Buttle et al. 1986). 
Chondroitin sulfate was used to create a standard curve and a chondroitin sulfate-to-GAG 
ratio of 1 was assumed. For compositional analysis of collagen, papain-digested samples 
were further incubated with 1 mg/mL pancreatic elastase in 1X Tris-buffered saline 
solution for 48 hours at 4˚C to cleave intra- and inter-molecular cross-linkages of 
collagen. Type I and II collagen contents were measured using enzyme-linked 
immunosorbent assay (ELISA)-based detection kits (Chondrex, Redmond, WA) and the 
manufacturer’s instructions were followed. GAG and type I and II collagen contents are 
presented in values normalized to the wet weight or the DNA weight of constructs. 
 
5.2.7 Histology and Immunohistochemistry 
 Constructs or hybrid composites were fixed, embedded in paraffin and sectioned 
in 5-μm thick slices. The slices were deparaffinized and stained for GAG and collagen 
using safranin-O/fast green and Masson’s trichrome methods, respectively. 
Type I and II collagen molecules were stained immunohistochemically. Briefly, 
deparaffinized sections were incubated with citrate buffer heated to 99°C for 25 minutes 
to retrieve antigens, followed by a 20-minute cooling at room temperature. The samples 
were then incubated with 0.3% hydrogen peroxide for 30 minutes, blocking buffer for 20 
minutes, and primary rabbit anti-bovine antibodies (1:1500, Abcam, Cambridge, MA) 
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overnight. Finally, the sections were treated with biotinylated secondary antibodies 
(1:200, Vector Labs, Burlingame, CA) for 30 minutes and streptavidin-conjugated 
horseradish-peroxidase complex (Vector Labs) for another 30 minutes, followed by the 
incubation with diaminobenzidine chromogen reagent until optimal staining was 
developed. Samples incubated with normal rabbit serum substituted for primary 
antibodies were used as negative controls and no non-specific staining was observed. 
Color images were captured under a light microscope (Nikon Eclipse Ti, Japan). 
 
5.2.8 Electron Microscopy 
 Harvested hybrid composites were fixed in 2% glutaradehyde solution in 0.1 M 
cacodylic acid buffer for 48 hours at 4ºC, followed by several rinses in the buffer and 
deionized water. For scanning electron microscopy (SEM), samples were dehydrated in a 
graded ethanol series (30%, 50%, 75%, 95% and 100%) and dried in a critical point dryer 
(Autosamdri-814, Tousimis, Rockville, MD). The dried samples were mounted onto 
aluminum stubs (Electron Microscopy Sciences, Hatfield, PA) and then coated with a 
thin layer of gold (SPI-Module Sputter, SPI Supplies, West Chester, PA). Images were 
captured using an SEM (Aquila, Topcon Positioning Systems, Livermore, CA). 
For transmission electron microscopy (TEM), rinsed composites were further 
fixed in 1% osmium tetroxide for 2 hours at room temperature and incubated with 0.5% 
uranyl acetate for another hour. After several washes, samples were dehydrated in a 
graded ethanol series (30%, 50%, 75%, 95% and 100%), followed by an Epon infiltration 
process to embed specimens in resin (Electron Microscopy Sciences). The resin blocks 
were then sectioned in 60-nm thick slices that were mounted onto meshed gilder grids 
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(Electron Microscopy Sciences) and post-stained with methanolic uranyl acetate and 
Reynold's lead citrate. The grids were viewed under a TEM (JEM-1210, Jeol, Japan) and 
images captured at 25000X were collected for image analysis using AMT Capture Engine 
Software V602 (Advanced Microscopy Techniques, Woburn, MA) to measure the 
diameter of collagen fibrils at the integration sites. 
 
5.2.9 Statistical Analyses 
 In the tissue homogeneity study, statistical data were obtained from experiments 
repeated twice with two replicates per group per experiment and knee chondrocytes 
harvested from three bovine donors (donors X, Y and Z) were pooled together and used 
in the entire study. 
 The tissue integration study was repeated three times and chondrocytes isolated 
from five donors (donors A, B, C, D and E) were mixed to grow different implanted 
tissue constructs required in all the three experiments. Prior to each experiment, fresh 
cartilage explants were collected from three donors (experiment 1: donors F, G and H; 
experiment 2: donors I, J and K; experiment 3: donors L, M and N) to prepare cartilage 
outer rings for the study. Similar trends were detected in all the three experiments and 
data shown here represent one of the experiments. 
Statistical data are presented as means ± one standard deviation and statistical 
analyses were performed by one-way or two-way ANOVA in conjunction with the 






5.3.1 Radial Variations 
 Evaluation of radial variations showed that the CC (1.45 ± 0.11% of wet weight) 
and the CF (2.65 ± 0.20% of wet weight) inner cores reached 51% and 79% of the 
collagen II contents achieved by the respective intact constructs and either inner core 
value was also lower than the corresponding outer annulus level (*p < 0.05) (Figure 
5.3A). When values were normalized to DNA weight (Figure 5.3B), chondrocytes in the 
CC outer annuli produced a greater amount of collagen including both type II (39.53 ± 
2.79 µg/µg DNA) and type I (20.72 ± 1.93 µg/µg DNA) relative to those in the inner 
cores (*p < 0.05) whereas comparable collagen synthetic activities were detected 
throughout the CF constructs. A significant difference in collagen I-to-II ratio (Figure 
5.3C) between outer annuli and inner cores was identified in the CC group (annulus: 0.52 






Figure 5.3 Type II collagen content (A), type II and I collagen synthetic potential (B) 
and collagen I to II ratio (C) of outer annuli and inner cores of 28-day hydrodynamic 
constructs transiently treated with IGF-1 (CC) or TGF-β1 (CF). Percentages represent the 
inner core values normalized to the corresponding intact construct values. *indicates 




In GAG analysis, the CF inner cores (3.82 ± 0.25% of wet weight) contained a 
GAG composition equivalent to that of the intact CF constructs (3.48 ± 0.20% of wet 
weight) whereas the CC inner cores (2.75 ± 0.04% of wet weight) had a compromised 
GAG content in comparison with both the outer annulus (4.11 ± 0.33% of wet weight) 
and the intact construct (3.73 ± 0.19% of wet weight) values (*p < 0.05) (Figure 5.4A). 
While cells in the CF inner cores (36.03 ± 8.53 µg/µg DNA) exhibited significantly 
weaker GAG synthetic potential than those in the outer annuli (50.80 ± 1.44 µg/µg DNA), 
opposite behavior was recognized in the CF group (*p < 0.05) (Figure 5.4B). 
Biomechanically, equilibrium moduli of the CC (33.72 ± 7.61 kPa) and the CF (76.40 ± 
14.44 kPa) inner cores matched 37% and 59% of the corresponding intact construct 






Figure 5.4 GAG content (A), GAG synthetic potential (B) and equilibrium 
compressive modulus (C) of outer annuli and/or inner cores of 28-day hydrodynamic 
constructs transiently treated with IGF-1 (CC) or TGF-β1 (CF). Percentages represent the 
inner core values normalized to the corresponding intact construct values. *indicates 







Histologically, the CF specimens were more intensely stained for type II collagen 
than the CC specimens in both the outer annulus and the inner core regions (Figure 5.5A). 
Abundant type I collagen molecules were present in the CC outer annuli. Figure 5.5B 
reveals that intense GAG staining was observed throughout the CF constructs while the 







Figure 5.5 Immunohistochemical staining of type II and type I collagen (A) and 
histological staining of GAG (B) in 28-day hydrodynamic constructs transiently treated 
with IGF-1 (CC) or TGF-β1 (CF). (A) Collagen molecules are stained brown. (B) GAG 
and cytoplasm are stained red and green, respectively. Images were taken under the same 
optical conditions for each molecule. Scale bar = 100 µm (10X magnification). CC: 




5.3.2 Tissue Integration 
5.3.2.1 Tissue Morphology of Grafts Used to Form Hybrid Composites 
 Prior to preparation of hybrid composites, tissue morphologies of the three types 
of grafts, i.e. native cartilage plug, CF construct and CC construct, were confirmed by 
histology and immunohistochemistry. Figure 5.6 shows that a fibrous capsule was only 






Figure 5.6 Histology and immunohistochemistry of tissue grafts for implantation. (1
st
 
row) GAG and cytoplasm are stained red and green, respectively. (2
nd
 row) type I 
collagen molecules are stained brown. (3
rd
 row) type II collagen molecules are stained 
brown. Images were taken under the same optical conditions for each molecule. Scale bar 







5.3.2.2 Adhesive Strength 
 At the end of the 4-week static cultivation, harvested hybrid composites were 
subjected to a push-out test to determine the adhesive strength at the cartilage-cartilage or 
the construct-cartilage interface. The results (Figure 5.7) revealed that the CC constructs 
(10.93 ± 0.76 kPa) possessed the strongest capability to integrate with the surrounding 
articular cartilage tissues, followed by the CF constructs (6.95 ± 0.25 kPa) and then the 






Figure 5.7 Adhesive strength of hybrid composites at the integration site. The CC and 
the CF constructs represented the engineered cartilage tissues transiently treated with 
IGF-1 and TGF-β1, respectively, in the pre-hydrodynamic cultivation. ***indicates 
significant difference between the groups; p < 0.001; n = 8 (cartilage plugs) or 9 (CC and 








5.3.2.3 Electron Microscopy and Histology 
 SEM (Figure 5.8) indicated that all the three types of hybrid composites 
demonstrated a certain level of integration on and/or close to the surface of the composite 






Figure 5.8 Scanning electron microscopy of 28-day hybrid composites. Images were 
captured at 30X (1
st
 row) or 350X (2
nd
 row). The 350X images represent the enlarged 






Histology and immunohistochemistry were used to visualize tissue integration at 
the disc-ring interface throughout the full depth of hybrid composites (Figure 5.9). 
Although most interfacial regions remained separate in all the cases, the CC and the CF 
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groups had some areas that showed integration. More cells and denser ECM components 
were accumulated at the integration site of the construct-cartilage composites in the CC 
group. Conversely, the implant and the adjacent native tissue were still intact in the native 
cartilage controls and a continuous gap (> 50 μm) existed at the disc-ring interface. In 







Figure 5.9 Histology and immunohistochemistry of 28-day hybrid composites. (1
st
 
row) Type I collagen molecules are stained brown. (2
nd
 row) Collagen molecules are 
stained blue. (3
rd
 row) GAG molecules are stained red. Scale bar = 50 µm (20X 







The deposition of collagen fibrils at the integration sites of the CC and the CF 
hybrid composites was detected by TEM (Figure 5.10). These collagen fibrils were found 
to highly align in the same direction parallel to the disc-ring interface. Specifically, the 
CC group contained an organization composed of tightly packed collagen fibrils while 
the CF group demonstrated a relatively low level of collagen alignment and sparse 
collagen molecules. In contrast, no collagen fibrils were identified at the disc-ring 
interface of the cartilage-cartilage composites since the gaps were not filled with any 






Figure 5.10 Transmission electron microscopy of 28-day hybrid composites. Images 
represent the regions at the integration sites and were captured at 12000X. Scale bar = 







5.3.2.4 Collagen Fibril Diameter 
 Twenty 25000X TEM images per group were collected to calculate the average 
diameters of collagen fibrils found at the integration sites and at least fifteen (CF) or 
twenty-five (CC) random fibrils were measured per image. The results showed that the 
average value of the CC group (25.58 ± 7.27 nm) was significantly higher than that of the 
CF group (18.08 ± 6.29 nm) while both of them were compromised relative to the 
average diameter of collagen fibrils (46.50 ± 13.69 nm) located in freshly harvested 
articular cartilage tissues (Figure 5.11A). In the diameter distribution (Figure 5.11B), 
about 59% of the collagen fibrils in the CC group had a diameter ranged from 20 nm to 
30 nm and at least 79% of the fibrils were thicker than 20 nm. Conversely, the majority 
of the collagen diameters in the CF group fell in the range between 10 nm and 20 nm 






Figure 5.11 Diameter (A) and diameter distribution (B) of collagen fibrils at the 
integration sites. (A) ***indicates significant difference between the groups; p < 0.001; n 
= 120 (articular cartilage) or > 300 (engineered constructs). (B) *p < 0.05; **p < 0.01; 




 Development of engineered cartilage with spatially homogeneous tissue 
properties remains challenging. Many studies have been focused on improving nutrient 
transport efficiency to yield better tissue homogeneity. For example, Kelly and coworkers 
cultivated chondrocyte-laden agarose gels under either free-swelling or compressively 
loaded conditions and found that a more even ECM synthetic potential was achieved by 
cells encapsulated in the loaded samples (Kelly, Ng et al. 2009). Under fluid agitation, 
similar hydrogel constructs embedded with microchannels also demonstrated greater 
tissue uniformity than those without channels (Sheehy, Buckley et al. 2011). To our best 
knowledge, however, no reported studies have evaluated the capsule effects on tissue 
homogeneity of engineered cartilage, probably due to the lack of techniques to produce 
intact capsule-free constructs. 
The CC and the CF engineered tissues were produced in the WWB system 
combined with the previously established growth factor supplementation protocols 
utilizing IGF-1 and TGF-β1, respectively (Chapter 4). The divergent tissue morphologies 
of the two types of the constructs due to the presence of a type I collagen-based fibrous 
layer covering the construct did influence the tissue homogeneity. Specifically, superior 
biochemical homogeneity was observed in the constructs without a capsule whereas the 
inner cores of the CC constructs exhibited significantly decreased type II collagen (Figure 
5.3A) and GAG (Figure 5.4A) contents compared with their own outer annuli. This 
reduction is likely due to compromised collagen (Figure 5.3B) and GAG (Figure 5.4B) 
synthetic abilities of the cells occupying the inner cores of the CC constructs. 
Suggestively, the fibrous capsule which is composed of abundant cells may block the 
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chondrocytes in the interiors of the constructs from receiving medium supplements, 
which thus demonstrate suppressed potential to synthesize ECM components. This 
blockage can be attributed to the capsule acting as a shield to hinder molecular transport 
similar to that observed on the exterior of embryoid bodies (Bratt-Leal, Carpenedo et al. 
2009) or as a sink to consume the majority of nutrients. Noteworthily, the increased 
production of type I collagen by the cells in the outer annuli of the CC constructs may be 
organized into the formation of the fibrous capsule (Figure 5.3C). In contrast, cells in the 
CF engineered tissues possessed uniform potential for collagen deposition throughout the 
constructs (Figure 5.3B & C) and slightly better GAG synthesis in the inner cores of the 
constructs (Figure 5.4B). Although greater biochemical homogeneity ultimately led to 
better mechanical strength exhibited by the CF constructs which had stronger inner cores 
in comparison with the CC constructs, the stiffness of the inner core was lower than that 
of the intact construct in both the CC and the CF cases (Figure 5.4C). This observation 
substantiates that even though a uniform biochemical composition is detected throughout 
a tissue construct, extraction of the inner core from the construct by a punch biopsy is 
likely to damage its matrix network at the cut surfaces, suggesting that removal of 
construct periphery, i.e. capsule, will compromise the mechanical integrity of the 
engineered tissue. 
Successful cartilage repair requires integration of implanted engineered constructs 
with surrounding host tissues to sustain the overall integrity and the long-term 
functionality of the restored joint when exposed to external loads (Khan, Gilbert et al. 
2008). The second part of the current study was aimed to evaluate the potential of the 
fibrous capsule to contribute to cartilage integration. The in-vitro cartilage explant model 
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employed here allows us to retain control over environmental variables (Obradovic, 
Martin et al. 2001; Hunter and Levenston 2004; Djouad, Rackwitz et al. 2009; Gilbert, 
Singhrao et al. 2009) and thus to concentrate on the capsule effects. Previous studies in 
which the same cartilage model was utilized suggested the possible formation of a fibrous 
tissue covering the surfaces of the cultured hybrid composites, resulting in overestimation 
of integrative strength at the disc-ring interface (Moretti, Wendt et al. 2005; Gilbert, 
Singhrao et al. 2009). We speculated that the basic mechanism that drives the creation of 
this fibrous layer is similar to that involved in the capsule formation, i.e. through the 
direct contact of cultured chondrocytes with medium supplements that induce fibrotic 
processes (Ignotz and Massagué 1986; Lohmann, Schwartz et al. 2000; Kelly, Fisher et al. 
2008). Therefore, hybrid composites were cultivated with a serum-free ITS-supplemented 
medium in the present study since we have previously demonstrated that this medium 
combination can potentially eliminate the formation of a fibrous capsule and 
simultaneously support cartilage development under loading-free conditions (Chapter 3). 
The SEM images confirm that the fibrous cell outgrowth on the composite surfaces was 
impeded or minimized as the implanted grafts were still distinguishable after 4 weeks in 
culture with native cartilage rings (Figure 5.8). 
While tissue integration occurred at the disc-ring interface on and/or close to the 
composite surfaces, different wound gap sizes were observed within the composite in all 
the three groups, with some regions in which the gaps were narrower or closed. This is in 
agreement with other studies (Obradovic, Martin et al. 2001; Hunter and Levenston 2004; 
Tognana, Chen et al. 2005; Gilbert, Singhrao et al. 2009; Theodoropoulos, De Croos et al. 
2011), suggesting that the cultivation time of 3 to 8 weeks is too short to achieve full 
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integration. The strongest and weakest integrative strengths were found in the CC and the 
native control groups, respectively (Figure 5.7). This outcome may be attributed to a 
combination of multiple factors. Sprouting of ECM components in the interfacial zone is 
a key indicator of tissue integration (Obradovic, Martin et al. 2001; Peretti, Zaporojan et 
al. 2003). Buds of new cartilage matrix, however, were only detected in the CC and the 
CF hybrid composites (Figure 5.9), which verified that native cartilage tissues barely 
bound to each other. Furthermore, one can expect that a greater extent of ECM 
penetration into the adjacent tissues will be accomplished when a longer culture period is 
applied (Peretti, Zaporojan et al. 2003). 
The initial affinity to host cartilage tissues may predominantly depend on the 
GAG content of the implant (Obradovic, Martin et al. 2001; Tognana, Chen et al. 2005). 
Rationally, negatively charged GAG molecules form the branches of aggrecan monomers 
present in articular cartilage and tend to generate repelling forces against each other 
(Knudson and Knudson 2004). The lack of GAG in the region of the capsule present at 
the periphery of the CC constructs (Figure 5.6) might decrease the initial resistance to the 
surrounding native tissues. Conversely, the cartilage plugs had the most abundant GAG 
amounts that theoretically yielded the strongest force opposing the cartilage rings and 
thereby suppressed the integration. Supportively, Tognana and coworkers revealed that 
the integrative affinity of engineered cartilage to bone, a tissue containing little GAG, 
was significantly higher than that to cartilage, suggesting a negative correlation between 
tissue GAG content and construct adhesion (Tognana, Chen et al. 2005). As a result, 
several bioactive agents such as trypsin and chondroitinase have been utilized to reduce 
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GAG concentrations at tissue edges in order to promote cartilage integration (Lee, Sung 
et al. 2000; Obradovic, Martin et al. 2001; Khan, Gilbert et al. 2008).  
Native cartilage rings used in this cartilage explant model are created by 
mechanical dissociation and cell death is then introduced at the cut surfaces that mimic 
surgical wounds (Tew, Kwan et al. 2000). Cell death occurring at the edges of both the 
inner disc and the outer ring may also account for the compromised adhesive strength 
determined at the cartilage-cartilage interface (Hunter and Levenston 2004; 
Theodoropoulos, De Croos et al. 2011). It has been demonstrated that this poor tissue 
integration can be improved by treating damaged articular cartilage with anti-apoptosis 
molecules such as Z-VAD-FMK during wound repair which increase the number of 
viable cells at the wound edge and prevent matrix loss (Gilbert, Singhrao et al. 2009). 
Thus, one of the benefits of implanting intact engineered cartilage is to maintain high cell 
viability such that cells at the implant periphery can migrate across the interfacial zone 
and facilitate tissue integration (Theodoropoulos, De Croos et al. 2011). In comparison 
with the CF composites, the high cellularity of the fibrous capsule is likely to further 
enhance the fusion of the CC constructs with native cartilage since more proliferating 
chondrocytes were observed at the integration site (Figure 5.9), leading to higher 
adhesive stress (Figure 5.7). 
In agreement with previous reports (Shapiro, Koide et al. 1993; Fujisato, Sajiki et 
al. 1996; Khan, Gilbert et al. 2008; Vinardell, Thorpe et al. 2009), deposition of type I 
collagen was identified at the wound edge and/or at the integration site in all the groups 
(Figure 5.9), suggesting the induction of fibrocartilage. Therefore, another contributing 
factor to the superior composite integration in the case in which a fibrous capsule was 
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included may be the accumulation of thicker collagen fibrils at the construct-cartilage 
interface (Figure 5.11). This observation is confirmed by Moretti et al. who found that 
more mature (thicker) collagen fibrils were only present within the narrowest interfacial 
regions (Moretti, Wendt et al. 2005). Interestingly, the newly synthesized collagen fibrils 
at the integration sites were approximately aligned in the same direction along the wound 
edge (Figure 5.10). One possible explanation is that the initial gaps between the 
implanted constructs and the adjacent native tissues were too wide for cells to cross so 
they had to migrate along the construct edges and simultaneously laid down new matrix 
components to narrow the fissures. The formation of denser and thicker collagen fibrils in 
the CC composites can be attributed to the combined effects of increased cell density and 
a decreased GAG content that are usually determined in the fibrous capsule (Figure 5.6). 
In the cartilage-cartilage composites, such collagen organization was not found and most 
interfacial areas remained void or contained sparse and scattered ECM molecules (images 
not shown). 
In this chapter, we report experiments that were designed to investigate the 
potential roles of a solid fibrous capsule in the development of tissue-engineered cartilage 
by employing two types of constructs with comparable bulk properties, but significantly 
divergent tissue morphologies. Our results suggest that the presence of a fibrous capsule 
potentially decreases tissue homogeneity of engineered cartilage such that the inner cores 
of the CC constructs demonstrate relatively compromised biochemical and mechanical 
properties. In contrast, the CF constructs exhibit greater material homogeneity and have 
stronger inner cores. Moreover, the inclusion of a fibrous capsule in engineered tissues 
effectively improves early (4 weeks) cartilage tissue integration. This outcome can result 
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from the combined effects of (1) the absence of GAG molecules and (2) increased cell 
contents in the capsule area and (3) deposition of thicker collagen fibrils at the integration 
site. Although the in-vitro cartilage explant model utilized in the current study represents 
a powerful template to evaluate and manipulate variables contributing to tissue 
integration, the findings will ultimately need to be verified in controlled in-vivo systems. 
In conclusion, the work summarized in this chapter provides a tool to study capsule 
functions and mechanics and indicates that the fibrous capsule is essential to enhance 
construct integration with native cartilage tissues even though its presence reduces 
construct homogeneity. Therefore, further refinement of bioprocessing conditions is 
necessary in order to maximize tissue homogeneity of engineered cartilage while 
















CONCLUSIONS AND FUTURE WORK 
  
 
Tissue engineering is a multidisciplinary subject that bridges engineering, 
material science, biology and medicine, all of which together hold promise for generation 
of functional and implantable substitutes to repair or restore damaged tissues including 
articular cartilage. Continuous refinement of tissue engineering strategies is required to 
optimize bioprocessing conditions for achievement of viable tissue replacements. The 
wavy-walled bioreactor (WWB, Chapter 2) employed here not only provides a 
hydrodynamic environment for cultivation of engineered constructs but also enables 
researchers to manipulate and study environmental factors that are vital to cultured cells 
and tissues. The type I collagen-based fibrous capsule which resembles fibrocartilage 
(Guh, Yang et al. 1996; Darling and Athanasiou 2005) represents a unique characteristic 
of tissue-engineered cartilage and is likely to be modulated by the synergy between 
environmental factors, yet its formation and function have not been thoroughly explored. 
In this dissertation, a better understanding of (1) the complex interplay between 
hydrodynamic forces and soluble biochemical cues in the capsule formation and (2) the 
roles of the capsule in the development of tissue-engineered cartilage was sought while 
the effort to systematically establish a novel low-serum/growth factor supplementation 
protocol for the WWB system was obtained. The findings, conclusions and 





6.1 Specific Aim 1 
6.1.1 Findings 
Chapter 3 summarizes the study that was aimed to evaluate (1) the feasibility of 
reduced serum contents to support hydrodynamic cultivation of tissue-engineered 
constructs and (2) the serum effects on the capsule formation. The results indicated that a 
serum-free ITS-supplemented culture medium was sufficient to maintain neocartilage 
quality under loading-free conditions. The presence of shear-sensitive serum constituents, 
however, may be required in order for cultured chondrocyte-seeded PGA scaffolds to 
benefit from turbulent flow-induced hydrodynamic forces. The evidence suggests that 
fluid shear stress is likely to stimulate chondrocyte growth and cartilage development via 
mediation of shear-sensitive soluble molecules such as TGF-β (Malaviya and Nerem 
2002). On the other hand, the serum concentration was recognized to be a key factor that 
activated and modulated the fibrotic process of the capsule formation. Based on our data, 
2% FBS or higher seemed to secure the capsule formation while fluid shear stress further 
promoted its development. The study outlined in Chapter 3 substantiates the importance 
of shear-sensitive signals derived from serum constituents in the development of 
hydrodynamically engineered cartilage and distinguishes potential mechanisms that drive 
the capsule formation and development.  
 
6.1.2 Limitations and Future Work 
In Specific Aim 1, the serum concentration was reduced by 80% (from 10% to 
2%) to produce hydrodynamic constructs morphologically, compositionally and 
mechanically comparable to the traditional high-serum constructs. While minimized, 
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uncertain soluble constituents (present in 2% FBS) still exist in culture, which persists as 
one of the major concerns of this study. The developed approach combining a low-serum 
content and an FBS substitute, ITS, represents a chemically more reliable, but still 
somewhat undefined media preparation protocol. A solution to this issue is to uncover the 
unidentified shear-sensitive and fibrosis-promoting soluble molecules that contribute to 
neocartilage development and capsule formation, respectively, by decomposition of 
serum constituents using ELISA, protein microarray or mass spectrometry. The process 
that decouples serum components is expected to be time-consuming and costly. However, 
it will be greatly helpful to formulate a chemically defined serum-free medium suitable 
for hydrodynamic cultivation of tissue-engineered cartilage. 
 
6.2 Specific Aim 2 
6.2.1 Findings 
Chapter 4 describes the experiments that were designed to investigate (1) the 
feasibility of transient exposure of hydrodynamically engineered cartilage to exogenous 
growth factors and (2) the effects of shear-sensitive growth factors on the capsule 
formation. Two shear-sensitive soluble molecules, TGF-β1 (fibrosis-promoting factor) 
and IGF-1 (non-fibrosis-promoting factor) (Ohno, Cooke et al. 1995; Sakai, Mohtai et al. 
1998; Negishi, Lu et al. 2001; Malaviya and Nerem 2002; Jin, Emkey et al. 2003; Lau, 
Kapur et al. 2006) were employed in this study. The key findings derived from this part 
of the thesis are as follows. Based on the low-serum culture medium formulated in 
Chapter 3, transient exposure to either TGF-β1 or IGF-1 potently supported and 
facilitated the development of hydrodynamic constructs, suggesting that the reduced 
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supplementation of shear-sensitive exogenous growth factors is an effective and 
economical tissue engineering strategy. One of the potential contributing mechanisms to 
the “transient” phenomenon, which is related to homeostasis between growth factor 
secretion and receptor expression by cultured chondrocytes, was proposed.  
The capsule formation in hydrodynamic cultures was identified as a biphasic 
fibrotic process in response to concentrations of fibrosis-promoting molecules (i.e. TGF-
β1 in this study). The elimination of the fibrous capsule from hydrodynamic constructs 
due to treatment with TGF-β1 (10 ng/mL) may be attributed to a combination of several 
reasons. For example, when elongated fibroblast-like chondrocytes occupying the capsule 
region were exposed to exogenous TGF-β1 at the specified concentration, they tended to 
suppress the expression of the corresponding receptors to block themselves from further 
receiving TGF-β signals and thus stopped acting like fibroblasts, which potentially 
impeded the capsule formation. Given that aggregation of fibroblasts is found to promote 
fibrosis of different tissues and organs (Katzenstein 1985; Carthew, Edwards et al. 1991), 
the disappearance of the capsule may also result from a reduced level of cell 
accumulation at the periphery of the TGF-β1 constructs.  
Modulation of intracellular Smad proteins associated with TGF-β signaling by 
TGF-β and Fluid shear stress was also uncovered. Specifically, both Smad2 and Smad3 
pathways were potently promoted by TGF-β or fluid shear stress while TGF-β reversely 
regulated Smad2 and Smad3 phosphorylation under hydrodynamic stimuli partially via 
Smad7. In combination with analyses of tissue morphology and properties of engineered 
cartilage, the Smad results provide valuable insights which suggest that Smad2 and 
Smad3 possibly dominate chondrocyte- and fibroblast-specific phenotypes, respectively, 
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in articular chondrocytes and that controlled neocartilage development and capsule 
formation may be achieved through manipulation of intracellular signals. 
The work outlined in Chapter 4 further combines the developed low-serum ITS-
supplemented culture medium with the use of exogenous growth factors in a cost-
efficient manner. The utilization of transient growth factor supplementation is expected to 
be applicable to other shear-sensitive growth factors that are vital to articular 
chondrocytes, such as BMPs (Khalafi, Schmid et al. 2007; Kim and Im 2008; Shen, Wei 
et al. 2008; An, Cheng et al. 2010). In addition, the creation of a robust capsule-free 
engineered construct by using the WWB system coupled with TGF-β1 will greatly 
benefit future studies (including the one summarized in Chapter 5) and tissue engineering 
applications. 
 
6.2.2 Limitations and Future Work 
In Specific Aim 2, the understanding of the “transient” phenomenon, capsule 
formation and Smad regulation is confined to one fluid agitation rate and one 
concentration for each growth factor, which needs to be broadened further. Results 
obtained from experiments that evaluate multiple combinations of fluid shear stress 
magnitude and growth factor concentration can be incorporated into the previously 
developed artificial neural network mathematical model (Bilgen, Uygun et al. 2009) to 
optimize the WWB culture conditions and to predict the capsule formation. An in-depth 
analysis of Smad expression by cells populating in different regions in a construct (for 
example, capsule versus core) needs to be carried out in order to confirm the diverse roles 
Smad2 and Smad3 may play in articular chondrocytes and their relation to cartilage 
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matrix production and capsule formation. In addition, the responses of Smad2, Smad3 
and Smad7 signaling to fluid shear stress and TGF-β or other soluble molecules can also 
be acquired by utilizing simple perfusion systems (Yeatts and Fisher 2010) or 
microfluidic hydrogel devices (Choi, Cabodi et al. 2007; Ling, Rubin et al. 2007; 
Borenstein, Megley et al. 2010) that provide controllable fluid shear and require 
relatively small amounts of growth factors and medium supplements.  
 
6.3 Specific Aim 3 
6.3.1 Findings 
Chapter 5 elucidates the potential effects of the presence of the capsule on tissue 
homogeneity of engineered cartilage and on construct capability to integrate with native 
cartilage. One of advantages of the use of the WWB system in combination with the 
growth factor supplementation protocol developed in Chapter 4 is to fabricate two types 
of cartilage constructs that have similar biochemical and mechanical properties, but 
exhibit different tissue morphologies. This benefit allows us to thoroughly focus on the 
capsule functions. In the evaluation of tissue homogeneity, the difference in tissue 
biochemical and mechanical properties between inner core and outer annulus of 
engineered cartilage was found to be relatively minor in the CF constructs. In contrast, 
the outer annuli of the CC constructs had significantly higher ECM contents and stronger 
mechanical strength in comparison with their own inner cores. On a per cell basis, the 
chondrocytes in the inner cores of the CC constructs exhibited weaker matrix synthetic 
potential than those in the outer annuli. The evidence suggests that the fibrous capsule 
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may block the cells in the interiors of the constructs from receiving medium supplements 
and nutrients and thereby hinders the development of the inner cores. 
Analyses of tissue integration revealed that constructs with a fibrous outer capsule 
had a stronger integrative affinity to native cartilage than those without a capsule while 
the poorest integration was found at the cartilage-cartilage interface. The improved 
integration of the CC constructs with the surrounding native tissues is likely to be 
attributed to a combination of (1) the absence of GAG molecules in the capsule which 
enhances the initial binding of the constructs to native cartilage, (2) a higher number of 
proliferating cells in the capsule which leads to increased sprouting and production of 
new matrix components in the interfacial zone and (3) the deposition of thicker and 
denser collagen fibrils at the integration site. Altogether, the presence of the fibrous 
capsule at the periphery of engineered constructs effectively accelerates early (4 weeks) 
cartilage tissue integration. Collectively, we have demonstrated that tissue-engineered 
cartilage with a fibrous capsule has a better integration capability, but compromised 
material homogeneity. Thus, further investigations are needed to find the balance 
between the two indicators. 
 
6.3.2 Limitations and Future Work 
In Specific Aim 3, tissue homogeneity of engineered cartilage was determined by 
quantifying variations between inner cores and outer annuli of constructs. This analysis 
allowed us to evaluate the bulk properties of construct inner cores for their potential use 
in future applications, but might only provide a rough estimate of material homogeneity. 
Therefore, a more thorough investigation should involve serial dissections of a construct 
135 
 
along the radial direction (Figure 6.1) to give a better definition of tissue homogeneity. 
Similar analyses should also be applied to assessment of variations in the axial direction 
to obtain a complete understanding of the capsule effects on distribution of ECM 
components within an engineered tissue. Homogeneity and distribution of tissue solid 
matrix can also be detected using other techniques such as micro-computed tomography 
(Case, Duty et al. 2003; Xie, Lin et al. 2009). Another limitation of this aim is the short 
culture period (4 weeks) applied to the tissue integration study, which resulted in poor 
integration detected in all the groups (large gaps still remained). This shortcoming can be 
overcome by extending the incubation time (Peretti, Zaporojan et al. 2003) or exposing 
hybrid composites to dynamic culture conditions (Obradovic, Martin et al. 2001). Either 
approach has been shown to greatly improve the adhesive strength at the integration site. 
Finally, although the cartilage explant model employed in the present work represents a 
useful tool to study cartilage tissue integration through manipulation of environmental 
parameters, it is also important to validate the findings reported here in controlled in-vivo 
 
 
Figure 6.1 Multi-layered evaluation of tissue homogeneity. The method used in 
the current work to determine tissue homogeneity of engineered cartilage is based on a 
2-layered approach (inner core versus outer annulus). A multi-layered analysis should 





























systems in order to determine the long-term stability of the capsule-improved cartilage 
integration. Available animal models include mice and rats (non-load-bearing) or mini-
pigs and goats (load-bearing) (Chu, Szczodry et al. 2009). 
 
6.4 Conclusions 
This dissertation work is built upon the use of juvenile cells isolated from bovine 
donors, given that the access to human primary chondrocytes is limited and passaged 
chondrocytes constantly experience rapid phenotypic changes (Darling and Athanasiou 
2005; Otero, Favero et al. 2012). While it may not be ideal, the use of these animal cells 
does enable researchers to study different environmental factors and conditions that can 
contribute to repair or regeneration of various tissues. Clinically however, investigations 
utilizing human cells will be required to verify the conclusions drawn from animal cells 
and studies. Additionally, general considerations that have to be kept in mind include 
factors like age (Tran-Khanh, Hoemann et al. 2005) and health status (Mohtai, Gupta et 
al. 1996; Fukui, Zhu et al. 2003) of donors that are also likely to influence the 
experimental outcome. 
In this dissertation, we have demonstrated that tissue morphology and properties 
of engineered constructs can be manipulated by altering environmental factors such as 
loading conditions and biochemical parameters. A chemically reliable media preparation 
protocol involving the use of a low serum concentration and transient growth factor 
supplementation has been established for the WWB cultivation of tissue-engineered 
cartilage, which is also expected to be applicable to other types of load-bearing tissues. 
The overall significance of this thesis work consists in characterization of capsule 
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formation, development and function. The findings suggest the need to incorporate the 
fibrous capsule into the design of neocartilage and provide important insights for future 
tissue engineering studies aimed to optimize bioprocessing conditions for the 




























1. Diluted tris-EDTA buffer 
 Dilute 20X tris-EDTA solution to 1X with deionized water. 
 
2. PicoGreen working solution 
 Mix 100 μL of PicoGreen stock solution with 19.9 mL of diluted tris-EDTA 
buffer. 
 Avoid placing the mixture in direct light. 
 The solution is stable for 1 day. 
 
3. DNA working standards 
 Dilute 30 μL of Lambda DNA standard with 1.47 mL of diluted tris-EDTA 
buffer (DNA stock solution: 2 μg/mL). 
 Prepare the working standards based on the table below (Table A.1). 
DNA stock volume 
(μL) 




1000 0 2 
500 500 1 
300 700 0.6 
100 900 0.2 
10 990 0.02 
1 999 0.002 
0 1000 0 
 
Assay Procedure 
1. Dilute samples and controls with diluted tris-EDTA buffer (dilution factor = 1:60 ~ 
1:120). 
 
2. Add 100 μL of working standards, diluted samples and controls to each well of a 96-
well plate in duplicate.  
 
3. Add 100 μL of PicoGreen working solution to each well. 
 
4. Incubate the plate in the dark at room temperature for 5 minutes. 
 
5. Read the plate using a fluorescence plate reader with an excitation wavelength of 480 





1. DMMB dye solution 
 Add 16 mg of DMMB to 5 mL of 100% ethanol and mix the solution for at 
least 12 hours until the DMMB is fully dissolved. 
 Mix the dissolved DMMB solution with 950 mL of deionized water, 8.7 mL 
of 1 N hydrogen chloride, 3.04 g of glycine and 2.367 g of sodium chloride. 
 Adjust pH to 3.0 using 1 N hydrogen chloride or sodium hydroxide. 
 Thoroughly mix using a stir bar. 
 Measure the absorbance of the DMMB dye solution using a 
spectrophotometer. 
 0.30 < A525 < 0.34 
 1.25 < A592 < 1.33 
o If the readings are too high, dilute the dye solution with 
deionized water. 
o If the readings are too low, add one grain of DMMB to the dye 
solution and stir it for 12 hours. 
o Re-measure the absorbance. 
 Store in the dark for up to 3 months. 
 
2. PBS-EDTA-cysteine solution 
 Dissolve 0.372 g of EDTA and 0.175 g of cysteine in 100 mL of PBS. 
 The solution is stable for 1 day. 
 
3. Chondroitin sulfate working standards 
 Dissolve 50 mg of chondroitin sulfate in 10 mL of PBS-EDTA-cysteine 
solution (chondroitin sulfate solution: 5 mg/mL). 
 Mix 2 mL of chondroitin sulfate solution with 48 mL of PBS-EDTA-cysteine 
solution (chondroitin sulfate stock solution: 200 μg/mL). 
 Prepare the working standards based on the table below (Table A.2). 
Chondroitin sulfate 





0 1000 0 
125 875 25 
250 750 50 
375 625 75 
500 500 100 
625 375 125 
750 250 150 
875 125 175 







1. Dilute samples and controls with PBS (dilution factor = 1:15 ~ 1:50). 
 
2. Add 8 μL of working standards, diluted samples and controls to each well of a 96-
well plate in duplicate.  
 
3. Add 200 μL of DMMB dye solution to each well. 
 
4. Incubate the plate at room temperature for 2 minutes. 
 
5. Read the plate using a spectrophotometer at 525 nm. 
 




















A.3 Total Collagen 
Reagent Preparation 
1. Assay stock buffer 
 Dissolve 25.217 g of monohydrate citric acid and 60 g of sodium acetate 
trihydrate in 423.17 mL of deionized water. 
 Add 6 mL of acetic acid, 70.83 mL of 6 N sodium hydroxide and 5 drops of 
toluene to the solution. 
 
2. Assay working buffer 
 Mix 10 mL of deionized water, 15 mL of isopropanol and 50 mL of assay 
stock buffer together. 
 Adjust pH to 6.0 using 1 N hydrogen chloride or sodium hydroxide. 
 Store at room temperature for up to several months. 
  
3. Chloramine-T solution 
 Mix 2 mL of deionized water, 2 mL of isopropanol and 16 mL of assay 
working buffer together. 
 Dissolve 0.282 g of Chloramine-T in the mixture. 
 Store in the dark at 4˚C for up to 1week.  
 
4. pDAB solution 
 Dissolve 3 g of pDAB in 12 mL of isopropanol. 
 Add 5.2 mL of 60% perchloric acid slowly. 
 Add 2.8 mL of n-propanol to the mixture. 
 The solution is stable for 1 day. 
 
5. Hydroxyproline working standards 
 Dissolve 10 mg of hydroxyproline in 100 mL of deionized water 
(hydroxyproline stock solution: 100 μg/mL). 
 Prepare the working standards based on the table below (Table A1.3). 
Hydroxyproline stock 
volume (μL) 




0 1000 0 
100 900 10 
200 800 20 
300 700 30 
400 600 40 
500 500 50 
600 400 60 
700 300 70 
800 200 80 
900 100 90 





1. Take 120 μL of working standards, samples and controls and place them in glass test 
tubes. 
 
2. Add 120 μL of 12 N hydrogen chloride to each tube and vortex. 
 
3. Cover the tubes with marbles and incubate them at 100˚C for 3 hours, followed by an 
18-hour incubation at 95˚C using an oven in a fume hood. 
 
4. Cool samples at room temperature. 
 
5. Re-suspend the dried standards, samples and controls in 1 mL of deionized water and 
vortex. 
 
6. Dilute samples and controls with deionized water (dilution factor = 1:2 ~ 1:10). 
 
7. Add 50 μL of standards and diluted samples and controls to each well of a 96-well 
plate in duplicate. 
 
8. Add 50 μL of chloramine-T solution to each well and incubate the plate in the dark at 
room temperature for 20 minutes. 
 
9. Add 50 μL of pDAB solution to each well and incubate the plate in water bath at 
60˚C for 30 minutes. 
 
10. Cool the plate at room temperature for 15 minutes. 
 
11. Read the plate using a spectrophotometer at 550 nm. 
 











A.4 Western Blot 
Reagent Preparation 
1. 1X running buffer 
 Dissolve 10 g of sodium dodecyl sulfate, 30 g of tris base and 144 g of glycine 
in 1 L of deionized water. 
 Adjust pH to 8.3 using 1 N hydrogen chloride or sodium hydroxide (10X 
running buffer). 
 Dilute 10X running buffer to 1X with deionized water. 
 
2. 1X transfer buffer 
 Dissolve 30 g of tris base and 144 g of glycine in 1 L of deionized water. 
 Adjust pH to 8.3 using 1 N hydrogen chloride or sodium hydroxide (10X 
transfer buffer). 
 Dilute 10X transfer buffer to 1X with deionized water. 
 
3. Diluted blocking buffer 
 Mix Li-Cor blocking solution with PBS at a ratio of 1:2. 
 
4. Diluted primary and secondary antibodies 
 Mix primary antibodies with diluted blocking buffer at a desired ratio. 
 Mix secondary antibodies (IRDye 800CW) with diluted blocking buffer at a 
ratio of 1:5000.  
 
Assay Procedure 
1. Add 20 µg of total proteins to 2 µL of 5X tracking dye solution and balance with lysis 
buffer to obtain a final volume of 10 µL. 
 
2. Load 10 µL of protein ladder and diluted samples into each channel of a 10% 
polyacrylamide gel and fill empty channels with 1X tracking dye solution diluted in 
lysis buffer. 
 
3. Run electrophoresis at 100 volts in 1X running buffer for at least 1 hour until the dye 
reaches the bottom of the gel. 
 
4. Rinse the gel with 1X transfer buffer. 
 
5. Soak 3 extra thick filter papers and 1 nitrocellulose membrane in 1X transfer buffer 
for 20 minutes. 
 
6. Transfer proteins from the gel to the membrane at 10 volts for 30 minutes. 
 





8. Incubator the membrane with diluted primary antibodies at 4˚C overnight under 
shaking. 
 
9. Wash the membrane with 1X PBS/Tween-20 buffer diluted with deionized water at 
room temperature under shaking (3 times, 20 minutes each). 
 
10. Incubate the membrane with diluted secondary antibodies in the dark at room 
temperature for 1 hour under shaking. 
 
11. Wash the membrane with 1X PBS/Tween-20 buffer diluted with deionized water at 
room temperature under shaking (3 times, 20 minutes each). 
 





















HISTOLOGY AND IMMUNOHISTOCHEMISTRY 
 
 
B.1 Hematoxylin and Eosin 
Table B.1 Hematoxylin and Eosin Staining Protocol 
Step Reagent Time (min : sec) 
1 Distilled water 01 : 00 
2 Hematoxylin 00 : 45 
3 Distilled water 01 : 00 
4 1% acid alcohol 00 : 01 
5 Distilled water 01 : 00 
6 Scott’s 00 : 30 
7 Deionized water 02 : 00 
8 95% alcohol 01 : 00 
9 Eosin, alcoholic 03 : 00 
10 95% alcohol 00 : 30 
11 100% alcohol 01 : 00 
12 100% alcohol 02 : 00 
13 100% alcohol 02 : 00 
14 Xylene substitute 02 : 00 
15 Xylene substitute 02 : 00 
16 Xylene 01 : 00 
 
Results: 











B.2 Safranin-O and Fast Green 
Table B.2 Safranin-O and Fast Green Staining Protocol 
Step Reagent Time (min : sec) 
1 Distilled water 01 : 00 
2 Weigert’s hematoxylin working solution 02 : 00 
3 Distilled water 05 : 00 
4 0.2% aqueous fast green 01 : 00 
5 1% acetic acid 00 : 03 
6 0.5% safranin-O 05 : 00 
7 95% alcohol 01 : 00 
8 100% alcohol 01 : 00 
9 100% alcohol 01 : 00 
10 100% alcohol 01 : 00 
11 Xylene substitute 01 : 00 
12 Xylene substitute 01 : 00 
13 Xylene 01 : 00 
 
Results: 



























B.3 Masson’s Trichrome 
Table B.3 Masson’s Trichrome Staining Protocol 
Step Reagent Time (min : sec) 
1 Distilled water 01 : 00 
2 Bouin’s solution (56˚C) 60 : 00 
3 Distilled water 05 : 00 
4 Weigert’s hematoxylin working solution 02 : 00 
5 Distilled water 05 : 00 
6 Biebrich scarlet-acid fuchsin solution 05 : 00 
7 Distilled water 01 : 00 
8 Phosphomolybdic-phosphotungstic acid 01 : 00 
9 2.5% aniline blue 05 : 00 
10 1% acetic acid 05 : 00 
11 95% alcohol 01 : 00 
12 100% alcohol 01 : 00 
13 100% alcohol 01 : 00 
14 100% alcohol 01 : 00 
15 Xylene substitute 01 : 00 
16 Xylene substitute 01 : 00 
17 Xylene 01 : 00 
 
Results: 






















1. Sodium citrate solution 
 Dissolve 2.94 g of sodium citrate in 1 L of deionized water. 
 Adjust pH to 6.0 using 1 N hydrogen chloride or sodium hydroxide. 
 Add 500 µL of 20X PBS/Tween-20 solution. 
 Store at room temperature for 3 months or at 4˚C for longer storage. 
 
2. 0.3% hydrogen peroxide solution 
 Dilute 1 mL of 3% hydrogen peroxide with 9 mL of DI water. 
   
3. Blocking buffer 
 Mix 150 µL of (goat) serum with 10 mL of PBS. 
 
4. Diluted primary and secondary antibodies 
 Mix primary antibodies with blocking buffer at a desired ratio. 
 Mix avidin-biotinylated secondary antibodies with blocking buffer at a ratio of 
1:200. 
 
5. Avidin-biotin complex (ABC) 
 Add 100 µL of avidin and 100 µL of biotinylated horseradish peroxidase to 10 
mL of PBS and incubate for 30 minutes before use. 
 
6. Diaminobenzidine working solution 
 Add 100 µL of diaminobenzidine stock solution and 50 µL of hydrogen 
peroxide to 1 mL of PBS. 
 Avoid placing the mixture in direct light. 
 
Staining Procedure 
1. Rinse sectioned samples with deionized water for 5 minutes. 
 
2. Incubate sections with 0.3% hydrogen peroxide solution at room temperature for 30 
minutes. 
 
3. Rinse sections 2 times with PBS, 2 minutes each. 
 
4. Antigen retrieval 
 Pre-heat sodium citrate solution to 100˚C. 
 Incubate sections with 100˚C sodium citrate solution for 30 minutes. 
 Cool sections at room temperature for 20 minutes. 
 
5. Rinse sections 2 times with PBS, 2 minutes each. 
 
6. Incubate sections with blocking buffer at room temperature for 20 minutes and 




7. Incubate sections with diluted primary antibodies at 4˚C for 17 hours. 
 
8. Rinse sections 2 times with PBS, 2 minutes each. 
 
9. Incubate sections with diluted secondary antibodies at room temperature for 30 
minutes. 
 
10. Rinse sections 2 times with PBS, 2 minutes each. 
 
11. Incubate sections with ABC solution at room temperature for 30 minutes. 
 
12. Rinse sections 2 times with PBS, 2 minutes each. 
 
13. Incubate sections with diaminobenzidine working solution at room temperature for 12 
minutes or until optimal staining developed. 
 






















C.1 Scanning Electron Microscopy 
Reagent Preparation 
1. 0.1 M cacodylic acid buffer 
 Dissolve 13.8 g of cacodylic acid in 1 L of deionized water. 
 Adjust pH to 7.3 using 1 N hydrogen chloride or sodium hydroxide. 
 
2. Fixing solution 
 Mix 10 mL of 25% glutaradehyde with 115 mL of 0.1 M cacodylic acid buffer. 
 
Sample Processing Procedure 
1. Wash samples 3 times with 0.1 M cacodylic acid buffer, 10 minutes each. 
 
2. Incubate samples with fixing solution at 4˚C for 48 hours. 
 
3. Rinse samples 3 times with 0.1 M cacodylic acid buffer, 25 minutes each. 
 
4. Rinse samples 3 times with deionized water, 20 minutes each. 
 
5. Dehydrate samples in a graded ethanol series based on the table below (Table C.1). 
Step Reagent Time (min) 
1 30% ethanol 25 
2 50% ethanol 25 
3 75% ethanol 25 
4 95% ethanol 25 
5 95% ethanol 25 
6 100% ethanol 25 
7 100% ethanol 25 
8 100% ethanol 25 
 
6. Dry samples in a critical point dryer. 
 
7. Mount the dried samples onto aluminum stubs with carbon stickers. 
 







C.2 Transmission Electron Microscopy 
Reagent Preparation 
1. 0.1 M cacodylic acid buffer 
 Dissolve 13.8 g of cacodylic acid in 1 L of deionized water. 
 Adjust pH to 7.3 using 1 N hydrogen chloride or sodium hydroxide. 
 
2. Primary fixing solution 
 Mix 10 mL of 25% glutaradehyde with 115 mL of 0.1 M cacodylic acid buffer. 
 
3. Secondary fixing solution 
 Mix 2%, w/v osmium tetroxide diluted with deionized water with 0.1 M 
cacodylic acid buffer at a ratio of 1:1. 
 
Sample Processing Procedure 
1. Wash samples 3 times with 0.1 M cacodylic acid buffer, 10 minutes each. 
 
2. Incubate samples with primary fixing solution at 4˚C for 48 hours. 
 
3. Rinse samples 3 times with 0.1 M cacodylic acid buffer, 15 minutes each. 
 
4. Post-fix samples in secondary fixing solution at room temperature for 2 hours. 
 
5. Rinse samples with 0.1 M cacodylic acid buffer for 20 minutes. 
 
6. Rinse samples 4 times with deionized water, 15 minutes each. 
 
7. Incubate samples with 0.5% uranyl acetate diluted with 0.1 M cacodylic acid buffer 
in the dark for 1 hour. 
 
8. Rinse samples 3 times with deionized water, 10 minutes each. 
 
9. Dehydrate samples based on the table below (Table C.2). 
Step Reagent Time (min) 
1 30% ethanol 20 
2 50% ethanol 20 
3 75% ethanol 20 
4 95% ethanol 20 
5 95% ethanol 20 
6 100% ethanol 20 
7 100% ethanol 20 
8 100% acetone 10 
9 100% acetone 10 
10 100% propylene oxide 15 




10. Infiltrate samples with Epon/Araldite-DDSA-DMP30 (EA mixture). 
 Incubate samples with EA mixture and propylene oxide mixed at a ratio of 1:1 
for 2 hours. 
 Incubate samples with fresh 100% EA mixture for 2 hours. 
 Incubate samples with fresh 100% EA mixture for an additional 2 hours. 
 
11. Embed samples in 100% EA mixture at 60˚C for 24 hours. 
 
12. Section resin blocks in 60-nm thick slices. 
 
13. Mount slices onto meshed gilder grids. 
 
14. Incubate grids with 5% methanolic uranyl acetate for 5 minutes. 
 
15. Rinse grids 2 times with deionized water, 1 minute each. 
 
16. Incubate grids with Reynold's lead citrate for 8 minutes. 
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